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Abstract

There is a paucity of research on the risk for sexually transmitted infections
(STIs) and sexual behavior among general populations of men. Research with
male populations predominantly has focused on those subgroups considered to
be at high risk of disease transmission, such as gay and bisexual men, injection
drug users, and adolescents/young adults. Considerably fewer studies have
examined factors among men, in general, and heterosexual men, specifically.
Therefore, I conducted analyses with a cross-national sample of adult, sexually
active men in Brazil, Mexico, and the United States to investigate sexual
behaviors and risk factors associated with the human papillomavirus (HPV) and
other STIs. The research questions were: 1) How does sexual risk differ among
men residing in Brazil, Mexico, and the US by age cohort?; 2) Do men’s sexual
behaviors change after being tested for HPV and other STIs?; and 3) Do men’s
sexual behaviors change after being informed of diagnosis with HPV and other
STIs? These research questions were explored through a quantitative
assessment of secondary data collected through a risk factor questionnaire
administered using computer assisted self-interviewing. The study findings
underscore the need for public health interventions to address STI risk and
transmission among men across the lifespan. Additionally, this study revealed
the potential of STI testing as an effective strategy to reduce sexual risk-taking
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among men. While this research identifies key issues of importance in improving
men’s sexual health, additional research is needed to provide an enhanced
contextual understanding of socio-cultural, interpersonal, and community level
factors that affect sexual behaviors and decision-making among men.
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Section One:
Introduction

Dissertation Format
This dissertation is presented in a manuscript-style format. Instead of the
traditional format of chapters featuring an introduction, literature review, methods,
results, and discussion, this dissertation is divided into sections. The first section
provides the Introduction, which is similar to the traditional chapter one, including
a problem statement, statement of the study purpose, research questions, and
significance of the study. However, the following two sections – sections two and
three – represent discrete manuscripts, each of which includes introduction,
methods, results, and discussion sections. The final section is a synthesis of the
findings, discussion, and conclusions. Although the dissertation is structured as
two separate manuscripts, they serve as phases of one comprehensive study.

Statement of the Problem
With the recent launch of vaccines from two different pharmaceutical
companies for the most common oncogenic strains of the Human Papillomavirus
(HPV) (American Cancer Society, 2007; Barr & Tamms, 2007; Bharadwaj,
Hussain, Nasare & Das, 2009; Giuliano & Salmon, 2008; World Health
Organization Information Centre on HPV and Cervical Cancer, 2007a, 2007b;
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World Health Organization, 2006), the infection and its related disease in women,
cervical cancer, have garnered much notoriety (Calloway, Jorgensen, Saraiya &
Tsui, 2006). In light of these advancements, within the last decade, numerous
studies have been conducted on HPV and cervical cancer among women to
investigate knowledge, beliefs, and attitudes regarding HPV and cervical cancer,
HPV vaccine acceptance, barriers and intentions for cervical cancer screening,
and risk factors associated with HPV and cervical cancer (Austin, Ahmad,
McNally & Stewart, 2002; Basu et al., 2006; Bazargan, Bazargan, Farooq &
Baker, 2004; Blomberg, Ternestedt, Törnberg & Tishelman, 2008; Bradley et al.,
2006; Byrd, Peterson, Chavez & Heckert, 2004; Castellsagué, Schneider,
Kaufmann & Bosch, 2009; Chew-Graham, Mole, Evans & Rogers, 2006; Fiebig,
Haas, Hossain, Street & Viney, 2009; Frega et al., 2003; Guilfoyle, Franco &
Gorin, 2007; Jennings-Dozier & Lawrence, 2000; Maissi et al., 2004; Maissi et
al., 2005; Merchant, Gee, Bock, Becker & Clark, 2007; Moreira, de Oliveira,
Ferraz et al., 2006; Moreira, de Oliveira, Neves et al., 2006; Mortensen & Adeler,
2010; Oscarsson, Wijma & Benzein, 2008; Philips, Johnson, Avis & Whynes,
2003; Pitts & Clarke, 2002; Pitts, Dyson, Rosenthal & Garland, 2007; Stark et al.,
2008; Swancutt, Greenfield & Wilson, 2008; Tiro, Meissner, Kobrin & Chollette,
2007; Vanslyke et al., 2008). However, the impact of HPV on men’s health and
factors associated with HPV infection among men are not widely understood.
While there is a growing interest in the issue of HPV among men, it remains
relatively unexplored (Daley, Marhefka, Buhi, Vamos, Hernandez & Giuliano,
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2010; Daley et al., 2011; Dunne, Nielson, Stone, Markowitz & Giuliano, 2006;
Giuliano, 2007; Giuliano, Tortolero-Luna et al., 2008).
HPV is a sexually transmitted virus that is passed to other persons
through skin-to-skin and genital contact (Centers for Disease Control and
Prevention, 2010). It is estimated that at least half of all people who have had
sex will acquire an HPV infection at some point in their lifetime (Centers for
Disease Control and Prevention, 2010; Vetter & Geller, 2007). HPV infection is
considered the most common sexually transmitted infection, with an estimated
6.2 million persons newly infected annually in the United States (Colon-Lopez,
Ortiz & Palefsky, 2010; Dunne et al., 2006; Liddon, Hood, Wynn & Markowitz,
2010; Nielson et al., 2007; Nielson et al., 2010). According to the World Health
Organization, the global prevalence of HPV infection is estimated to be between
nine and thirteen percent, which is equivalent to approximately 630 million people
(Colon-Lopez et al., 2010). HPV infections are largely asymptomatic and
transient among both men and women (Dunne et al., 2009; Giuliano, 2007;
Nielson et al., 2007), as most HPV infections spontaneously vanish within 2-4
years (Thun, DeLancey, Center, Jemal & Ward, 2010). Consequently,
individuals may unknowingly transmit HPV to their sexual partners (Giuliano,
2007).
To date, there are over 100 known types of HPV (American Cancer
Society, 2006; Bharadwaj et al., 2009; Calloway et al., 2006; Centers for Disease
Control and Prevention, 2007; Colon-Lopez et al., 2010; Donovan, 2004; Dunne
et al., 2006; Mortensen & Larsen, 2010b; Schiffman & Castle, 2003). Of these
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known HPV strains, approximately 30 are associated with anogenital cancer and
are considered high-risk strains (Bharadwaj et al., 2009), whereas 60 are known
to infect the genital tract (Nielson et al., 2007). Additionally, roughly 15 strains
may potentially cause cervical tumors (Lowy, Solomon, Hildesheim, Schiller &
Schiffman, 2008). Due to the numerous strains that infect shared regions,
concurrent infection with multiple types of HPV is common (Nielson et al., 2009).
A population-based study detected multiple HPV types in approximately 20 to
30% of HPV-positive women (Herrero et al., 2000), whereas 27.4% of men in a
multi-site study were observed to have more than one HPV type (Nielson, Harris
et al., 2009).
HPV is strongly associated with the development of invasive cervical,
vulvar, oropharyngeal, and anal cancers in women and penile, oropharyngeal,
and anal cancers in men (Castellsagué, Bosch & Muñoz, 2003; Chaturvedi,
2010; Colon-Lopez et al., 2010; Giuliano, Lazcano-Ponce et al., 2008; Giuliano &
Salmon, 2008; Giuliano, Tortolero-Luna et al., 2008; "Human papillomavirus
infection in men residing in Brazil, Mexico, and the USA," 2008; Lowy et al.,
2008; Lu et al., 2009; Nielson et al., 2007; Parkin & Bray, 2006; Thun et al.,
2010). An estimated 5.2% of cancers worldwide are attributable to infection with
some type of HPV (Chaturvedi, 2010; Colon-Lopez et al., 2010; Parkin & Bray,
2006). Of these cases, the majority (71.8%) is attributable to HPV type 16 and
HPV type 18 (Donovan, 2004; Parkin & Bray, 2006). Epidemiological studies
examining penile and anal HPV infection and cancers in men have shown that
prevalence rates may vary by multiple factors, including country, population
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studied, and area of the genitalia sampled (Colon-Lopez et al., 2010; Hernandez,
Wilkens, Zhu, McDuffie et al., 2008).
HPV is universally recognized as the primary cause of cervical cancer
(American Cancer Society, 2006, 2007; Barr & Tamms, 2007; Bosch, 2003;
Centers for Disease Control and Prevention, 2008; Clifford, Smith, Plummer,
Muñoz & Franceschi, 2003; Cox, 2006; Donovan, 2004; Franco, Duarte-Franco &
Ferenczy, 2001; Nielson, Harris et al., 2009; Pan American Health Organization,
2007; Sankaranarayanan, Budukh & Rajkumar, 2001; Vetter & Geller, 2007;
Walboomers et al., 1999; World Health Organization Information Centre on HPV
and Cervical Cancer, 2007a, 2007b; World Health Organization, 2006).
Approximately 99.7% of cervical cancers are due to infection with some strain of
HPV (Pan American Health Organization, 2004; Walboomers et al., 1999). Two
specific HPV strains, HPV type 16 and HPV type 18, account for more than twothirds of cervical cancer cases worldwide (American Cancer Society, 2006;
Calloway et al., 2006; Centers for Disease Control and Prevention, 2007; Cox,
2006; Lowy et al., 2008; Vetter & Geller, 2007; World Health Organization
Information Centre on HPV and Cervical Cancer, 2007a, 2007b; World Health
Organization, 2006).
HPV prevalence rates among men are a significant public health concern.
A recent systematic literature review found that the HPV prevalence in men was
between 1.3% and 72.9% in studies in which multiple anatomic sites or
specimens were evaluated; more than half (56%) of the studies reported HPV
prevalence of 20% or higher (Dunne et al., 2006). The broad range in

5

prevalence may be attributable to the variance in populations of men studied
(e.g., university students, men in the military, partners of women with cervical
dysplasia, STI clinic attendees) and/or differing methodologies for specimen
collection and testing (Dunne et al., 2006). Most studies of HPV seroprevalence
report information on HPV type 16. Two studies of representative samples of
men in the US reported HPV-16 seroprevalence of 5.1% (95% CI: 4.3-6.1)
(Dunne et al., 2009; Markowitz, Sternberg, Dunne, McQuillan & Unger, 2009)
and 7.9% (95% CI: 6.4-9.8) (Stone et al., 2002). Additionally, assessments of
seropositivity of other common types of HPV in men have recently been
published, asserting rates of 6.3% for HPV-6, 2.0% for HPV-11, and 1.5% for
HPV-18 (Dunne et al., 2009; Markowitz et al., 2009). In an assessment of genital
warts between 1999-2004 in the United States, the prevalence was about 4.0%
among sexually active men aged 18-59 years old (Colon-Lopez et al., 2010).
Previous studies have found that HPV infection is highest among younger
women, less than 30 years, and decreases with escalating age (Baseman &
Koutsky, 2005; Chin-Hong et al., 2004). However, minimal research has
unearthed age-specific information regarding HPV in men.
Sexual behavior has been identified as the primary factor associated with
HPV infection and seropositivity in men across multiple studies (Dunne et al.,
2006; Giuliano, Lazcano-Ponce et al., 2008; Vaccarella et al., 2006). More
specifically, lifetime number of sex partners, number of recent sex partners, age
at first sexual intercourse, condom use, and sexual frequency are significantly
associated with HPV infection in men (Baseman & Koutsky, 2005; Dunne et al.,
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2006; Lu et al., 2009; Nielson et al., 2007). Other identified risk factors for HPV
infection include smoking status, age, educational level, and race/ethnicity (Lu et
al., 2009; Nielson et al., 2007; Nielson et al., 2010). Consistent condom use has
been strongly associated with lower HPV prevalence in men (Nielson et al.,
2010). Additionally, the prevalence of anal HPV infection has been found to be
lower in heterosexual men in their 30s, as compared to younger men (Nyitray et
al., 2008).
HPV infection has frequently been found to co-occur with other sexually
transmitted infections (STIs), such as chlamydia, gonorrhea, syphilis, and herpes
(Kjaer et al., 1997; Soong et al., 2011; Souza, Miller, Nery, Andrade & Asensi,
2009; Trottier & Franco, 2006; Vaccarella et al., 2006). STIs are caused by
various biological organisms that can result in no symptoms, mild or transient
symptoms, or severe, long-term symptoms, including infertility, premature
mortality, and cervical, anal and penile cancers (De Schryver & Meheus, 1990;
Genuis & Genuis, 2004; Gerbase, Rowley, Heymann, Berkley & Piot, 1998;
Mayaud & Mabey, 2004; Mayaud & McCormick, 2001; World Health
Organization, Joint United Nations Programme on HIV/AIDS, 1999; World Health
Organization, 2007). Global estimates for bacterial STIs (e.g., chlamydia,
gonorrhea, syphilis) are greater than 340 million new cases each year (Gerbase
et al., 1998; World Health Organization, Joint United Nations Programme on
HIV/AIDS, 1999; World Health Organization, 2007). Due to the adverse
outcomes associated with STIs, as well as their impact on quality of life, STIs are
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a critical public health concern (Glasier, Gulmezoglu, Schmid, Moreno & Van
Look, 2006; Low et al., 2006).
Unlike other factors associated with increased risk for HPV, male
circumcision has been revealed to be protective for HPV infection (Almonte et al.,
2008; Castellsagué et al., 2002; Castellsagué et al., 2003; Colon-Lopez et al.,
2010; Drain, Halperin, Hughes, Klausner & Bailey, 2006; Giuliano et al., 2009;
Giuliano & Salmon, 2008; Hernandez, Wilkens, Zhu, McDuffie et al., 2008; Lu et
al., 2009; Mcintosh, Sturpe & Khanna, 2008; Murthy & Mathew, 2000; Nielson et
al., 2007; Nielson, Schiaffino, Dunne, Salemi & Giuliano, 2009; Schiffman &
Brinton, 1995; Schiffman & Castle, 2003; Thun et al., 2010; Waller, McCaffery,
Forrest & Wardle, 2004). A recent study reported that circumcised men were
three times more likely to clear infection with any type of HPV (Lu et al., 2009).
Additionally, several studies have reported male circumcision to be associated
with a reduced risk for HPV infection and cervical cancer among female sexual
partners (Almonte et al., 2008; Castellsagué et al., 2003; Drain et al., 2006;
Hernandez, Wilkens, Zhu, McDuffie et al., 2008; Mcintosh et al., 2008; Murthy &
Mathew, 2000; Nielson, Schiaffino et al., 2009; Schiffman & Brinton, 1995;
Schiffman & Castle, 2003; Waller et al., 2004). Another protective factor for HPV
is condom use; however, sexual transmission is still possible through skin-to-skin
contact in the genital area (Colon-Lopez et al., 2010; Mortensen & Larsen,
2010b).
Previous research has indicated that men are an important link in the
epidemiological chain between HPV and cervical cancer among women
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(Agarwal, Sehgal, Sardana, Kumar & Luthra, 1993; Almonte et al., 2008; Bosch
et al., 1996; Campion et al., 1988; Giuliano, 2007; Giuliano, Lazcano-Ponce et
al., 2008; Giuliano & Salmon, 2008; "Human papillomavirus infection in men
residing in Brazil, Mexico, and the USA," 2008; Kyo et al., 1994; Lu et al., 2009;
Muñoz & Bosch, 1997; Schiffman & Brinton, 1995; Schiffman & Castle, 2003;
Waller et al., 2004). Multiple studies have shown that a high proportion of the
male sexual partners of HPV positive women were also HPV positive (M C
Bleeker et al., 2002; Kyo et al., 1994; Mbulawa et al., 2009; Nicolau et al., 2005).
Initial evidence of the male sexual partner’s influence in cervical cancer and HPV
transmission was unearthed through studies of marital clusters that showed that
the wives of men with penile cancer were more likely to develop cervical cancer
(Castellsagué et al., 2003; Franco et al., 2001). Furthermore, research has
shown that male sexual partners of women with cervical neoplasia had higher
prevalence rates of penile HPV infection and lesions, as compared to women
without cervical cancer (M C Bleeker et al., 2002; Campion et al., 1988;
Campion, Singer, Clarkson & McCance, 1985; Castellsagué et al., 1997;
Mbulawa et al., 2009; Rombaldi et al., 2006). Although men with HPV infection
are largely asymptomatic, men are considered to be the conduit for sustained
HPV transmission to their female partners (Mbulawa et al., 2009). Consequently,
men who are carriers of HPV may be vectors for high-risk HPV types, placing
their female partners at risk of developing cervical cancer (Agarwal et al., 1993;
Bosch et al., 1996; Giuliano, Lazcano-Ponce et al., 2008; Hernandez, Wilkens,
Zhu, Thompson et al., 2008; Muñoz & Bosch, 1997; Schiffman & Castle, 2003).
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Studies examining HPV concordance among sexual partners, in which partners
are both HPV-positive and share one or more of the same strain of HPV, have
been mixed, with results ranging from 22.7% to 65% (Baken et al., 1995; M C
Bleeker et al., 2005; Burchell, Tellier, Hanley, Coutlée & Franco, 2010;
Giovannelli et al., 2007; Hippelainen et al., 1994; Parada et al., 2010).
Women’s risk to the human papillomavirus and cervical cancer is
dependent on the sexual behaviors and practices of their male partners (Agarwal
et al., 1993; Almonte et al., 2008; Bosch et al., 1996; Castellsagué et al., 2003;
de Sanjosé, Bosch, Muñoz & Shah, 1997; Giuliano, 2007; Giuliano, LazcanoPonce et al., 2008; Giuliano & Salmon, 2008; "Human papillomavirus infection in
men residing in Brazil, Mexico, and the USA," 2008; Lu et al., 2009; Nielson,
Schiaffino et al., 2009). In previous analyses of behavioral characteristics of
male sexual partners, there was an increased risk of cervical cancer among
women whose husbands or male partners had significantly more sexual partners
(Almonte et al., 2008; Castellsagué et al., 2003; Schiffman & Brinton, 1995;
Waller et al., 2004). Furthermore, male partners of patients with cervical cancer
were also more likely to report histories of sexually transmitted infections,
whereas those of control subjects reported more frequent condom usage
(Schiffman & Brinton, 1995).

Previous Research
Recently, research has been published to determine factors associated
with HPV in men. A prominent study that has yielded critical information on the
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natural history of HPV infection is the HIM (HPV Infection in Men) Study.
Spearheaded by Dr. Anna Giuliano, this research undertaking has involved a
cross-national sample of men aged 18 to 70 recruited from Brazil, Mexico, and
the US. This prospective, longitudinal study collects biologic samples and
behavioral data from the same cohort of men on a biannual basis (i.e., every six
months) for a period of four years. Study recruitment in Brazil is facilitated
through media advertising and a center for urogenital care in Sao Paulo, while in
Mexico, participants are recruited through the public health system, local
factories, and military personnel in Cuernavaca. In the US, recruitment efforts
involve print and radio advertising within a local university, as well as in the
greater metropolitan area of Tampa, Florida. The HIM study is the parent study
for this dissertation research.
Multiple epidemiological studies have been conducted through the HIM
study, resulting in significant findings that help elucidate pathways to HPV
infection among men. A recent publication reported that circumcision (assessed
by clinical examination) was associated with reduced risk of HPV detection,
whereas risky sexual practices, such as having 50 or more lifetime sexual
partners, was associated with a nearly six-fold increase in likelihood of having
any type of HPV (Giuliano et al., 2009). Other collaborative publications have
examined prevalence of HPV infection in men, as well as associated risk factors,
among self-identified heterosexual men (Giuliano, Lazcano-Ponce et al., 2008;
Nyitray et al., 2010). Across the different sites, variances in HPV prevalence and
type-specific rates have been reported (Giuliano, Lazcano-Ponce et al., 2008;
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Nyitray et al., 2010). The overall prevalence of HPV based on genotyping was
50.5%, with rates of 62.3% in Brazil, 48.4% in Mexico, and 41.3% in the US
(Giuliano, Lazcano-Ponce et al., 2008). Oncogenic strains of HPV were highest
among Brazilian men (36.1%), followed by Mexican men (30.4%) and US men
(23.3%) (p=0.002), whereas nononcogenic strains were found in half of the
sample of Brazilian men (50.5%) and about one-third of Mexican and US men
(35.1% and 30.3%, respectively) (p<0.0001) (Giuliano, Lazcano-Ponce et al.,
2008). Furthermore, within this multi-site study population, statistically significant
associations for infection with any oncogenic type of HPV were found with marital
status and ever having sex with a man (Nyitray et al., 2010). Married men had
47% decreased odds of having an oncogenic strain of HPV, compared to single,
never married men (OR=0.53, 95% CI=0.30-0.96), and men who reported ever
having oral or anal sex with a man had a two-fold increased likelihood of testing
positive for an oncogenic type of HPV (OR=2.16, 95% CI=1.10-4.21) (Nyitray et
al., 2010). Race-specific analysis revealed that Asian/Pacific Islanders within the
study population had the lowest HPV prevalence of 42.2%, compared to black
participants (66.2%), and white participants (71.5%) (Akogbe et al., 2011).
Most recently, results of incidence and clearance of type-specific genital
HPV infection in men from the HIM study were published in the journal, Lancet
(Giuliano et al., 2011). In a sub-sample of 1,159 study subjects across all three
sites, the overall rate of infection with any type of HPV was 50% (Giuliano et al.,
2011). For oncogenic strains, the overall prevalence was 30%, whereas the
prevalence of non-oncogenic strains was 38% (Giuliano et al., 2011). Infection
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with an oncogenic HPV type was associated with a high number of lifetime
female sexual partners, as well as number of male sexual partners (Giuliano et
al., 2011). Interestingly, the risk for acquiring HPV among male participants
appears to remain stable throughout their lifetimes, whereas it has been found
that women’s risk declines with age (Giuliano et al., 2011).
Overall, the HIM study has been in the forefront of public health research
to gain further understanding of the natural history of HPV in men, as well as the
risk and protective factors associated with this disease in men. As the first
international study to examine HPV in a general population of men, the HIM
study provides rich data that can yield new insights regarding the regional impact
of HPV and subsequent cancer risk. This information may prove beneficial in the
development and implementation of policies and interventions that may be
enacted on the regional and local level to improve health outcomes.

Theoretical Framework: Social Ecological Model
Public health research on sexual behavior and risk has documented the
influence factors that operate on several levels within society. Therefore, the
utilization of the Social Ecological Model (SEM) as the core organizing framework
for the interpretation of the outcomes of this research is critical in understanding
its implications and potential applications in public health (McLeroy, Bibeau,
Steckler & Glanz, 1988; Reifsnider, Gallagher & Forgione, 2005). SEM is an
overarching model that consists of multiple interrelated principles and concepts
that aid in the understanding of diverse personal and environmental factors on
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health and wellness (McLeroy et al., 1988; Stokols, 1996, 2000). SEM is ideal
for this study because, unlike many health education and behavior theories and
models, it moves beyond the intrapersonal and interpersonal levels to explore the
dynamic interaction of people with groups and their physical and socio-cultural
environment (National Cancer Institute, 2005; Stokols, 1992, 1996). This
perspective “emphasizes the interaction between, and interdependence of,
factors within and across all levels of a health problem” (National Cancer
Institute, 2005, p. 10).
SEM is inherently multidisciplinary, emerging during the 1960s and 1970s
in the disciplines of sociology and psychology and being applied to the field of
public health, anthropology, and medicine (Sallis & Owen, 1997; Stokols, 1992,
1996, 2000). However, it stems from the field of ecology, which examines
relationships between organisms and the environment (Sallis & Owen, 1997;
Stokols, 1992, 1996, 2000). Unlike its predecessor, social ecology incorporates
the social, cultural, and institutional context of behaviors with the analysis of the
environment (Heise, 1998; Panter-Brick, Clarke, Lomas, Pinder & Lindsay, 2006;
Stokols, 1992, 1996, 2000). Consequently, within health, these multiple
dimensions interact to result in a range of health outcomes, affecting agency
(Panter-Brick et al., 2006; Stokols, 1996).
The Social Ecological Model draws largely from Systems Theory (Coreil,
Bryant & Henderson, 2001; Stokols, 1996, 2000). Concepts from Systems
Theory, such as interdependence, homeostasis, and negative feedback, are
incorporated into SEM to explain the dynamic relationship between people and
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their environments (Stokols, 1996, 2000). The systems framework, in its
simplest terms, suggests “the whole is greater than the sum of its parts” (Hecker,
Mims & Boughner, 2003, p. 40). The focus of systems theory is the interaction
between objects within a system, which is any set of elements that coexist or
mutually relate to one another (Coreil et al., 2001; Hecker, Mims & Boughner,
2003). Systems theory is grounded in four basic assumptions: (1) systems
elements are interrelated; (2) systems can only be fully understood in their
entirety; (3) all systems act reciprocally with the environment; and (4) systems
are not reality (White & Klein, 2002).
Urie Bronfenbrenner is credited with the conceptualization of the basic
tenets of the Social Ecological Model, as they are known today (Cairns & Cairns,
2005). Central to SEM is the argument that “the social development of
individuals cannot be divorced from the social networks in which they are
embedded” (Cairns & Cairns, 2005, p. 17). Segmented analysis of individuals
and groups is insufficient and may be misleading, as it does not consider the
interdependence of social status and structure and excludes the reciprocal
nature of behavior and biology (Cairns & Cairns, 2005; Foster-Fishman, Salem,
Allen & Fahrbach, 1999; Stokols, 1992, 1996). Instead, the SEM examines
integrated systems through social and physical relationships among different
levels in society (Coreil et al., 2001).
An assumption of the Social Ecological Model is the interdependent nature
of human behavior and the physical, social, and cultural contexts (FosterFishman et al., 1999; McLeroy et al., 1988; National Cancer Institute, 2005; Sallis
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& Owen, 1997; Stokols, 1992, 1996, 2000). Interactions between people and the
environment are deemed to be mutually influential, in which physical and social
settings affect individual and group health outcomes (Sallis & Owen, 1997;
Stokols, 2000). Behaviors and attitudes are influenced by the community context
in which people live and work (Foster-Fishman et al., 1999; Stokols, 1992).
Environmental settings encompass multiple physical and social components that
influence a wide range of health outcomes, such as physical health status,
emotional wellness, and social cohesion (Stokols, 1996, 2000). Overall, the SEM
underscores the importance of addressing interpersonal, organizational,
community, and public policy factors to support and maintain healthy behaviors
(McLeroy et al., 1988).
SEM recognizes the interplay between personal and environmental
conditions (Foster-Fishman et al., 1999; McLeroy et al., 1988; National Cancer
Institute, 2005; Sallis & Owen, 1997; Stokols, 1992, 1996, 2000). Human
behavior is not only affected by environmental or situational conditions, but also
personal attributes, such as character, values, norms, and genetic factors
(Foster-Fishman et al., 1999; Stokols, 1992, 1996, 2000). The SEM posits that
appropriate changes in the social environment will produce individual level
change (McLeroy et al., 1988). However, individuals may respond differently to
the same environmental conditions, making one’s personal compatibility with the
environment a key predictor of well-being (Stokols, 1996). Furthermore, health
initiatives should not address separate environmental features but the cumulative
and interactive nature of diverse personal and social conditions that may affect
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health and well-being (Stokols, 1996, 2000).
Structural level factors are described within SEM as part of the physical
and social environment in which behavior takes place. According to Cohen and
colleagues (2000), there are four different categories of structural factors that can
influence and explain behavior: (1) availability of protective or harmful consumer
products; (2) physical structures; (3) social structures and policies; and (4) media
and cultural messages. While consumer products, physical entities, and social
policies may either facilitate or constrain behavior, media may influence behavior
by changing knowledge, attitudes, and beliefs, as well as norms, regarding
behavior (Cohen, Scribner & Farley, 2000).
The Social Ecological Model requires multiple levels of analysis and
diverse methods to assess the complexities of environments, groups, and
individuals (National Cancer Institute, 2005; Sallis & Owen, 1997; Stokols, 1996,
2000). Transactions among people are examined within their social and physical
environments, over time and across multiple levels of analysis (Panter-Brick et
al., 2006). From this perspective, health promotion programs and interventions
may be more effective when acting on different levels (Stokols, 2000). The
different levels of influence utilized within public health are intrapersonal factors
(e.g., knowledge, attitudes, and behaviors); interpersonal factors (e.g., peers,
social networks); institutional or organizational factors (e.g., access to services);
community factors (e.g., social norms, relationships between organizations); and
public policy factors (e.g., local, state, and national laws and policies) (Gregson
et al., 2001; National Cancer Institute, 2005; Sallis & Owen, 1997) (A diagram
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depicting the multiple levels of influence in the Social Ecological Model is
available in Figure 1.1.). While a basic assumption from the ecological
perspective is that a single level of influence cannot explain or predict behavior
and health outcomes (Bronfenbrenner, 1979), the use of the SEM in research
and interventions may address all levels within the SEM or only focus one or two
levels of influence.

Applications of Social Ecological Model
Overall, the value and relevance of the Social Ecological Model to explain
and understand health behavior is widely acknowledged (McLeroy et al., 1988;
Sallis & Owen, 1997). Ecological frameworks have been applied in the
examination of a variety of public health issues, including eating behavior (Sallis
& Owen, 1997), physical activity (Sallis & Owen, 1997), homelessness (Toro,
Trickett, Wall & Salem, 1991), and violence against women (Heise, 1998). More
specifically, ecological approaches have been applied to the investigation of
various cancer related issues, including breast cancer and survivorship (AshingGiwa et al., 2004; Revenson & Pranikoff, 2005), diet and different types of cancer
(Cai, Yu, Ye & Yi, 2000; Nagata, 2000; Sasaki, Horacsek & Kesteloot, 1993;
Stoneham, Goldacre, Seagroatt & Gill, 2000; Taioli, Nicolosi & Wynder, 1991;
Tominaga & Kuroishi, 1997), psychosocial issues in childhood cancer,
(Etherington, Pheby & Bray, 1996), hormone replacement and mammography
(Verkooijen et al., 2008), and risk communication in cancer (Patrick, Intille &
Zabinski, 2005). Additionally, this framework has been used to examine various
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dimensions of sexual behavior research, such as contextual influences on
contraception and condom use among women (Bull & Shlay, 2005), STI risks
and sexual behaviors in adolescents (Corcoran, 2000; DiClemente, Salazar &
Crosby, 2007; Mandara, Murray & Bangi, 2003; Salazar et al., 2010; Voisin,
DiClemente, Salazar, Crosby & Yarber, 2006), substance abuse-related sexual
behavior (Elkington, Bauermeister & Zimmerman, 2011; Tubman & Langer,
1995), factors that influence condom use among female sex workers (Larios et
al., 2009), aspects of sexual identity change (i.e., “coming out”) (Hollander &
Haber, 1992), and the impact of sexual assault on women (Campbell, Dworkin &
Cabral, 2009; Heise, 1998; Messman-Moore & Long, 2003; Neville & Heppner,
1999). However, minimal research on the human papillomavirus, sexually
transmitted infections, and sexual behaviors within adult male populations has
utilized ecological perspectives.
The examination of HPV, as well as other sexually transmitted infections,
within the cultural context may be achieved more effectively through the
application of an ecological perspective, incorporating an assessment of the
environment, interpersonal factors, political issues, and individual variables
(Granda-Cameron, 1999). Additionally, the use of the social ecological model
may be valuable in the design and development of culturally appropriate,
culturally compelling public health interventions (Panter-Brick et al., 2006). This
is achieved by examining psychosocial variables as they are embedded within
social and physical contexts and in micro and macrolevels of support and
resources (Panter-Brick et al., 2006). Therefore, from a social ecological
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perspective, effective approaches to reduce sexual risk behaviors enhance
individual level knowledge, attitudes, and behaviors, influence interpersonal
relationships that affect decision-making regarding sexual behavior, and affect
structural determinants of sexual relationships and behaviors.

Methodological Approach: Social Epidemiology
The design and methodology of this dissertation research is guided by a
social epidemiological approach, which complements the social ecological
model. Social epidemiology is defined as the systematic and comprehensive
study of health and well-being within the context of social and environmental
factors (Cwikel, 2006; Krieger, 2001, 2002). The overarching goal of social
epidemiology is to conceptualize, define, and assess the relationship between
different aspects of the social environment and the health of the community
(Kawachi, 2002). It builds on epidemiological concepts and integrates social
science approaches to yield greater understanding of diseases and their
determinants, as well as associated social conditions or problems (Cwikel, 2006;
Krieger, 2001, 2002). Simply stated, social epidemiology combines
epidemiology, which is the study of disease distribution and determinants in
human populations, with concepts and techniques from the social and behavioral
sciences (Cwikel, 2006). The underlying premise for social epidemiology is
incorporation of societal-level, contextual determinants of risk into investigations
of individual risk factors (Cohen, Wilson & Aiello, 2007). This integrative
approach aids in the development of interventions, policies, and institutions that
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may reduce the extent, impact, or incidence of a health condition or social
problem and enhance overall health (Cwikel, 2006).
Inherent within social epidemiology is the equal importance of
psychosocial and biological determinants of disease and wellness (Berkman,
Glass, Brissette & Seeman, 2000; Cohen et al., 2007; Cwikel, 2006). The
importance of sociocultural and socioeconomic factors in multiple health
outcomes has been described (Berkman et al., 2000; Cohen et al., 2007; Krieger,
1994; Link & Phelan, 1995; Phelan, Link, Diez-Roux, Kawachi & Levin, 2004).
From a social epidemiological perspective, disease is considered to be the
product of both biological and social processes and mechanisms (Cohen et al.,
2007; Krieger, 2002). The investigation of determinants of disease and health
outcomes within communities and populations with consideration of social
conditions that are intrinsically linked to these issues enhances the relevance
and applicability of the research findings (Cwikel, 2006). Consequently, a critical
strategy within social epidemiology is the focus on social conditions rather than
on specific health outcomes (Cohen et al., 2007; Kawachi, 2002; Poundstone,
Strathdee & Celentano, 2004). Furthermore, social epidemiology considers what
is known regarding risk factors for a particular condition to enhance and maintain
optimal health and wellness (Cwikel, 2006).
Three main approaches have been utilized within social epidemiology, all
of which help elucidate principles capable of explaining social determinants in
heath (Krieger, 2001):
1. Psychosocial theory;
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2. Social production of disease (also known as political economy of health);
and
3. Ecosocial theory and related multi-level dynamic frameworks.
Psychosocial Theory links vulnerability to disease to both physical and
psychological stress, highlighting behavioral and biological responses to human
interactions (Krieger, 2001, 2002). Historically, the determination of the etiology
of disease was grounded in the “germ theory,” which hypothesized that people
exposed to germs associated with a disease become infected (Cassel, 1964;
Krieger, 2001). However, when it was observed that not all exposed persons
develop disease, it was recognized that the germ theory only provides partial
knowledge regarding the causation of disease (Cassel, 1964; Krieger, 2001). In
response, the etiological framework for disease was expanded to encompass the
environment (Diez-Roux, 1998; Krieger, 1994, 2001). This perspective was
further broadened to incorporate psychosocial factors to explain the
disproportionate burden of diseases (Cassel, 1976; Krieger, 1994, 2001).
Consequently, the psychosocial theory of social epidemiology moves beyond the
agent-host framework for disease transmission to incorporate the environment,
which is inclusive of social, political, and economic factors (Krieger, 2001).
Social Production of Disease, which is also known as the political
economy of health, refers to economic and political determinants of health and
disease outcomes, as well as structural barriers, within and across societies
(Krieger, 2001, 2002). Instead of focusing on individual choices and
responsibilities, this approach broadly examines determinants of health in
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relation to costs and benefits of specific policies and practices; in other words,
who benefits and at whose cost (Krieger, 2001)? However, biological factors are
not readily addressed within the perspective of the social production of disease
(Krieger, 2001). In cross-national analysis, the focus is on health inequities by
class within and between countries (Krieger, 2001). The underlying hypothesis is
that economic and political institutions produce and perpetuate economic and
social privilege and inequality, which are the fundamental causes of disparities in
health (Krieger, 2001, 2002). Consequently, individuals are not solely
responsible for their health status (Krieger, 2001).
Ecosocial Theory is a multi-level framework that fosters the analysis of
current and changing population patterns of health, disease, and wellness in
relation to biological, ecological, and social factors (Krieger, 2001). In this
approach, evolving patterns of health, disease, and wellness are analyzed within
each level of biological, ecological, and social organization (Krieger, 2001). In
short, ecosocial theory posits that disease is the result of interactions between
biological organisms and their social environment (Krieger, 1994, 2001).
Furthermore, information on evolving patterns of health can be uncovered
through the examination of the dynamic socioecological context in which people
live their lives (Krieger, 2005). The ecosocial approach incorporates a social
production of disease perspective with biological and ecological analysis
(Krieger, 2001). Historical and ecological perspectives are integrated into this
approach to gain insights into the determinants and distribution of disease over
time and evolving social inequalities in health (Krieger, 2002).
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Applications of Social Epidemiology
Historically, public health has been more heavily focused on biological and
medical determinants of disease and well-being (Cassel, 1964; Krieger, 1994,
2001). However, it is becoming increasingly more common for public health
programs, policies, and research to encompass physiological factors, as well
social determinants. It has been well-established that a broader, multi-level
examination of the causes of diseases is important, as individually-based risk
factors must be contextualized, and social factors are likely to affect multiple
disease outcomes (Cassel, 1964; Cohen et al., 2007; Cwikel, 2006; Krieger,
1994; Link & Phelan, 1995; Phelan et al., 2004). Examples of such integrative
approaches can be found within the public health initiatives addressing obesity,
violence, substance use, chronic diseases, and sexually transmitted infections,
which have been associated with individual-level factors (e.g., knowledge,
attitudes, behaviors), as well as community and institutional level factors (e.g.,
poverty, access to resources, media, economy) (Cwikel, 2006). These public
health issues are viewed as complex social problems that benefit from
multidisciplinary approaches to intervention development and research (Cwikel,
2006).
Although recent public health investigations have begun to move beyond
the former focus on individual-level factors to examine social conditions in which
individual risk factors may be experienced, few studies have actively utilized a
social epidemiological framework, isolating contextual conditions in relation to
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health outcomes. A recent literature review spanning four decades (1966-2005)
explored articles on three frequently used public health search engines (i.e.,
MEDLINE, PsycINFO, and ISI Web of Science) to unearth publications
containing the term “social epidemiology” (Cohen et al., 2007). A total of 137
articles were found that addressed the social epidemiology of various health
outcomes (Cohen et al., 2007). Most of the identified studies focused on
neuropsychiatric disorders (i.e., substance-related disorders, mental disorder),
chronic diseases (e.g., heart diseases, neoplasms, cerebrovascular disorders,
pulmonary disease, digestive system diseases), sexually transmitted infections
(e.g., HIV/AIDS, hepatitis B), or infectious diseases (i.e., malaria, tuberculosis,
measles, diphtheria, pertussis, tetanus, respiratory tract infections) (Cohen et al.,
2007).
Minimal research has been conducted that actively utilizes a social
epidemiology framework to examine factors associated with cancer (Cohen et al.,
2007; Graham & Gibson, 1972; Graham & Schneiderman, 1972; Kaufman, 1999;
Wardle, McCaffery, Nadel & Atkin, 2004). However, the epidemiologic study of
social factors associated with various forms of cancer has gained prominence,
particularly with the identification of multiple socially mitigated exposures that
increase the likelihood of cancer, including tobacco use and exposure, nutrition,
and physical activity (Kaufman, 1999). Similarly, racial/ethnic identity and
socioeconomic status have been determined to be key factors associated with
many exposures that are relevant to cancer research (Kaufman, 1999). With
HPV and its related cancers, sexual behaviors have emerged as an important
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risk factor, particularly among men. Sexual behaviors are strongly influenced by
the interplay of sociocultural, economic, and community factors. Therefore,
social epidemiology is an appropriate framework to utilize in this study.

Purpose of the Study
The purpose of this research is two-fold: 1) to provide further
understanding of factors associated with HPV among men from the social
epidemiological perspective; and 2) to assess the impact of HPV testing and
reporting on sexual risk taking among men. The long-term goal is to expand the
knowledge base regarding HPV and sexual behavior among men to enhance
service provision and intervention development to reduce the rates of HPV.

Research Questions
The overall purpose of this study is to increase understanding of factors
associated with the human papillomavirus (HPV) and other sexually transmitted
infections (STIs) among heterosexual men, including sexual behaviors and
sociodemographic factors associated with men’s behavioral responses to testing
and diagnosis. This purpose is achieved through the following specific aims and
research questions:

Specific Aim 1: To identify the most salient correlates of sexual behaviors among
men residing in Brazil, Mexico, and the US.
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Research Question 1.1: How does sexual risk differ among men residing
in Brazil, Mexico, and the US by age cohort?

Specific Aim 2: To assess the impact of testing and knowledge of diagnosis with
human papillomavirus and/or other sexually transmitted infections on sexual
behavior among men.
Research Question 2.1: Do men’s sexual behaviors change after being
tested for HPV and other STIs?
Research Question 2.2: Do men’s sexual behaviors change after being
informed of diagnosis with HPV and other STIs?

These research questions were explored through a quantitative assessment of
secondary data collected through a risk factor questionnaire among a crossnational study population using computer assisted self-interviewing (CASI). This
research was conducted by the H. Lee Moffitt Cancer Center and Research
Institute in Tampa, Florida, in partnership with the Ludwig Institute for Research
on Cancer in São Paulo, Brazil and the Instituto Nacional de Salud Pública in
Cuernavaca, Mexico.

Data Source for the Study
To address the research questions, a secondary data analysis was
conducted. The data source is the dataset from the HPV in Men (HIM) study.
Participants for the HIM study were recruited from the cities of Sao Paulo, Brazil;
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Cuernavaca, Mexico; and Tampa, Florida (US), and their surrounding areas.
The study population consisted of men who met the following inclusionary
criteria: (a) ages 18 to 70 years; (b) residents of one of three target sites; (c)
reported no prior diagnosis of penile or anal cancers; (d) have never been
diagnosed with genital or anal warts; (e) currently report no symptoms of a
sexually transmitted infection or treatment for a sexually transmitted infection; (f)
not participating in an HPV vaccine study; (g) no history of HIV or AIDS; (h) no
history of imprisonment, homelessness, or drug treatment during the past 6
months; and (i) willing to comply with 10 scheduled visits every 6 months for 4
years with no plans to relocate within the next four years.
The HIM Study protocol includes a pre-enrollment visit, a baseline
(enrollment) visit, and nine additional visits after enrollment, each of which is
scheduled six (6) months apart. For this analysis, the data from the baseline visit
and three subsequent visits were utilized. Data include results from a Risk
Factor Questionnaire, which assess sociodemographic characteristics, sexual
and contraceptive history, condom use practices, and alcohol and tobacco use.
The questionnaire was self-administered using computer assisted selfinterviewing (CASI) and was provided in the primary language of the region (i.e.,
Portuguese in Brazil, Spanish in Mexico, or English in the US). Additionally,
biological samples were collected from the external genitalia of participants,
including the glans penis/coronal sulcus, the penile shaft, and the scrotum and
combined to produce a single clinical specimen, which is used for HPV testing
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and STI testing. The results of the HPV and STI tests at each visit were included
in the dataset.
A test-retest reliability study has been conducted of the CASI instrument
among men recruited in Brazil, Mexico, and the US in 2005 and 2006 (Nyitray et
al., 2009). This study was designed to assess the consistency of participant
responses between two time points, approximately three weeks apart. Overall,
the reliability coefficients for each study site and the combined population for
sexual health history and sexual behavior items were acceptable (κ = 0.61-0.80)
(Nyitray et al., 2009).

Overview of Study Methodology
A secondary data analysis was conducted using the HPV in Men (HIM)
dataset (described above). This analysis utilized data from the baseline
assessment and two subsequent visits (at six month intervals), consisting of data
over a two-year period for each participant. Descriptive statistics (e.g.,
frequencies, measures of central tendency and variability, and bivariate
correlation by country of residence, age cohort, and by HPV status) were
computed to summarize the sample characteristics, to explore relationships
among variables, and to guide development of the repeated measures models.
Three age cohorts were constructed for this study: 18-30 years, 31-44 years, and
45-70 years. HPV and STI status were dichotomous variables (‘yes’ or ‘no’), and
country of residence was limited to three countries (i.e., Brazil, Mexico, and
United States). Other sociodemographic variables included: race/ethnicity;
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marital status; educational level; circumcision status; and smoking status.
Factors related to sexual behavior included: age at first vaginal sex; previous oral
sex; previous anal sex; paying for sexual intercourse; number of lifetime sexual
partners; and condom use within the last six months. Data reduction techniques
were used to eliminate variables with low or no predictive power and to combine
variables into meaningful indices and scales with good psychometric properties
to obtain relatively parsimonious sets of predictors.
In the first manuscript, logistic regression was used to assess the
association between sociodemographic factors and sexual risk by age cohort.
Adjusted odds ratios and 95% confidence intervals were calculated using the
standard errors from the corresponding logistic regression models. However,
repeated measures analysis was conducted using GLIMMIX in the second
manuscript to compute estimates of the longitudinal relationship between sexual
behaviors, HPV and STI testing, and the knowledge of HPV and STI diagnoses
among study participants. SAS (SAS Institute, Inc., Cary, North Carolina, version
9.2) was used for data management and for all data manipulations. All tests of
hypotheses were two-tailed with a type 1 error rate of 5%. Details regarding the
statistical analyses for each manuscript are provided in the respective Methods
sub-sections for each manuscript in Sections Two and Three.

Limitations
There are some limitations to the research design. As this study is
structured within an existing research study that is being conducted by the H. Lee
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Moffitt Cancer Center and Research Institute (Moffitt) and the University of South
Florida (USF) College of Public Health, the research questions and methodology
must fall within this existing framework. The results of the secondary data
analysis may not be generalizable to all men in the United States, Brazil, and
Mexico, as the sampling process was not randomized and was conducted
through community settings. Given the differences in the recruitment strategies
utilized at each of the study sites, the sub-populations within this cross-national
study are intrinsically different. Additionally, the socio-cultural norms of the three
study sites may differentially affect factors that influence sexual behaviors, as
well as sexual behaviors themselves. Therefore, the study findings may not be
uniformly applicable to men across each of the study sites.
Since much of the research relied on self-reported data, particularly
regarding practices and behaviors, there is a possibility of social desirability bias,
which may affect the validity of the data utilized in this study. The individuals
who voluntarily agreed to participate in the study may be inherently different from
those who choose not to participate, which may affect the results of the study.
Because the quantitative data utilized in this study was collected using
instruments developed for a separate study, the variables may not be the most
appropriate to elucidate the information desired to address the research
questions. As the study originated in the US, the items included in the Risk
Factor Questionnaire were initially constructed in English by US-based
researchers. Therefore, although the survey instrument was later translated into
the primary language of each of the study sites (i.e., Portuguese in Sao Paulo,
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Brazil; Spanish in Cuernavaca, Mexico) and back-translated to English, the
appropriateness and relevance of some socially constructed items (e.g.,
race/ethnicity) may be questionable. However, since this is a secondary
analysis, the study was limited to the analysis of the available data.

Organization of the Dissertation
While this is a cohesive study exploring the multiple factors associated
with the human papillomavirus and sexually transmitted infections among men,
the results of this study were grouped and developed in two distinct manuscripts
for publication, which coincide with each of the two specific aims, as follows:

Manuscript 1: “Age-related variation in sexual behaviors among heterosexual
men residing in Brazil, Mexico, and the United States”; and

Manuscript 2: “The impact of testing and diagnosis for the human papillomavirus
and other sexually transmitted infections on sexual behavior in a
cross-national sample of men.”

The first manuscript, provided in Section Two, is titled “Age-related
variation in sexual behaviors among heterosexual men residing in Brazil, Mexico,
and the US.” This manuscript presents the descriptive findings of an analysis of
age cohorts and their respective sexual behaviors within the study population.
The intended audiences for these results are public health providers who work
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with at-risk male populations and develop interventions and programs to improve
sexual health outcomes. Therefore, the study findings may be appealing to the
readers of the Archives of Sexual Behavior (2010 Impact factor: 3.66), which is
committed to the dissemination of information in the field of sexual science.
The second manuscript, provided in Section Three, is titled “The impact of
testing and diagnosis for the human papillomavirus and other sexually
transmitted infections on sexual behavior in a cross-national sample of men.”
This paper explores the relationship between HPV and STI testing and
subsequent sexual behaviors among the cohort of men followed as part of the
HIM study in the three study sites of Brazil, Mexico, and the United States. The
findings of this manuscript may be of interest with public health professionals
who develop policies, as well as interventions, regarding STI prevention. This
manuscript may be suitable for the American Journal of Public Health (2010
Impact Factor: 3.85), which is the official journal of the American Public Health
Association. Each month, this journal publishes articles on a wide range of
cross-cutting public health issues that encompass policy and practice.
Section Four of the dissertation provides the comprehensive, synthesized
findings and discussion of the dissertation. Furthermore, this section includes
recommendations for future research, strengths and limitations, and public health
implications. Because of the nature of the dissertation format, the information in
this final section highlights the results and conclusions reported in the previous
sections as part of the three separate manuscripts.
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Figure 1.1: Social Ecological Model
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Section Two:
Manuscript One
Age-related variation in sexual behaviors among heterosexual men residing in
Brazil, Mexico, and the United States
JOURNAL: Archives of Sexual Behavior

Introduction
Most research on the prevalence of risky sexual behaviors has focused on
sub-groups of men thought to be at high risk for sexually transmitted infections
(STIs), including men who have sex with men and substance using males (Aidala
et al., 2006; Dworkin, 2005; Exner, Gardos, Seal & Ehrhardt, 1999; Seal &
Ehrhardt, 2004). Due to this focus, research examining factors associated with
heterosexual men’s acquisition of STIs has been limited (Aidala et al., 2006;
Campbell, 1995; Dworkin, Fullilove & Peacock, 2009; Exner et al., 1999; Flood,
2003; Higgins, Hoffman & Dworkin, 2010; Neumann et al., 2002; Seal &
Ehrhardt, 2004). Furthermore, studies assessing sexual behaviors among
heterosexuals have focused primarily on women (Aidala et al., 2006; Campbell,
1995; Dworkin et al., 2009; Exner et al., 1999; Flood, 2003; Higgins et al., 2010;
Neumann et al., 2002; Seal & Ehrhardt, 2004). Thus, there is a need for
research on STI risk factors for heterosexual men who do not belong to groups
thought to be at “high risk.”
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Similarly, while numerous studies have investigated sexual behavior by
gender and race/ethnicity, most research on men’s sexual risk practices has
focused on younger populations, including adolescents and young adults
(Chopra et al., 2009; Harrison, Cleland, Gouws & Frohlich, 2005; Makenzius,
Gadin, Tyden, Romild & Larsson, 2009; Mooney-Somers & Ussher, 2008;
O'Donnell, O'Donnell & Stueve, 2001; Sandfort, Orr, Hirsch & Santelli, 2008).
The focus on younger adults may be attributed to the higher prevalence and
incidence of STIs, as well as higher rates of disease transmission, within this
population (LaBrie, Pedersen, Thompson & Earleywine, 2008; Noar, Morokoff &
Redding, 2001; Tan, Wong & Chan, 2006). However, in recent years, HIV/AIDS
cases among older adults have been on the rise (Casau, 2005; Coleman & Ball,
2007; Goodroad, 2003; Kohli et al., 2006; Savasta, 2004). Furthermore, sexual
risk-taking has been found to be frequent within older age cohorts (Bruhin, 2003;
Kohli et al., 2006; Rogstad & Bignell, 1991; Stall & Catania, 1994).
Overall, there is a paucity of data on sexual risk-taking among various age
cohorts of heterosexual men, including middle-aged and older men. In this
study, we examined the prevalence and correlates of sexual behaviors by age
cohort within a cross-national sample of adult, heterosexual, sexually active men
in Brazil, Mexico, and the United States. The purpose of this study was two-fold:
(1) to compare the prevalence of different demographic characteristics and
sexual behaviors across age groups and (2) to estimate the significance of
multiple demographic and behavioral variables in predicting sexual risk by age
cohort.
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Methods
Study Design and Sample. This is a cross-sectional analysis of baseline
data collected within a cohort study. The study sample was drawn from men who
were enrolled in the HPV in Men (HIM) Study from June 2005 to December 2009
(N=4,074). The HIM Study is a cross-national, natural history study that explores
factors associated with HPV prevalence and incidence among men in Sao Paulo,
Brazil, Cuernavaca, Mexico, and Tampa, Florida in the United States (US). Data
collected from this study were used to investigate sexual risk behavior across the
lifespan.
To ensure the inclusion of a broad range of men, participants for the
parent study were recruited from the general population. In Brazil, study
recruitment was facilitated through media advertising and a center for urogenital
care. In Mexico, beneficiaries of the public health system, factory employees,
and officials of the Mexican army living and working in the geographic community
around the study site were enrolled. Recruitment efforts in the US involved flyers
and media advertising at a local university and in the greater metropolitan area.
Prior to enrollment in the study, all participants provided written informed
consent.
The study population for the parent study consisted of men who met the
following inclusion criteria: a) aged 18 to 70 years; b) residents of one of the
three study sites; c) no reports of prior diagnosis with penile or anal cancers; d)
no report of symptoms of or treatment for an STI; e) not currently participating in
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an HPV vaccine study; f) no history of HIV/AIDS; g) no history of imprisonment,
homelessness, or drug treatment during the past six months; and h) willingness
to comply with ten scheduled study visits conducted every six months over a four
year period with no plans to relocate during study implementation. For the
present analysis, we restricted the study population to heterosexual men,
excluding any men who reported prior sexual activity with a male partner,
including oral and/or anal intercourse (n=596). We also excluded men who were
not sexually active (n=431), defined as those who did not report ever
experiencing vaginal intercourse. This resulted in a final sample size of 3,047
men. The elimination process that resulted in our study population is depicted in
Figure 2.1.
Risk Factor Questionnaire. A comprehensive sexual history and health
questionnaire was administered to study participants at enrollment. This
instrument assesses socio-demographic characteristics, alcohol and tobacco
use, sun exposure, history of STIs, circumcision status, sexual history, and
contraceptive practices. The original survey instrument was written in English
and was later translated into the primary language of each of the survey sites
(i.e., Portuguese in Sao Paulo, Brazil; Spanish in Cuernavaca, Mexico) and backtranslated to English to ensure accuracy in the assessment process. A testretest reliability study of the instrument was previously conducted in all three
languages utilized in the study and yielded high reliability coefficients for all
variables (intraclass correlation coefficient (ICC) ≥ 0.85) (Nyitray et al., 2009).
The questionnaire required approximately 20 minutes to complete and was
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administered using Computer-Assisted Self-Interviewing (CASI). For each
survey item, participants were given the option to refuse to answer. These
responses were treated as missing observations, as the values are unknown.
Testing for Sexually Transmitted Infections. Upon study enrollment, men
who provided consent for participation underwent a clinical examination. At the
time of survey administration, participants were tested for chlamydia, gonorrhea,
herpes simplex virus 2 (HSV2; also known as genital herpes), and syphilis. Urine
specimens (20-30 mLs) were collected in urine collection cups free of any
preservatives for testing to detect gonorrhea and chlamydia RNA, TMA. A 2 mL
urine specimen was transferred into the GenProbe specimen transport tube
within 24 hours of collection before being assayed. Sera were tested for syphilis
infection by Rapid Plasma Reagin (RPR). Positive results were confirmed with
the more specific FTA-ABS. A reactive FTA-ABS test confirms the presence of
treponemal antibodies but does not indicate the stage or presence of active
infection. Sera were also tested for HSV2 by Immunoassay with the IgG Type
Specific Antibody (HerpeSelect) test. All STI assays were performed by Quest
Laboratories, Tampa, Florida, US. Participants with positive test results were
offered treatment at no cost.
Variables. We compared participants by age cohort on a range of
demographic variables and sexual behaviors found to affect the likelihood of STI
transmission, based on biologic plausibility and a review of the literature. The
age cohorts were defined as 18 to 30 years, 31 to 44 years, and 45 to 70 years
(i.e., young adults, middle-aged adults, and older adults, respectively).
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Demographic variables included in the analysis were: country of residence
(Brazil, Mexico, US); self-identified race (White, Black, Asian/Pacific Islander,
American Indian, Mixed); Hispanic (Yes, No); marital status (single, married,
cohabitating, divorced/separated/widowed); educational level (<12 years, 12
years, 13 to 15 years, 16 years, ≥17 years); self-reported circumcision status
(Yes, No); and current smoking status (Yes, No). All men included in the sample
were defined as heterosexual (i.e., no reported history of sexual intercourse with
men) with a history of sexually activity (i.e., ever experiencing vaginal sexual
intercourse).
Multiple variables regarding men’s sexual behaviors were incorporated in
the analysis, including history of anal and oral sexual activity, age at first vaginal
sex, lifetime number of female sexual partners, if they had ever paid for sexual
intercourse (i.e., exchanged sex for money or drugs), and condom use within the
recent past (i.e., up to six months preceding survey administration). Selfreported data on previous diagnoses of multiple sexually transmitted infections
by a health care provider were also considered, including genital herpes,
chlamydia, gonorrhea, syphilis, non-gonococcal urethritis, hepatitis B, hepatitis C,
and HIV.
The primary outcome of interest in this study was sexual risk. While a
standardized means of assessing sexual risk has not been established in the
literature, the prevalence and occurrence of STIs have been identified as critical
outcome measures of sexual risk (Beck, McNally & Petrak, 2003; Kirby, Laris &
Rolleri, 2007; Slaymaker, 2005). Therefore, sexual risk was quantified through
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the composite variable for STI test results. This composite variable was
constructed to denote a positive test result for the presence of at least one of the
four STIs tested for in this study (i.e., chlamydia, gonorrhea, genital herpes, and
syphilis). The composite variable for sexual risk excluded HPV, as its prevalence
is much higher relative to other STIs; within the study population, approximately
half of the men are positive for HPV. Therefore, the exclusion of HPV ensured
that the study assessed risky behavior associated with general STI prevalence,
rather than HPV prevalence (which has previously been published as part of the
parent study) (Akogbe et al., 2012; Nyitray et al., 2011; Nyitray et al., 2010).
Statistical Analysis. Since all variables were categorical, differences in the
distribution of demographic characteristics and sexual behaviors were examined
by age cohort were tested using the chi-square test. Logistic regression was
conducted to examine the association between demographic factors and sexual
behaviors and the likelihood of testing positive for an STI. Odds ratios, along
with their corresponding 95% confidence limits, were generated to assess the
association of the predictor variables and sexual risk. We also stratified the
regression analyses by age cohort to evaluate group differences. Variables
included in the multivariate model were those found to be statistically significant
in the bivariate analysis.
All tests of hypotheses were two-tailed with a Type I error rate set at 5%.
SAS (version 9.2) was used for data management and for all data manipulations
(SAS Institute, Cary, NC, USA). This investigation was approved by the
Institutional Review Board of the University of South Florida.

69

Results
The study sample consisted of 3,047 men, aged 18 to 70 years, with a
mean age of 32.3 years (standard deviation [SD] ±11.1; median=31.0 years). A
comparison of selected demographic characteristics by age cohort is presented
in Table 2.1. The study sample consisted predominately of young adult men,
with half being between the ages of 18 and 30 years (n=1,523; 50.0%) and more
than one-third aged 31 to 44 years (n=1,131; 37.1%). Roughly one-third of the
sample resided in each of the three study sites, Brazil (29.1%), Mexico (35.0%),
and the US (35.6%). Most of the study sample in Brazil and Mexico consisted of
middle-aged adults (31 to 44 years; Brazil=37.1%; Mexico=43.3%), whereas
nearly half (47.8%) of the US participants were young adults (18 to 30 years).
Regardless of age cohort, the study sample was predominantly self-identified as
white (43.7%) and Hispanic (46.7%). Young adult males were more likely to be
single, whereas middle-aged and older adults (45 to 70 years) were more likely
to be married. Younger and older males were more likely to have some
advanced/college level education, but middle-aged males were more likely to
have lower levels of education. Although the majority of men in the study sample
were uncircumcised (60.7%), the levels varied by age cohort, with young adults
having the highest proportion of circumcision (47.1%) and middle-aged adults
having the lowest (28.0%).
Table 2.2 provides information on the participants’ self-reported sexual
behaviors with women by age cohort. The majority of men (43.8%), across age
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cohorts, reported their first experience of vaginal intercourse between the ages of
15 and 17 years. The mean age of the men’s first experience of vaginal sexual
intercourse was 16.9 years (SD±3.2; median=17.0 years). The majority of men
(90.0%) reported ever having performed and/or experienced oral sex, and half
(49.7%) reported ever having insertive anal sex. The frequency of oral sex was
observed to decrease with increasing age (18 to 30: 92.9%; 31 to 44: 89.3%; 45
to 70: 80.9%). However, men within the middle-aged category reported the
highest rates of anal intercourse (57.3%). Middle-aged adults also reported the
highest proportion of experiences exchanging sexual intercourse for money or
drugs (13.9%). When asked about condom use with vaginal intercourse during
the three to six month period prior to the survey, the most frequent response
across age cohorts was “never” (36.9%). The absence of condom use with
vaginal sex increased with increasing age, with approximately one-fourth of
young men (24.4%) reporting never using them compared to more than half of
older men (55.7%).
In the study sample, the mean number of lifetime female sexual partners
was 18.8 (SD±104.7; median=7.0). Further information regarding the number of
sexual partners reported by participants is provided in Table 2.2. Overall, the
largest proportion of participants reported 2 to 9 lifetime female sexual partners
(45.3%); however, the variance in numbers varied by age cohort, with reported
lifetime numbers being more concentrated in this range among young adults and
being more widely distributed among middle-aged and older adults.
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Table 2.3 provides information on prior diagnoses with a sexually
transmitted infection (STI), as reported by the participants. When asked about
whether they had ever been diagnosed with any STI by a physician or health
care provider, more than one-fourth (26.0%) of older adults, aged 45 to 70 years,
responded affirmatively compared to 7.8% of young adults and 17.4% of middleaged adults. Similarly, older adults reported the highest proportions of
gonorrhea, syphilis, non-gonococcal urethritis, and hepatitis C, compared to
other age cohorts; however, the reported occurrence of genital herpes in the
study sample was similar among middle-aged and older adults.
When examining the results for STI tests given at the same time of survey
administration, genital herpes, chlamydia, and syphilis showed significant
variation by age cohort (Table 2.4). Of these STIs, the most prevalent was
genital herpes, with 17.7% of men testing positive. The largest proportion of
genital herpes and syphilis cases occurred among older men (32.3% and 1.8%,
respectively), whereas younger men had the highest percentage of chlamydia
cases (2.6%). Overall, 19.7% of the study sample tested positive for at least one
of the four STIs observed, with prevalence increasing with age.
The risk estimates for the model of association with a positive test for an
STI in this study sample by age cohort are presented in Table 2.5. Relative to
the oldest cohort of men, young adult men and middle-aged men both have
reduced odds for a positive STI test (AOR=0.29, 95% CI=0.20-0.40 and
AOR=0.74, 95% CI=0.55-0.98, respectively). Overall, Brazilian men had the
highest risk of testing positive for an STI (AOR=3.00, 95% CI=2.14-4.20). Black
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men in the study sample were nearly 1.5 times more likely to test positive for an
STI (AOR=1.50, 95% CI=1.15-1.96), relative to white participants. Men who
were divorced, separated, or widowed were also 1.5 times more likely to test
positive for an STI, as compared to married men (AOR=1.46, 95% CI=1.04-2.06).
Men who did not complete secondary education were at increased sexual risk,
relative to men with advanced levels of education (AOR=1.62, 95% CI=1.012.59). Additionally, early age of sexual debut was associated with a more than
two-fold heightened risk for a positive STI test (AOR=2.15, 95% CI=1.43-3.23).
Experiences exchanging sex for money or drugs was found to elevate sexual risk
in the general study sample (AOR=1.35, 95% CI=1.01-1.80). Higher numbers of
lifetime sexual partners intensified the risk of a positive STI test in the study
sample (20-49 partners: AOR=1.48, 95% CI=1.02-2.16; ≥50 partners: AOR=2.07,
95% CI=1.31-3.28).
Within the youngest cohort (18 to 30 year olds), Brazilian men had a more
than seven-fold risk for testing positive for an STI (AOR=7.47, 95% CI 3.9014.28), compared to men in the US. Advanced levels of education were found to
be protective for testing positive for an STI among young men (16 years:
AOR=0.37, 95% CI=0.15-0.92), whereas young men with larger numbers of
lifetime sexual partners had a two to four-fold increased risk (20-49 partners:
AOR=2.06, 95% CI=1.04-4.13; ≥50 partners: AOR=4.33, 95% CI=1.74-10.76).
Multiple variables amplified sexual risk for middle-aged men (31 to 44
years) (Table 2.5). Black men in this age group had 64% increased odds of
testing positive for an STI (AOR=1.64, 95% CI=1.10-2.42), whereas men in the
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study population who were divorced, separated, or widowed had a 91% elevated
risk (AOR=1.91, 95% CI=1.21-3.02). Both a lower and a higher level of formal
education (<12 years: AOR=3.04, 95% CI=1.53-6.06; 13-15 years: AOR=2.85,
95% CI=1.43-5.68) were found to amplify sexual risk by nearly three times.
Similarly, early and older ages at sexual initiation (≤14 years: AOR=2.37, 95%
CI=1.34-4.18; 18-20 years: AOR=1.80, 95% CI=1.05-3.07) were associated with
a higher likelihood of STI positivity.
Within the study’s oldest cohort (45 to 70 years old), men living in Brazil
(AOR=2.25; 95% CI=1.03-4.89) and those who reported previously exchanging
sex for money or drugs (AOR=2.30, 95% CI=1.05-5.04) had a more than two-fold
increased risk of testing positive for an STI. Furthermore, older men who first
had sexual intercourse at the age of 14 or younger had a nearly four-fold
elevated sexual risk (AOR=3.75, 95% CI=1.45-9.74).

Discussion
Our study found that STI positivity varied significantly by age group among
heterosexual men. In younger men, having higher educational levels had a
protective effect, whereas higher numbers of sexual partners elevated the risk for
STIs. Middle-aged men who were black and divorced/separated/widowed had
an increased risk for a positive STI test. However, inconsistencies regarding risk
associated with education and age of sexual initiation were observed among men
within this age cohort. Middle-aged men with less than a secondary level
education (<12 years) and some college education (13 to 15 years) were found
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to have elevated sexual risk, and those who had an early age of sexual debut
(≤14 years) and young adult onset of sexual activity (18 to 20 years) had higher
risk estimates for a positive STI test. For older men, a younger age at first
vaginal sexual encounter and a history of exchanging sex for money or drugs
heightened sexual risk.
Our study has important public health implications. Most research studies
examining sexual behavior have been conducted with adolescents and young
adults (Chopra et al., 2009; Harrison et al., 2005; Makenzius et al., 2009;
Mooney-Somers & Ussher, 2008; O'Donnell et al., 2001; Sandfort et al., 2008);
however, sexual risk-taking and STI transmission among older adults is now
recognized as a growing public health problem (Bruhin, 2003; Coleman & Ball,
2007; Goodroad, 2003; Kohli et al., 2006; Rogstad & Bignell, 1991; Savasta,
2004; Stall & Catania, 1994). Therefore, our examination of risk and protective
factors for sexual risk by age cohort, inclusive of men aged 18 to 70 years, fills
an important gap in the literature. Furthermore, few sexual research studies
have investigated factors related to heterosexual men (Aidala et al., 2006;
Campbell, 1995; Dworkin et al., 2009; Exner et al., 1999; Flood, 2003; Higgins et
al., 2010; Neumann et al., 2002; Seal & Ehrhardt, 2004). Consequently, our
study provides information that may be beneficial for interventions to prevent and
reduce the heterosexual transmission of STIs across age groups. More
specifically, our results suggest that age cohort is a key factor in the development
and implementation of targeted approaches for STI prevention among men.
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In our analysis, we identified multiple protective and risk factors for STIs
among heterosexual men that reinforce previous research findings. Numerous
studies have consistently shown that paid sex increases the risk for HIV and
other STIs (Chen et al., 2007; Mimiaga, Reisner, Tinsley, Mayer & Safren, 2009;
Patterson et al., 2009). This study provides further evidence of this assertion, as
there was a 35% increased risk for STIs among men who reported ever
exchanging sex for money or drugs. Our study also found that young men with
higher numbers of lifetime sexual partners had a two to four-fold heightened risk
for a positive STI test. Similarly, previous research has observed a relationship
between an increasing number of sexual partners and the risk of STIs (Dunne,
Nielson, Stone, Markowitz & Giuliano, 2006; Lu et al., 2009; Nielson et al., 2007).
Additionally, early sexual debut was associated with a more than two-fold
elevated risk of STIs in our study sample, which was amplified among middleaged and older adult males. Likewise, our findings support those from multiple
studies that have determined that young age at sexual initiation increases
likelihood of HIV and STI transmission among men (Dunne et al., 2006; Harrison
et al., 2005; Kahn, Rosenthal, Succop, Ho & Burk, 2002; Lu et al., 2009; Nielson
et al., 2007; O'Donnell et al., 2001; Sandfort et al., 2008); however, most of these
prior studies were conducted with adolescents or young adults.
Although many of our results support those of earlier studies, some of our
findings are somewhat counterintuitive, underscoring the need for further
investigation. For example, educational level within the study population of
young men showed that advanced education was protective for STI risk;
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however, among middle-aged men, those with 13 to 15 years of education had a
nearly three-fold increased risk of a positive STI test (relative to men with 17 or
more years of education). Additionally, older age at initiation of sexual activity
(18 to 20 years) was found to increase sexual risk among middle-aged men, in
contrast to previous findings of heightened risk with early sexual debut (Dunne et
al., 2006; Harrison et al., 2005; Kahn et al., 2002; Lu et al., 2009; Nielson et al.,
2007; O'Donnell et al., 2001; Sandfort et al., 2008). As there is no clear
explanation for these findings, mixed methods approaches that incorporate
qualitative methodologies may prove beneficial in the determination of underlying
factors that may explain these contradictions within our findings.
There are some potential limitations in this study. First, as we utilized an
existing dataset, we were restricted in the variables considered in the
examination of sexual behaviors and risk among heterosexual men. Within this
secondary dataset, some of the variables considered in this analysis were based
on self-reported data, which may be affected by recall bias. Particularly because
this study addresses highly sensitive information and practices (i.e., sexual
behaviors and history), there is a possibility of social desirability bias in the
manner in which participants responded to survey items. However, the use of
Computer-Assisted Self-Interviewing (CASI) has been shown to decrease the
possibility of biased information being collected and improving the validity of
study findings, particularly in sexual behavior research (Fenton, Johnson,
McManus & Erens, 2001; Ghanem, Hutton, Zenilman, Zimba & Erbelding, 2005;
Kissinger et al., 1999; Kurth et al., 2004). It is important to mention that socio-
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cultural factors may have affected the validity of findings, as cultural expectations
for men in their sexual relationships may affect reporting on key variables, such
as the number of sexual partners and age of sexual initiation. For example, in
Latin American countries, such as Mexico and Brazil, cultural expectations that
closely associate multiple partners and early sexual debut with
conceptualizations of virility and machismo may lead respondents to over-report
the number of partners (Falicov, 2010; Parker, 1996; Perez-Jimenez, Seal &
Serrano-Garcia, 2009; Villarruel & Rodriguez, 2003; Wallace, 2011). In spite of
this potential bias, we have previously found that the utilization of CASI in the
data collection process for the parent study (i.e., HIM Study) demonstrated high
reliability in response to sensitive sexual behavior questions (Nyitray et al.,
2009).
It is noteworthy that recruitment strategies varied in the three study sites
(i.e., Brazil, Mexico, and the US), which may have affected our findings. For
example, because the US site had concentrated activities on a university
campus, the study participants from this site were more likely to be younger.
However, in Brazil and Mexico, recruitment strategies included centers devoted
to urogenital care and worksite promotion, resulting in more effective
identification of middle-aged to older adult participants. Additionally, our findings
may underscore socio-cultural factors that influence sexual risk outcomes by
age. For example, our analysis found that Brazilian men had a heightened risk
for STI positivity, which varied by age cohort. Further research may elucidate the
role of socio-cultural factors in the association between STI risk and age cohort.
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Despite these limitations, this study has some noteworthy strengths. The
study sample size is sufficient to offer substantial power for the detection of
group variances in the analysis. Although we cannot exclude the possibility of
residual confounding due to unmeasured variables, we controlled for several
potential confounders in our statistical analysis. The sub-analysis conducted by
age cohort yields important information on the age-related variances in sexual
behaviors and risk.
Due to the dearth of studies on sexual risk among heterosexual men,
continued research is needed regarding sexual behaviors within this population,
particularly among older age groups. Our study findings highlight the need for
added public health efforts to reduce STI risk and transmission among
heterosexual men beyond the adolescent period. Determining which male subpopulations have an increased risk of STI infection and understanding trend
patterns over time is helpful in allocating resources for effective prevention,
treatment, and management necessary for curtailing STI transmission.
Moreover, information on the prevalence of sexual behaviors by sociodemographic characteristics is beneficial in the development and implementation
of relevant policies and interventions to reduce STI prevalence, increase
awareness, and improve quality of life.
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Table 2.1: Demographic characteristics by age cohort a

Country of Residence
Brazil
Mexico
United States
Race
White
Black
Asian/Pacific Islander
American Indian/
Alaskan
Mixed
Unknown/Refused
Hispanic
Yes
No
Unknown/Refused
Marital Status
Single
Married
Cohabitating
Divorced/Separated/
Widowed
Unknown/Refused
Educational Level
<12 years
12 years
13-15 years
16 years

TOTAL

18-30 years

31-44 years

45-70 years

N=3,047

N=1,523

N=1,131

N=393

n (%)

n (%)

n (%)

n (%)
<.0001

888 (29.1)
1,075 (35.0)
1,084 (35.6)

352 (23.1)
443 (29.1)
728 (47.8)

419 (37.1)
490 (43.3)
222 (19.6)

117 (29.8)
142 (36.1)
134 (34.1)
<.0001

1,330 (43.7)
425 (14.0)
87 (2.9)

723 (47.5)
202 (13.3)
70 (4.6)

428 (37.8)
160 (14.2)
16 (1.4)

179 (45.6)
63 (16.0)
1 (0.3)

55 (1.8)

20 (1.3)

28 (2.5)

7 (1.8)

1,002 (32.9)
148 (4.9)

415 (27.3)
93 (6.1)

450 (39.8)
49 (4.3)

137 (34.9)
6 (1.5)
<.0001

1,423 (46.7)
1,599 (52.5)
25 (0.8)

633 (41.6)
881 (57.9)
9 (0.6)

616 (54.5)
501 (44.3)
14 (1.2)

174 (44.3)
217 (55.2)
2 (0.5)
<.0001

1,303 (42.8)
1,082 (35.5)
380 (12.5)

1,063 (69.8)
244 (16.0)
168 (11.0)

200 (17.7)
611 (54.0)
174 (15.4)

40 (10.2)
227 (57.8)
38 (9.7)

273 (9.0)

42 (2.8)

143 (12.6)

88 (22.4)

9 (0.3)

6 (0.4)

3 (0.3)

0 (0.0)

650 (21.3)
808 (26.5)
813 (26.7)
584 (19.2)
184 (6.0)
8 (0.3)

231 (15.2)
415 (27.3)
556 (36.5)
270 (17.7)
47 (3.1)
4 (0.3)

314 (27.8)
322 (28.5)
169 (14.9)
227 (20.1)
97 (8.6)
2 (0.2)

105 (26.7)
71 (18.1)
88 (22.4)
87 (22.1)
40 (10.2)
2 (0.5)

<.0001

≥17 years
Unknown/Refused
Circumcision Status
Yes
1,197 (39.3)
No
1,850 (60.7)
Current Smoking Status
Yes
713 (23.4)
No
2,328 (76.4)
Unknown/Refused
6 (0.2)
a

P-value

<.0001
718 (47.1)
805 (52.9)

317 (28.0)
814 (72.0)

162 (41.2)
231 (58.8)
0.3758

356 (23.4)
1,162 (76.3)
5 (0.3)

Percentages may not total to 100 due to rounding.
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275 (24.3)
855 (75.6)
1 (0.1)

82 (20.9)
311 (79.1)
0 (0.0)

Table 2.2: Self-reported sexual behaviors by age cohort a
TOTAL
N=3,047
n (%)

18-30 years
N=1,523
n (%)

31-44 years
N=1,131
n (%)

45-70 years
N=393
n (%)

Age at first vaginal sex

≤14 years
15-17 years
18-20 years

≥21 years
Unknown/Refused
Ever had oral sex
Yes
No
Ever had anal sex
Yes
No
Unknown/Refused

<.0001
551 (18.1)
1,335 (43.8)
816 (26.8)
317 (10.4)
28 (0.9)

265 (17.4)
722 (47.4)
427 (28.0)
100 (6.6)
9 (0.6)

203 (18.0)
455 (40.2)
286 (25.3)
172 (15.2)
15 (1.33)

83 (21.1)
158 (40.2)
103 (26.2)
45 (11.5)
4 (1.02)

2,743 (90.0)
304 (10.0)

1,415 (92.9)
108 (7.2)

1,010 (89.3)
121 (10.7)

318 (80.9)
75 (19.1)

1,514 (49.7)
1,513 (49.7)
20 (0.7)

674 (44.3)
840 (55.2)
9 (0.6)

648 (57.3)
475 (42.0)
8 (0.7)

192 (48.9)
198 (50.4)
3 (0.8)

<.0001

<.0001

Ever exchanged sex for money or drugs
Yes
328 (10.8)
134 (8.8)
1,384 (90.9)
No
2,707 (88.8)
5 (0.3)
Unknown/Refused
12 (0.4)
Condom use with vaginal sex in recent past
No vaginal sex in
recent past
221 (7.3)
114 (7.5)
Never
1,123 (36.9)
372 (24.4)
654 (42.9)
Sometimes
1,054 (34.6)

0.0001
157 (13.9)
971 (85.9)
3 (0.3)

37 (9.4)
352 (89.6)
4 (1.0)
<.0001

57 (5.0)
532 (47.0)
342 (30.2)

50 (12.7)
219 (55.7)
58 (14.8)

368 (24.2)

189 (16.7)

53 (13.5)

15 (1.0)
Unknown/Refused
39 (1.3)
Number of Lifetime Female Sexual Partners
1
283 (9.3)
201 (13.2)
2-9
1,381 (45.3)
804 (52.3)
236 (15.5)
10-19
546 (17.9)
20-49
492 (16.2)
180 (11.8)
44 (2.9)
179 (5.9)
≥50
58 (3.8)
Unknown/Refused
166 (5.5)

11 (1.0)

13 (3.3)

Always

a

P-value

610 (20.0)

Percentages may not total to 100 due to rounding.
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<.0001
69 (6.1)
455 (40.2)
229 (20.3)
211 (18.7)
92 (8.1)
75 (6.6)

13 (3.3)
122 (31.0)
81 (20.6)
101 (25.7)
43 (10.9)
33 (8.4)

Table 2.3: Self-reported prior diagnosis with an STI by age cohort a
TOTAL
N=3,047
n (%)
Genital Herpes
Yes
67 (2.2)
No
2,898 (95.1)
Don't Know
77 (2.5)
Unknown/Refused
5 (0.2)
Chlamydia
Yes
59 (1.9)
No
2,873 (94.3)
Don't Know
110 (3.6)
Unknown/Refused
5 (0.2)
Gonorrhea
Yes
193 (6.3)
No
2,776 (91.1)
Don't Know
73 (2.4)
Unknown/Refused
5 (0.2)
Syphilis
Yes
30 (1.0)
No
2,941 (96.5)
Don't Know
71 (2.3)
Unknown/Refused
5 (0.2)
Non-gonococcal Urethritis
Yes
40 (1.3)
No
2,902 (95.2)
Don't Know
100 (3.3)
Unknown/Refused
5 (0.2)
Hepatitis B
Yes
44 (1.4)
No
2,880 (94.5)
Don't Know
118 (3.9)
Unknown/Refused
5 (0.2)
Hepatitis C
Yes
21 (0.7)
No
2,905 (95.3)
Don't Know
116 (3.8)
Unknown/Refused
5 (0.2)

18-30 years
N=1,523
n (%)

31-44 years
N=1,131
n (%)

45-70 years
N=393
n (%)

P-value
<.0001

15 (1.0)
1,459 (95.8)
46 (3.0)
3 (0.2)

39 (3.5)
1,067 (94.3)
23 (2.0)
2 (0.2)

13 (3.3)
372 (94.7)
8 (2.0)
0 (0.0)
0.9336

29 (1.9)
1,439 (94.5)
52 (3.4)
3 (0.2)

23 (2.0)
1,060 (93.7)
46 (4.1)
2 (0.2)

7 (1.8)
374 (95.2)
12 (3.1)
0 (0.0)
<.0001

22 (1.4)
1,451 (95.3)
47 (3.1)
3 (0.2)

103 (9.1)
1,006 (89.0)
20 (1.8)
2 (0.2)

68 (17.3)
319 (81.2)
6 (1.5)
0 (0.0)
<.0001

2 (0.1)
1,475 (96.9)
43 (2.8)
3 (0.2)

14 (1.2)
1,094 (96.7)
21 (1.9)
2 (0.2)

14 (3.6)
372 (94.7)
7 (1.8)
0 (0.0)
<.0001

16 (1.0)
1,453 (95.4)
51 (3.4)
3 (0.2)

9 (0.8)
1,081 (95.6)
39 (3.5)
2 (0.2)

15 (3.8)
368 (93.6)
10 (2.5)
0 (0.0)

17 (1.1)
1,440 (94.6)
63 (4.1)
3 (0.2)

18 (1.6)
1,069 (94.5)
42 (3.7)
2 (0.2)

9 (2.3)
371 (94.4)
13 (3.3)
0 (0.0)

6 (0.4)
1,454 (95.5)
60 (3.9)
3 (0.2)

9 (0.8)
1,079 (95.4)
41 (3.6)
2 (0.2)

6 (1.5)
372 (94.7)
15 (3.8)
0 (0.0)

0.2016

0.0468
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Table 2.3 (Continued)
HIV
Yes
No
Don't Know
Unknown/Refused
Any STI
Yes
No
Don't Know
Unknown/Refused
a

0.9322
7 (0.23)
2,957 (97.1)
78 (2.6)
5 (0.2)

3 (0.2)
1,476 (97.0)
41 (2.7)
3 (0.2)

3 (0.3)
1,100 (97.3)
26 (2.3)
2 (0.2)

1 (0.3)
381 (97.0)
11 (2.8)
0 (0.0)
<.0001

418 (13.7)
2,543 (83.6)
83 (2.7)
3 (0.1)

119 (7.8)
1,353 (88.8)
49 (3.2)
2 (0.1)

Percentages may not total to 100 due to rounding.
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197 (17.4)
907 (80.2)
27 (2.4)
0 (0.0)

103 (26.0)
283 (72.0)
78 (1.8)
1 (0.3)

Table 2.4: Results of STI tests by age cohort a
TOTAL
N=3,047
n (%)

18-30 years
N=1,523
n (%)

31-44 years
N=1,131
n (%)

45-70 years
N=393
n (%)

Genital Herpes
Positive
540 (17.7)
121 (7.9)
292 (25.8)
127 (32.3)
Negative
2,504 (82.2)
1,401 (92.0)
837 (74.0)
266 (67.7)
1 (0.1)
2 (0.2)
0 (0.0)
No Result
3 (0.1)
Chlamydia
Positive
52 (1.7)
40 (2.6)
10 (0.9)
2 (0.5)
1,483 (97.4)
1,121 (99.1)
391 (99.5)
Negative
2,995 (98.3)
Gonorrhea
Positive
9 (0.3)
7 (0.5)
2 (0.2)
0 (0.0)
Negative
3,037 (99.7)
1,516 (99.5)
1,128 (99.7)
393 (100.0)
0 (0.0)
1 (0.1)
0 (0.0)
No Result
1 (0.0)
Syphilis
Positive
16 (0.5)
5 (0.3)
4 (0.4)
7 (1.8)
Negative
3,027 (99.3)
1,515 (99.5)
1,126 (99.6)
386 (98.2)
3 (0.2)
1 (0.1)
0 (0.0)
No Result
4 (0.1)
Composite STI: Positive for one of any of the four above STIs tested
Positive
601 (19.7)
165 (10.8)
305 (27.0)
131 (33.3)
Negative
2,446 (80.3)
1,358 (89.2)
826 (73.0)
262 (66.7)
a

Percentages may not total to 100 due to rounding.

84

P-value
<.0001

0.0004

0.2127

0.0011

<.0001

Table 2.5: Adjusted estimates of the likelihood of a positive test for a sexually
transmitted infection by age cohort a
TOTAL
N=3,047
b
AOR (95% CI)

18-30 years
N=1,523
b
AOR (95% CI)

31-44 years
N=1,131
b
AOR (95% CI)

45-70 years
N=393
b
AOR (95% CI)

0.29 (0.20-0.40)
0.74 (0.55-0.98)
Referent

c

c

c

3.00 (2.14-4.20)
0.55 (0.27-1.14)
Referent

7.47 (3.91-14.30)
0.71 (0.21-2.41)
Referent

1.75 (1.03-2.95)
0.36 (0.13-1.03)
Referent

2.25 (1.03-4.89)
1.09 (0.14-8.31)
Referent

Referent
1.50 (1.15-1.96)
0.81 (0.38-1.74)
0.80 (0.43-1.48)
1.30 (0.67-2.50)

Referent
1.07 (0.67-1.72)
0.47 (0.13-1.67)
0.63 (0.21-1.87)
1.67 (0.55-5.09)

Referent
1.64 (1.10-2.42)
1.67 (0.51-5.43)
1.20 (0.53-2.72)
1.24 (0.49-3.10)

Referent
1.48 (0.76-2.87)
0.23 (0.04-1.40)
0.65 (0.10-4.33)

0.93 (0.69-1.25)
Referent
1.06 (0.77-1.46)

1.00 (0.58-1.73)
Referent
1.15 (0.61-2.19)

0.96 (0.63-1.47)
Referent
0.93 (0.61-1.43)

1.73 (0.74-4.08)
Referent
1.34 (0.59-3.07)

1.46 (1.04-2.06)

1.68 (0.61-4.62)

1.91 (1.21-3.02)

0.83 (0.43-1.62)

1.62 (1.01-2.59)
1.25 (0.79-1.96)
1.25 (0.79-1.99)
1.15 (0.72-1.82)
Referent

0.53 (0.20-1.38)
0.44 (0.18-1.07)
0.41 (0.17-1.02)
0.37 (0.15-0.92)
Referent

3.04 (1.53-6.06)
1.85 (0.95-3.59)
2.85 (1.43-5.68)
1.82 (0.92-3.62)
Referent

1.03 (0.39-2.72)
1.33 (0.50-3.55)
1.07 (0.42-2.70)
0.88 (0.34-2.25)
Referent

2.15 (1.43-3.23)
15-17 years
1.11 (0.76-1.62)
18-20 years
1.28 (0.87-1.89)
Referent
≥21 years
Ever exchanged sex for money or drugs
1.35 (1.01-1.80)
Yes
No
Referent

1.24 (0.55-2.79)
0.67 (0.31-1.44)
0.81 (0.37-1.79)
Referent

2.37 (1.34-4.18)
1.28 (0.76-2.14)
1.80 (1.05-3.07)
Referent

3.75 (1.45-9.74)
1.42 (0.60-3.37)
1.08 (0.44-2.68)
Referent

1.01 (0.59-1.72)
Referent

1.18 (0.78-1.78)
Referent

2.30 (1.05-5.04)
Referent

Age
18-30 years
31-44 years
45-70 years
Country of Residence
Brazil
Mexico
United States
Race
White
Black
Asian/Pacific Islander
American Indian/ Alaskan
Mixed
Marital Status
Single
Married
Cohabitating
Divorced/ Separated/
Widowed
Educational Level
<12 years
12 years
13-15 years
16 years

≥17 years

d

Age at first vaginal sex

≤14 years
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Table 2.5 (Continued)
Number of Lifetime Female Sexual Partners
1
Referent
2-9
1.04 (0.75-1.46)
10-19
1.02 (0.70-1.49)
1.48 (1.02-2.16)
20-49
2.07 (1.31-3.28)
≥50

Referent
1.19 (0.67-2.11)
0.77 (0.37-1.60)
2.06 (1.04-4.06)
4.33 (1.74-10.76)

a

Referent
1.13 (0.68-1.90)
1.14 (0.65-2.00)
1.48 (0.83-2.63)
1.34 (0.68-2.65)

Referent
0.65 (0.29-1.49)
0.80 (0.33-1.90)
0.47 (0.20-1.13)
1.04 (0.38-2.84)

Outcome is composite STI variable: testing positive for at least one of the following STIs – genital herpes,
chlamydia, gonorrhea, and/or syphilis.
Model is adjusted for the following variables: country of residence, race, ethnicity/Hispanic, marital status,
educational level, circumcision status, age at first vaginal sex, previous oral sex and anal sex activity,
condom use, and number of lifetime female sexual partners. Ethnicity/Hispanic, circumcision status,
previous oral and anal sex activity, and condom use are not included in the table due to lack of significant
findings.
b
AOR=Adjusted Odds Ratio, 95% CI=95% Confidence Intervals; Significant values in bold font.
c
Not applicable.
d
Insufficient cell size.
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Enrollment dataset for HPV in Men Study (2005-2009)
= 4,074

Eliminate men who reported previous sexual experiences
with men (i.e., oral or anal intercourse) (n=596)
= 3,478

Eliminate men who are not sexually active (i.e., never
experienced vaginal intercourse) (n=431)
= 3,047

Final records retained for analyses:
N= 3,047

Figure 2.1: Flow chart of exclusion process for the study
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Section Three:
Manuscript Two
The impact of testing and diagnosis for the human papillomavirus and other
sexually transmitted infections on sexual behavior in a cross-national sample of
men
JOURNAL: American Journal of Public Health

Introduction
Despite scientific and medical advances to minimize their reach and
impact, sexually transmitted infections (STIs) continue to threaten the health and
well-being of individuals and communities (Gerbase, Rowley, Heymann, Berkley
& Piot, 1998; World Health Organization, Joint United Nations Programme on
HIV/AIDS, 1999; World Health Organization, 2007). STIs are caused by diverse
bacterial organisms and viral agents that can result in no symptoms, mild,
transient symptoms, or severe, long-term sequelae, such as infertility, premature
mortality, and cervical, anal, and penile cancers (De Schryver & Meheus, 1990;
Genuis & Genuis, 2004; Gerbase et al., 1998; Mayaud & Mabey, 2004; Mayaud
& McCormick, 2001; World Health Organization, Joint United Nations
Programme on HIV/AIDS, 1999; World Health Organization, 2007). It is
estimated that more than 340 million new cases of bacterial STIs (e.g.,
chlamydia, gonorrhea, syphilis) occur annually worldwide (Gerbase et al., 1998;
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World Health Organization, Joint United Nations Programme on HIV/AIDS, 1999;
World Health Organization, 2007). As the most common STI, HPV will affect
more than half of all sexually active individuals at some point in their lifetime
(Centers for Disease Control and Prevention, 2010; Genuis & Genuis, 2004;
Vetter & Geller, 2007).
Unfortunately, with the advent of HIV/AIDS more than 25 years ago, other
STIs have increasingly been neglected (World Health Organization, 2007). While
reducing HIV infection is highly ranked on the international policy agenda and is
noted as one of the Millennium Development Goals, the prevention of other STIs
are not prioritized (Low et al., 2006; United Nations, 2000). Instead, measures to
reduce other STIs have been generally taken as a means to reduce HIV
infections, as they have been found to facilitate HIV transmission (Low et al.,
2006; Mayaud & McCormick, 2001; Wasserheit, 1992; World Health
Organization, Joint United Nations Programme on HIV/AIDS, 1999; World Health
Organization, 2007). Given the potential adverse outcomes and impact on
quality of life, STIs are an important public health concern, regardless of their
association with HIV (Glasier, Gulmezoglu, Schmid, Moreno & Van Look, 2006;
Low et al., 2006).
Overall, diagnosis and treatment have been prioritized as an important
strategy for the prevention and treatment of STIs (World Health Organization,
2007). It is widely believed that learning one’s STI status contributes to safer
sexual behavior (Thornton, 2008; World Health Organization, Joint United
Nations Programme on HIV/AIDS; UNICEF, 2009). Additionally, the identification
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of those who are infected is an essential first step for treatment (World Health
Organization, Joint United Nations Programme on HIV/AIDS; UNICEF, 2009).
Therefore, knowledge of one’s disease status constitutes an important public
health strategy because it allows for fundamental actions that can prevent the
spread of infection and provide infected individuals with necessary services
(World Health Organization, Joint United Nations Programme on HIV/AIDS;
UNICEF, 2009). However, previous empirical research has provided mixed
evidence regarding the role of HIV testing on sexual behaviors (Denison,
O’Reilly, Schmid, Kennedy & Sweat, 2008; Marks, Crepaz, Senterfitt & Janssen,
2005; Sherr et al., 2007; Weinhardt, Carey, Johnson & Bickham, 1999; Wolitski,
MacGowan, Higgins & Jorgensen, 1997).
Given the lack of information on the impact of STI testing and diagnosis on
subsequent sexual behavior, as well as the ongoing policy recommendations
regarding knowledge of one’s status for enhanced prevention and treatment, we
analyzed the impact of testing and learning one’s HPV and STI status on
subsequent sexual behavior within a cross-national sample of sexually active,
adult men in Brazil, Mexico, and the United States. There is a dearth of studies
that examine the impact of STI testing among men, as research on testing
services has historically been conducted with high-risk populations (e.g., men
who have sex with men, injection drug users) or special populations (e.g.,
pregnant women) (Denison et al., 2008; Marks et al., 2005; Wolitski et al., 1997).
The present study addresses this gap with the utilization of data collected from a
general population of men to describe the consequences of STI testing on sexual
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behavior. In this study, we sought to assess whether men’s sexual behaviors
change following HPV and STI testing and whether men’s sexual behaviors
change upon notification of HPV and/or STI diagnosis.

Methods
Study Design and Sample. This is a prospective cohort analysis utilizing
data from a cross-national, HPV, natural history study in men. The parent study
– the HPV in Men (HIM) Study – explores factors associated with HPV
prevalence and incidence among men in Sao Paulo, Brazil, Cuernavaca, Mexico,
and Tampa, Florida in the United States (US) (Giuliano et al., 2008; Giuliano et
al., 2011). A complete description of the protocols and procedures for the HIM
Study has previously been published (Giuliano et al., 2008; Giuliano et al., 2011).
Diverse recruitment strategies were utilized to identify eligible men for
study participation from the general population. In Brazil, study recruitment was
facilitated through media advertising and a center for urogenital care in Sao
Paulo, while in Mexico, participants were recruited through the public health
system, local factories, and military personnel in Cuernavaca. In the US,
recruitment efforts involved print and radio advertising within a local university, as
well as in the greater metropolitan area of Tampa, Florida. Prior to enrollment in
the study, all participants provided written informed consent.
The study sample was drawn from men who were enrolled in the HIM
Study from June 2005 to December 2009 (N=4,072). The HIM Study protocol
includes a pre-enrollment visit, a baseline/enrollment visit, and nine additional
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visits following enrollment, scheduled every six months. To encourage
compliance with follow-up, men received compensation for their participation.
For the present analysis, we included men who participated in the baseline
assessment (Visit 1) and remained in the study for two follow-up visits (Visits 2
and 3), each of which was conducted at six-month intervals (Figure 3.1). At each
study visit, men completed a risk factor questionnaire via Computer-Assisted
Self-Interviewing (CASI) and were tested for HPV and other STIs, including
chlamydia, gonorrhea, syphilis, and genital herpes. HPV and STI test results
from the baseline visit (Visit 1) were used in this analysis. Men were informed of
their HPV and STI diagnoses at the first follow-up visit (Visit 2). Self-reported
data on men’s sexual behavior were collected at the ensuing follow-up visit (Visit
3).
For the parent study, the study population consisted of men who met the
following inclusion criteria (N=4,072): a) aged 18 to 70 years; b) residents of one
of the three study sites; c) no reports of prior diagnosis with penile or anal
cancers; d) no report of symptoms of or treatment for an STI; e) not currently
participating in an HPV vaccine study; f) no history of HIV/AIDS; g) no history of
imprisonment, homelessness, or drug treatment during the past six months; and
h) willingness to comply with ten scheduled study visits conducted every six
months over a four year period with no plans to relocate during study
implementation. For this study, the sample was restricted to men who were
sexually active, excluding any men who reported no prior experience with
vaginal, anal, or oral intercourse (n=453). We further eliminated men who did not
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return for their HPV and STI test results at first follow-up visit (Visit 2; n=570) and
those who did not remain in the study subsequent to the receipt of their test
results (Visit 3; n=701). The overall study sample totaled 2,351 men. The
elimination process that resulted in our study sample is depicted in Figure 3.2.
Risk Factor Questionnaire. The risk factor questionnaire is administered
at baseline/enrollment (Visit 1) and at all follow-up visits. This instrument
consists of socio-demographic characteristics, alcohol and tobacco use, sun
exposure, history of STIs, circumcision status, sexual history, and contraceptive
practices. While the original survey instrument was developed in English, it was
later translated into the primary language of each of the survey sites (i.e.,
Portuguese in Sao Paulo, Brazil; Spanish in Cuernavaca, Mexico) and backtranslated into English to ensure accuracy and cross-cultural understanding. A
test-retest reliability assessment of the instrument was conducted in all three
languages and yielded high reliability coefficients for all variables (intraclass
correlation coefficient (ICC) ≥ 0.85) (Nyitray et al., 2009). The questionnaire
required approximately 20 minutes to complete via CASI. For each survey item,
participants were given the option to refuse to answer, which were treated as
missing observations.
Testing for HPV and STIs. Upon study enrollment (Visit 1), men who
provided consent underwent a clinical examination. Additionally, participants
were tested for HPV and other STIs, including chlamydia, gonorrhea, syphilis,
and herpes simplex virus 2 (HSV2; also known as genital herpes). Biological
samples were collected from all of the participants from the external genitalia,
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including the coronal sulcus, the gland penis, and shaft of the penis, for HPV
testing. Prior to DNA extraction, the three samples were combined to produce
one DNA extract per participant to maximize HPV detection. HPV testing was
conducted using polymerase chain reaction (PCR) and the Linear Array HPV
genotyping test. Urine specimens (20-30 mLs) were collected in collection cups
free of any preservatives for testing to detect gonorrhea and chlamydia RNA,
TMA. A 2 mL urine specimen was transferred into the GenProbe specimen
transport tube within 24 hours of collection before being assayed. Sera were
tested for syphilis infection by Rapid Plasma Reagin (RPR). Positive results
were confirmed with the more specific FTA-ABS, which confirms the presence of
treponemal antibodies but does not indicate the stage or presence of active
infection. Sera were also tested for HSV2 by Immunoassay with the IgG Type
Specific Antibody (HerpeSelect) test. Participants with positive test results were
offered treatment at no cost.
Variables. HPV and STI diagnoses were categorized in the following
mutually exclusive groups: positive for HPV and other STIs; positive for HPV
only; positive for other STIs only; or negative for both HPV and other STIs. Due
to the high prevalence of HPV compared to other STIs (Centers for Disease
Control and Prevention, 2010; Genuis & Genuis, 2004; Vetter & Geller, 2007),
HPV diagnosis was not grouped with the other STIs examined in this study (i.e.,
chlamydia, gonorrhea, syphilis, herpes). Multiple sexual behaviors served as the
outcomes of interest in this study, including vaginal or oral sex, exchanging sex
for money or drugs (i.e., paid sex), condom use with vaginal sex, and number of
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new sexual partners in the past six months.
Covariates included in the analysis were based on biologic plausibility and
a review of the literature. Demographic variables included in the analysis were:
age (18-30 years, 31-44 years, 45-70 years); country of residence (Brazil,
Mexico, US); self-identified race (White, Black, Asian/Pacific Islander, American
Indian, Mixed); Hispanic (Yes, No); marital status (single, married, cohabitating,
divorced/separated/widowed); educational level (<12 years, 12 years, 13 to 15
years, 16 years, ≥17 years); sexual orientation (heterosexual, homosexual,
bisexual); self-reported circumcision status (Yes, No); and current smoking status
(Yes, No). Additionally, behavioral factors included age at first vaginal sexual
encounter (≤14 years, 15-17 years, 18-20 years, ≥21 years) and number of
lifetime sexual partners (1, 2-9, 10-19, 20-40, ≥50).
Statistical Analysis. Baseline descriptive statistics (e.g., frequencies and
measures of central tendency and variability) for demographic and behavioral
characteristics were computed by HPV and STI status using the chi-square test
to summarize sample characteristics, to explore relationships among variables,
and to guide development of the repeated measures models. Preliminary
analyses were conducted with McNemar’s test to assess differences in selfreported sexual behaviors by visit (i.e., baseline/Visit 1, Visit 2, and Visit 3) within
correlated data. These analyses were conducted within the overall study sample
and were further stratified by HPV and STI status. Effect sizes were also
assessed for dichotomous outcomes. SAS (version 9.2) was used for data
management and for all data manipulations. All tests of hypotheses were two-
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tailed with a type 1 error rate of 5%.
Proc GLIMMIX in SAS (SAS Institute, Inc., Cary, North Carolina, version
9.2) was used to analyze longitudinal trends in sexual behavior. Regression
models were developed for each of the sexual behavior outcomes and condom
use variables. To assess differential trends in behavior over follow-up time,
interactions between covariates and follow-up time were evaluated.
Furthermore, interaction terms were added to the models to determine whether
the effects by visit were moderated by HPV and STI diagnosis (i.e., time by
group). Prior to implementation, this investigation was approved by the
Institutional Review Board of the University of South Florida.

Results
A comparison of selected demographic and behavioral characteristics at
baseline (Visit 1) by HPV and STI status within the study sample is presented in
Table 3.1. The study sample consisted of 2,351 men, aged 18 to 70 years, with
a mean age of 32.8 years (standard deviation [SD] ±11.5; median=31.0 years).
Of the men in the study sample, nearly half (46.3%) were diagnosed with only
HPV, while 16.8% were diagnosed with HPV and other STIs (i.e., chlamydia,
gonorrhea, syphilis, or herpes), and 6.1% were positive for at least one of the
other tested STIs (excluding HPV). The highest exposure category across all
observed covariates was positivity for HPV only. In this cross national sample,
Mexicans had the lowest frequency of infection, with 65% testing positive for
HPV and/or STIs, compared to Brazilians, who had the highest disease
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prevalence at 81.1%. The highest proportions of combined HPV and/or STI
positivity were observed among American Indian/Alaskan men (86%), followed
by Black men (78.1%). When observing prevalence by marital status, the
highest combined proportion of HPV and/or STIs were observed among men
who were divorced, separated, or widowed (84.7%), whereas the lowest were
seen among single men (65.2%), followed closely by married men (68.9%). The
highest rates of HPV and/or STIs were observed among bisexual (85.1%) and
homosexual (79.8%) men. Within our study sample, the proportions of HPV and
STI diagnosis, as well as diagnosis with STIs only, increased with increasing
number of lifetime sexual partners.
HPV and STI prevalence at baseline (Visit 1) by self-reported sexual
behaviors is presented in Table 3.2. Within this sexually active sample, oral and
paid sexual encounters in the past six months were associated with significantly
higher rates of diagnosis with HPV and STIs (17.0% and 25.6%, respectively).
Men who reported vaginal and oral sex in the past six months had higher
frequencies of HPV only (46.6% and 47.7%, respectively), whereas men who
reported paid sex in the past six months had higher frequencies of STIs only
(8.5%). Men who reported never using condoms for vaginal sex had higher rates
for HPV only (53.2%). The highest frequency of HPV and STIs (29.2%) was
observed among men who reported three or more new sexual partners in the
past six months.
Changes in self-reported sexual behaviors following STI testing and the
receipt of test results are summarized in Table 3.3. In the overall study sample,
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statistically significant decreases were only observed in vaginal sex throughout
the study period (baseline/Visit 1 to Visit 2, p<.0001; Visit 2 to Visit 3, p=0.0257).
For all other sexual behaviors, significant changes were only noted from baseline
to the first /Visit 1 to Visit 2, prior to receipt of HPV and STI test results (p<.0001).
Reduced levels of oral sex and paid sex were reported, along with fewer
numbers of new sexual partners in the prior six-month period. Similar behavioral
patterns were observed among men with positive diagnoses for HPV and/or
other STIs. However, among men who were negative for both HPV and other
STIs, reductions in vaginal sex did not persist beyond the receipt of their HPV
and STI test results (i.e., from Visit 2 to Visit 3). Additionally, paid sexual
encounters among these men decreased immediately after being tested for HPV
and STIs (i.e., from baseline/Visit 1 to Visit 2); however, this behavior increased
following the receipt of their negative test results. No significant changes were
detected in numbers of new sexual partners among men without HPV/STI
diagnoses.
Adjusted odds ratios and 95% confidence intervals for sexual behaviors
among study participants are presented in Table 3.4. Significant changes were
observed in reported vaginal, oral, and paid sexual encounters from
baseline/Visit 1 to Visit 2, following testing for HPV and other STIs. Our findings
indicate that, during the six months following testing, the odds of vaginal sex
decreased by 66% (AOR=0.34, 95% CI=0.27-0.41), while those of oral sex
decreased by 41% (AOR=0.59, 95% CI=0.48-0.72). Paid sexual encounters
showed the largest likelihood of reduction following testing, with a decrease in
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odds of 75% (AOR=0.25, 95% CI=0.20-0.32). Additionally, the likelihood of
having no new sexual partners during the preceding six-month period decreased
by 28% following testing (AOR=0.72, 95% CI=0.61-0.84). No changes in sexual
behaviors were observed following notification of HPV/STI status (between Visits
2 and 3). While there were no changes in condom use based on testing, men
whose results indicated they were positive for HPV (and not other STIs) had a
39% reduced likelihood of using condoms with vaginal sex (AOR=0.61, 95%
CI=0.40-0.92) over the study period. Furthermore, men who tested positive for
HPV and other STIs or HPV only were 49-50% less likely to report no new sexual
partners in the most recent six-month period (Positive for HPV and other STIs:
AOR=0.51, 95% CI=0.31-0.83; Positive for HPV only: AOR=0.50, 95% CI=0.340.72). No significant interactions between visit and HPV/STI diagnoses were
observed for any of the outcome variables.

Discussion
Our study found a significant change in men’s sexual behaviors in the sixmonth period following testing for HPV and other STIs, regardless of their
diagnoses. Being informed of one’s test results did not lead to further behavioral
change. Significant reductions in vaginal and oral sex, as well as paid sexual
encounters, were reported among men in the study sample following HPV and
STI testing. While the impact of STI testing on sexual behaviors is relatively
unstudied, similar research on HIV testing has found subsequent decreases in
paid sex (Bentley et al., 1998) and vaginal sex (Hernando et al., 2009). It is
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possible that the reduction in sexual behaviors revealed in our study might be the
product of the “Hawthorne Effect,” indicating that changes within the study
sample are the result of the process of participating in a study and being
observed (Gall, Gall & Borg, 2007; Neuman, 1997). Alternatively, the act of
being tested for HPV and other STIs may be the motivator for behavioral change
among study participants.
Interestingly, men who tested positive for HPV only (and not other STIs)
had a significantly reduced likelihood of using condoms with vaginal sex. This
increase in sexual risk behavior, despite HPV diagnosis, may be attributable to a
lack of knowledge regarding HPV among men, as previous research has
indicated that HPV knowledge among men is relatively low (Brewer, Ng, McRee
& Reiter, 2010; Bynum, Brandt, Friedman, Annang & Tanner, 2011; Gerend &
Barley, 2009; Nandwani, 2010; Tider, Parsons, & Bimbi, 2005). However, recent
analyses with the US sub-population of this study have revealed that men are
knowledgeable about HPV (Daley, 2009). Therefore, this supposition may only
be applicable to Brazilian and Mexican men. Furthermore, in the present study,
this conclusion is speculative, as we did not have information on the participants’
HPV knowledge for analysis.
It is important to note that the testing scenario presented within this study
may not reflect real-world circumstances for men. The ability to be tested for
STIs is critically dependent on the availability and access to health services.
Within this cross-national study, men were provided with testing services at no
cost. However, structural barriers, such as lack of health care coverage or
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transportation to the health care facility, may serve as a barrier to receiving such
services (Parrish & Kent, 2008; Politzer et al., 2001; Weissman, Stern, Fielding &
Epstein, 1991). As some STIs are asymptomatic for men, if men do not present
with visible signs or symptoms, they may not elect to obtain STI testing.
Furthermore, a simple, ubiquitous means for testing for the presence of HPV is
not currently available for men (Centers for Disease Control and Prevention,
2012; McGinley, Hey, Sussman & Brown, 2011).
There are some potential limitations in this study. Since this study used
data from an existing dataset, the variables considered were restricted to those
readily available. The enrollment procedure in this cross-national study was not
uniform across the three research sites (i.e., Brazil, Mexico, and the US), which
may have influenced the external validity of our study. Furthermore, the variance
in socio-cultural norms and beliefs regarding sexual behavior, STIs, and testing
may have also affected the study outcomes. Although we did not have
community level data regarding sex and sexuality, significant differences were
observed by country (i.e., Brazil, Mexico, and the US), indicating that there may
be cultural factors at play. Taking into consideration these various issues, the
generalizability of our study is minimized.
The men included in this analysis were those who participated in all study
visits (i.e., Visits 1, 2, and 3). Men who initially enrolled the study may be
inherently different than those who did not, as previous research has indicated
that volunteers for sexual behavior research may be more sexually informed and
experienced to some extent (Catania, McDermott & Pollack, 1986; Gaither,
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Sellbom & Meier, 2003; Strassberg & Lowe, 1995). Additionally, those lost to
follow-up may have different perceptions of risk and beliefs about STIs from
those who stayed in the study for its duration. The pattern of attrition in our study
population suggests that the data are not missing at random (Tables D1, D2, and
D3) and, consequently, could not be modeled in our analysis (Allison, 2002; Little
& Rubin, 2002).
Due to the highly sensitive nature of the outcomes of interest in this study
(i.e., sexual behaviors), there is a possibility of social desirability bias in
participant responses, as behavioral variables were all self-reported. However,
Computer-Assisted Self-Interviewing (CASI), which was used in this study for the
risk factor questionnaire, has been demonstrated as an effective option in sexual
behavior research for the presentation of questions in a less threatening manner,
which reduces non-responses to items and the likelihood of biased information
being reported, improving the overall validity of study findings (Fenton, Johnson,
McManus & Erens, 2001; Ghanem, Hutton, Zenilman, Zimba & Erbelding, 2005;
Kissinger et al., 1999; Kurth et al., 2004). Given the nature of these variables,
estimation of their validity is not possible; however, reliability assessments serve
as a measure of consistency and stability of the variables (Saltzman, Stoddard,
McCusker, Moon & Mayer, 1987). A prior test-retest reliability assessment of the
risk factor questionnaire utilized in this study yielded strong results (Nyitray et al.,
2009) , which indicates that recall bias should be minimal. Furthermore, previous
research has indicated that sexual behavior reported at time intervals of six
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months or less can improve subject recall (Catania, Gibson, Marin, Coates &
Greenblatt, 1990).
In spite of these limitations, this study provides some noteworthy insights
and information regarding the potential implications of STI testing and sexual
behavior among men that may prove beneficial for intervention development.
Our study used a large cross-national sample of a general population of men,
which enhances the strength of our results. Since few studies have explored
factors associated with STI testing of men, our findings provide important
information on an understudied group. While we cannot eliminate the possibility
of residual confounding in our analysis attributable to unmeasured variables, we
controlled for several potential confounders. Male involvement, male motivation,
and services for men have been recommended as an innovative approach to STI
prevention (World Health Organization, 2007). Therefore, this data should prove
useful for the development and planning of programs to prevent the spread of
STIs and provide more opportunities for treatment and education among men.
While our findings suggest that there are short-term effects on sexual
behavior following STI testing, further research into individual level factors, such
as knowledge and attitudes regarding STIs and sexual behavior, as well as
psychosocial and sociocultural constructs (e.g., gender norms, stigma), is
warranted. Prior research has indicated that testing positive for HPV, the most
common STI, can result in adverse psychosocial outcomes, including anxiety and
distress and concern about their sexual relationships (Daley et al., 2010; Kahn et
al., 2005; McCaffery et al., 2004; McCaffery, Waller, Nazroo & Wardle, 2006;
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Waller, McCaffery, Forrest & Wardle, 2004). Additionally, perceptions of risk and
stigma regarding HPV testing have been assessed (Daley et al., 2010; Kahn et
al., 2005; McCaffery et al., 2006; Waller et al., 2004). However, these studies
have predominantly been conducted with women; the influence of these issues
on HPV and STI testing within a general male population (i.e., not specifically
men who have sex with men or injection drug users) is virtually unexplored.
Future studies should also examine partner-level correlates, which were not
included in this analysis and may have implications on sexual behavior and
health outcomes. Disclosure of one’s disease status is an important aspect of
STI prevention, potentially reducing the likelihood of transmission through
treatment and protective behaviors (e.g., condom use) (McKay & Mutchler, 2010;
Mutchler et al., 2008; Wong et al., 2009).
Overall, our study highlights the potential for STI testing to reduce sexual
risk taking among men. However, given the noted limitations within this study,
the development and implementation of STI testing initiatives should be
approached with caution. The short-term effects on behavioral changes in our
study sample underscores the need for further investigation to maximize the
effectiveness of STI testing programs for men. Furthermore, coupling testing
strategies with education on STIs and risk reduction approaches may improve
long-term health outcomes.
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Table 3.1: Baseline demographic and behavioral characteristics among study participants by HPV and STI test results a, b
TOTAL
Characteristics

N=2,351
n (%)

Country of Residence
Brazil
Mexico
United States
Age
18-30 years
31-44 years
45-70 years
Race
White
Black
Asian/Pacific Islander
American Indian/Alaskan
Mixed
Hispanic
Yes
No
Marital Status
Single
Married
Cohabitating
Divorced/Separated/Widowed
Educational Level
<12 years
12 years
13-15 years
16 years
≥17 years

Positive for
HPV & STIs
n=395
(16.8%)
n (%)

Positive for
HPV only
n=1,088
(46.3%)
n (%)

Positive for
STIs only
n=143
(6.1%)
n (%)

Negative for
HPV & STIs
n=725
(30.8%)
n (%)

P-value c
<.0001

943 (40.1)
560 (23.8)
848 (36.1)

262 (27.8)
58 (10.4)
75 (8.8)

416 (44.1)
288 (51.4)
384 (45.3

87 (9.2)
18 (3.2)
38 (4.5)

178 (18.9)
196 (35.0)
351 (41.4)

1,142 (48.6)
880 (37.4)
329 (14.0)

113 (9.9)
211 (24.0)
71 (21.6)

563 (49.3)
392 (44.6)
133 (40.4)

35 (3.1)
65 (7.4)
43 (13.1)

431 (37.7)
212 (24.1)
82 (24.9)

1,218 (52.4)
392 (16.9)
58 (2.5)
50 (2.2)
608 (26.1)

216 (17.7)
92 (23.5)
8 (13.8)
13 (26.0)
61 (10.0)

555 (45.6)
175 (44.6)
18 (31.0)
24 (48.0)
303 (49.8)

77 (6.3)
39 (10.0)
0 (0.0)
6 (12.0)
20 (3.3)

370 (30.4)
86 (21.9)
32 (55.2)
7 (14.0)
224 (36.8)

908 (38.8)
1,430 (61.2)

134 (14.8)
259 (18.1)

440 (48.5)
643 (45.0)

35 (3.9)
107 (7.5)

299 (32.9)
421 (29.4)

1,125 (47.9)
732 (31.2)
270 (11.5)
223 (9.5)

158 (14.0)
125 (17.1)
50 (18.5)
62 (27.8)

520 (46.2)
327 (44.7)
133 (49.3)
108 (48.4)

55 (4.9)
52 (7.1)
17 (6.3)
19 (8.5)

392 (34.8)
228 (31.2)
70 (25.9)
34 (15.3)

383 (16.3)
627 (26.7)
683 (29.1)
491 (20.9)
166 (7.1)

80 (20.9)
129 (20.6)
84 (12.3)
79 (16.1)
23 (13.9)

172 (44.9)
277 (44.2)
303 (44.4)
246 (50.1)
89 (53.6)

27 (7.1)
45 (7.2)
31 (4.5)
30 (6.1)
10 (6.0)

104 (27.2)
176 (28.1)
265 (38.8)
136 (27.7)
44 (26.5)

<.0001

<.0001

0.0002

<.0001

<.0001
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Table 3.1 (Continued)
Sexual Orientation
Heterosexual
2,068 (88.0)
306 (14.8)
974 (47.1)
Homosexual
109 (4.6)
35 (32.1)
41 (37.6)
Bisexual
174 (7.4)
54 (31.0)
73 (42.0)
Circumcision Status
Yes
925 (39.3)
105 (11.4)
438 (47.4)
No
1,426 (60.7)
290 (20.3)
650 (45.6)
Smoking Status
Yes
483 (20.5)
87 (18.0)
259 (53.6)
No
1,868 (79.5)
308 (16.5)
829 (44.4)
Number of Lifetime Sexual Partners
1
184 (8.0)
6 (3.3)
48 (26.1)
2-9
971 (42.0)
105 (10.8)
413 (42.5)
10-19
484 (21.0)
95 (19.6)
260 (53.7)
20-49
472 (20.4)
105 (22.3)
269 (57.0)
≥50
199 (8.6)
71 (35.7)
76 (38.2)
Abbreviations: HPV=Human Papillomavirus; STI=Sexually Transmitted Infections
a
Percentages may not total to 100 due to rounding. Totals exclude unknown/refused values.
b
STIs include chlamydia, gonorrhea, herpes, and syphilis.
c
Significant values in bold font. P-values <0.05 considered significant.

114

<.0001
111 (5.4)
11 (10.1)
21 (12.1)

677 (32.7)
22 (20.2)
26 (14.9)

43 (4.7)
100 (7.0)

339 (36.7)
386 (27.1)

27 (5.6)
116 (6.2)

110 (22.8)
615 (32.9)

6 (3.3)
47 (4.8)
32 (6.6)
30 (6.4)
26 (13.1)

124 (67.4)
406 (41.8)
97 (20.4)
68 (14.4)
26 (13.1)

<.0001

0.0001

<.0001

Table 3.2: Self-reported sexual behaviors among study participants at baseline by HPV and STI test results a, b
TOTAL
Behaviors

N=2,351
n (%)

Positive for
HPV & STIs
n=395
(16.8%)
n (%)

Positive for
HPV only
n=1,088
(46.3%)
n (%)

Positive for
STIs only
n=143
(6.1%)
n (%)

Vaginal sex in past 6 months
Yes
2,272 (96.6)
373 (16.4)
1,059 (46.6)
137 (6.0)
No
79 (3.4)
22 (27.9)
29 (36.7)
6 (7.6)
Oral sex in past 6 months
Yes
2,068 (88.0)
352 (17.0)
986 (47.7)
116 (5.6)
43 (15.2)
102 (36.0)
27 (9.5)
No
283 (12.0)
Paid for sex in past 6 months
Yes
414 (17.6)
106 (25.6)
189 (45.7)
35 (8.5)
No
1,934 (82.4)
289 (14.9)
899 (46.5)
106 (5.5)
Condom use for vaginal sex in recent past
No vaginal sex
79 (3.8)
22 (27.9)
29 (36.7)
6 (7.6)
32 (13.1)
107 (43.7)
11 (4.5)
Always
245 (11.6)
Sometimes
1,628 (77.2)
266 (16.3)
780 (47.9)
97 (6.0)
34 (21.8)
83 (53.2)
6 (3.9)
Never
156 (7.4)
Number of new sexual partners in past 6 months
0
1,437 (63.6)
221 (15.4)
630 (43.8)
101 (7.0)
1
540 (23.9)
76 (14.1)
269 (49.8)
21 (3.9)
2
137 (6.1)
25 (18.3)
80 (58.4)
3 (2.2)
42 (29.2)
72 (50.0)
7 (4.9)
3+
144 (6.4)
Abbreviations: HPV=Human Papillomavirus; STI=Sexually Transmitted Infections
a
Percentages may not total to 100 due to rounding. Totals exclude unknown/refused values.
b
STIs include chlamydia, gonorrhea, herpes, and syphilis.
c
Significant values in bold font. P-values <0.05 considered significant.
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Negative for
HPV & STIs
n=725
(30.8%)
n (%)

P-value c
0.0440

703 (30.9)
22 (27.9)
<.0001
614 (29.7)
111 (39.2)
<.0001
84 (20.3)
640 (33.1)
0.0015
22 (27.9)
95 (38.8)
485 (29.8)
33 (21.2)
<.0001
485 (33.8)
174 (32.2)
29 (21.2)
23 (16.0)

Table 3.3: Change in self-reported sexual behaviors following HPV/STI testing and receipt of test results a, b
OVERALL STUDY POPULATION
Behaviors
Vaginal sex in
past 6 months
Oral sex in
past 6 months
Paid for sex in
past 6 months
Condom use
for vaginal
sex in recent
past
Number of
new sexual
partners in
past 6 months

Behaviors
Vaginal sex in
past 6 months
Oral sex in
past 6 months
Paid for sex in
past 6 months

Response
Categories
Yes
No
Yes
No
Yes
No
No vaginal sex
Always
Sometimes
Never
0
1
2
3+

Response
Categories
Yes
No
Yes
No
Yes
No

STUDY VISITS

Change from
Visit 1 to Visit 2 c
McNemar
p-value
<.0001

Change from
Visit 2 to Visit 3 c
McNemar
p-value
0.0257

<.0001

0.5221

<.0001

0.8312

<.0001

0.1196

<.0001

0.9930

Change from
Visit 1 to Visit 2 c
McNemar
p-value
<.0001

Change from
Visit 2 to Visit 3 c
McNemar
p-value
0.0187

<.0001

0.3830

<.0001

0.3458

Visit 1
Visit 2
Visit 3
n (%)
n (%)
n (%)
2,241 (96.6)
1,918 (82.7)
1,881 (81.1)
79 (3.4)
402 (17.3)
439 (18.9)
1,754 (88.9)
1,615 (81.8)
1,625 (82.3)
220 (11.1)
359 (18.2)
349 (17.7)
359 (18.8)
96 (5.0)
98 (5.1)
1,556 (81.3)
1,819 (95.0)
1,817 (94.9)
65 (3.2)
249 (12.2)
277 (13.6)
233 (11.4)
202 (9.9)
166 (8.1)
1,592 (78.0)
1,445 (70.8)
1,465 (71.8)
151 (7.4)
145 (7.1)
133 (6.5)
1,097 (62.9)
1,005 (57.6)
1,006 (57.7)
416 (23.8)
440 (25.2)
432 (24.8)
113 (6.5)
170 (9.7)
178 (10.2)
119 (6.8)
130 (7.5)
129 (7.4)
POSITIVE FOR HPV AND/OR OTHER STIs
STUDY VISITS
Visit 1
n (%)
1,547 (96.5)
57 (3.6)
1,235 (90.2)
135 (9.9)
288 (21.6)
1,043 (78.4)

Visit 2
n (%)
1,327 (82.7)
277 (17.3)
1,129 (82.4)
241 (17.6)
82 (6.2)
1,249 (93.8)
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Visit 3
n (%)
1,294 (80.7)
310 (19.3)
1,140 (83.2)
230 (16.8)
74 (5.6)
1,257 (94.4)

Table 3.3 (Continued)
Condom use
for vaginal
sex in recent
past
Number of
new sexual
partners in
past 6 months

Behaviors

No vaginal sex
Always
Sometimes
Never
0
1
2
3+

Response
Categories

47 (3.3)
173 (12.1)
201 (14.1)
144 (10.1)
144 (10.1)
114 (8.0)
1,119 (78.4)
1,003 (70.2)
1,012 (70.9)
118 (8.3)
108 (7.6)
101 (7.1)
725 (60.9)
640 (53.8)
646 (54.3)
277 (23.3)
321 (27.0)
310 (26.1)
87 (7.3)
126 (10.6)
136 (11.4)
101 (8.5)
103 (8.7)
98 (8.2)
NEGATIVE FOR HPV AND OTHER STIs
STUDY VISITS

<.0001

0.0573

<.0001

0.9761

Change from
Visit 1 to Visit 2 c
McNemar
p-value
<.0001

Change from
Visit 2 to Visit 3 c
McNemar
p-value
0.6506

Visit 1
Visit 2
Visit 3
n (%)
n (%)
n (%)
Vaginal sex in
Yes
694 (96.9)
591 (82.5)
587 (82.0)
past 6 months
No
22 (3.1)
125 (17.5)
129 (18.0)
Oral sex in
0.0008
Yes
519 (85.9)
486 (80.5)
485 (80.3)
past 6 months
No
85 (14.1)
118 (19.5)
119 (19.7)
Paid for sex in
<.0001
Yes
71 (12.2)
14 (2.4)
24 (4.1)
past 6 months
No
513 (87.8)
570 (97.6)
560 (95.9)
Condom use
<.0001
18 (2.9)
76 (12.4)
76 (12.4)
No vaginal sex
for vaginal
Always
89 (14.5)
58 (9.5)
52 (8.5)
sex in recent
Sometimes
473 (77.2)
442 (72.1)
453 (73.9)
past
Never
33 (5.4)
37 (6.0)
32 (5.2)
Number of
0
372 (67.0)
365 (65.8)
360 (64.9)
0.0848
new sexual
1
139 (25.1)
119 (21.4)
122 (22.0)
partners in
2
26 (4.7)
44 (7.9)
42 (7.6)
past 6 months
3+
18 (3.2)
27 (4.9)
31 (6.6)
a
Percentages may not total to 100 due to rounding. Analysis excludes unknown/refused values.
b
Other STIs include chlamydia, gonorrhea, herpes, and syphilis.
c
Significant values in bold font. P-values < 0.05 considered significant.
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0.9136
0.0124
0.9284

0.7266

Table 3.4: Adjusted odds ratios and 95% confidence intervals for sexual behaviors following HPV/STI testing and receipt
of test results a, b
Vaginal sex in
past 6 months c

Oral sex in
past 6 months

Paid sex in
past 6 months

AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
MODEL ESTIMATES BY STUDY PERIOD
PRE-DIAGNOSIS PERIOD:
Visit 2 compared to Visit
1/ Baseline
POST-DIAGNOSIS PERIOD:
Visit 3 compared to Visit 2

Condom use
with vaginal sex
in recent past d
AOR (95% CI)

# of new sexual
partners in
past 6 months e
AOR (95% CI)

0.34 (0.27-0.41)

0.59 (0.48-0.72)

0.25 (0.20-0.32)

0.94 (0.71-1.24)

0.72 (0.61-0.84)

0.87 (0.70-1.08)

0.96 (0.77-1.20)

1.05 (0.81-1.37)

1.05 (0.79-1.39)

1.01 (0.89-1.20)

MODEL ESTIMATES ACROSS ALL THREE VISITS
HPV and STI Results f
Positive for both HPV and
other STIs
Positive for HPV only
Positive for other STIs
Negative for HPV and
other STIs

0.57 (0.29-1.12)
1.15 (0.69-1.90)
0.48 (0.19-1.21)
Referent

0.78 (0.41-1.47)
1.40 (0.88-2.21)
0.46 (0.20-1.08)
Referent

1.01 (0.60-1.70)
0.66 (0.42-1.03)
1.45 (0.71-2.94)
Referent

0.69 (0.39-1.24)
0.61 (0.40-0.92)
0.64 (0.28-1.43)
Referent

0.51 (0.31-0.83)
0.50 (0.34-0.72)
1.43 (0.70-2.96)
Referent

Abbreviations: AOR=Adjusted Odds Ratio; CI=Confidence Interval; HPV=Human Papillomavirus; STI=Sexually Transmitted Infections
a
Significant values in bold font.
b
Model is adjusted for the following variables: country of residence, race, ethnicity/Hispanic, age, marital status, educational level, sexual
orientation, circumcision status, smoking status, and number of lifetime sexual partners.
c
Men categorized as homosexual men were excluded from analysis for vaginal sex due to plausibility of behavior.
d
Modeling any condom use (sometimes and always) vs. never using condoms during last six months. Men reporting no vaginal sex
during last six months were excluded from analysis.
e
Modeling zero new sexual partners during last six months vs. 1, 2, or 3+ new sexual partners.
f
Other STIs include chlamydia, gonorrhea, herpes, and syphilis.
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6 months

6 months

Visit 3

Visit 2

Baseline/
Visit 1
PREDIAGNOSIS
Assess change in
sexual behavior from
Baseline to Visit 2,
prior to receipt of test
results

Tested
for HPV
& STIs

Risk Factor
Questionnaire
Administered

Risk Factor
Questionnaire
Administered

Risk Factor
Questionnaire
Administered

POSTDIAGNOSIS
Assess change in
sexual behavior from
Visit 2 to Visit 3,
following receipt of
test results

Receive
test results
for HPV &
STIs

Figure 3.1: Study Design
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Prospective dataset for Parent Study (2005-2009)
= 4,072

Eliminate men who are not sexually active (i.e., never
experienced vaginal, anal, or oral intercourse) (n=450)
= 3,622

Tested
for HPV
& STIs at
Baseline

Eliminate men who did not return for HPV & STI results
(Visit 2; n=570)
= 3,052

Eliminate men who did not stay in study following receipt
of test results (Visit 3; n=701)
N = 2,351

TOTAL POPULATION = 2,351

Figure 3.2: Flow chart of exclusion process for the study

120

References
Allison, P. D. (2002). Missing Data. Thousand Oaks, CA: Sage Publications.
Bentley, M. E., Spratt, K., Shepherd, M. E., Gangakhedkar, R. R., Thilikavathi,
S., Bollinger, R. C., et al. (1998). HIV testing and counseling among men
attending sexually transmitted disease clinics in Pune, India: changes in
condom use and sexual behavior over time. AIDS, 12(14), 1869-1877.
Brewer, N., Ng, T., McRee, A.-L. & Reiter, P. (2010). Men’s beliefs about HPVrelated disease. Journal of Behavioral Medicine, 33(4), 274-281.
Bynum, S. A., Brandt, H. M., Friedman, D. B., Annang, L. & Tanner, A. (2011).
Knowledge, Beliefs, and Behaviors: Examining Human PapillomavirusRelated Gender Differences Among African American College Students.
Journal of American College Health, 59(4), 296-302.
Catania, J. A., Gibson, D. R., Marin, B., Coates, T. J. & Greenblatt, R. M. (1990).
Response bias in assessing sexual behaviors relevant to HIV
transmission. Evaluation and Program Planning, 13(1), 19-29.
Catania, J. A., McDermott, L. J. & Pollack, L. M. (1986). Questionnaire response
bias and face-to-face interview sample bias in sexuality research. Journal
of Sex Research, 22(1), 52-72.
Centers for Disease Control and Prevention. (2010). Fact Sheet: Genital HPV.
Retrieved January 23, 2011, from http://www.cdc.gov/std/hpv/hpv-factsheet.pdf

121

Centers for Disease Control and Prevention. (2012). HPV and Men - Fact Sheet
Daley, E. M., Perrin, K. M., McDermott, R. J., Vamos, C. A., Rayko, H. L.,
Packing-Ebuen, J. L., et al. (2010). The psychosocial burden of HPV: a
mixed-method study of knowledge, attitudes and behaviors among HPV+
women. Journal of Health Psychology, 15(2), 279-290.
De Schryver, A. & Meheus, A. (1990). Epidemiology of sexually transmitted
diseases: the global picture. Bulletin of the World Health Organization,
68(5), 639-654.
Denison, J., O’Reilly, K., Schmid, G., Kennedy, C. & Sweat, M. (2008). HIV
Voluntary Counseling and Testing and Behavioral Risk Reduction in
Developing Countries: A Meta-analysis, 1990–2005. AIDS and Behavior,
12(3), 363-373.
Fenton, K. A., Johnson, A. M., McManus, S. & Erens, B. (2001). Measuring
sexual behaviour: methodological challenges in survey research. Sexually
Transmitted Infections, 77(2), 84-92.
Gaither, G. A., Sellbom, M. & Meier, B. P. (2003). The effect of stimulus content
on volunteering for sexual interest research among college students.
Journal of Sex Research, 40(3), 240-248.
Gall, M. D., Gall, J. P. & Borg, W. R. (2007). Educational Research: An
Introduction: Pearson/Allyn & Bacon.
Genuis, S. J. & Genuis, S. K. (2004). Managing the sexually transmitted disease
pandemic: A time for reevaluation. American Journal of Obstetrics and
Gynecology, 191(4), 1103-1112.

122

Gerbase, A. C., Rowley, J. T., Heymann, D. H., Berkley, S. F. & Piot, P. (1998).
Global prevalence and incidence estimates of selected curable STDs.
Sexually Transmitted Infections, 74(Suppl 1), S12-16.
Gerend, M. A. & Barley, J. (2009). Human Papillomavirus Vaccine Acceptability
Among Young Adult Men. Sexually Transmitted Diseases, 36(1), 58-62.
Ghanem, K. G., Hutton, H. E., Zenilman, J. M., Zimba, R. & Erbelding, E. J.
(2005). Audio computer assisted self interview and face to face interview
modes in assessing response bias among STD clinic patients. Sexually
Transmitted Infections, 81(5), 421-425.
Giuliano, A. R., Lazcano-Ponce, E., Villa, L. L., Flores, R., Salmeron, J., Lee, J.
H., et al. (2008). The human papillomavirus infection in men study: Human
papillomavirus prevalence and type distribution among men residing in
Brazil, Mexico, and the United States. Cancer Epidemiology Biomarkers &
Prevention, 17(8), 2036-2043.
Giuliano, A. R., Lee, J.-H., Fulp, W., Villa, L. L., Lazcano, E., Papenfuss, M. R.,
et al. (2011). Incidence and clearance of genital human papillomavirus
infection in men (HIM): a cohort study. Lancet, 377(9769), 932-940.
Glasier, A., Gulmezoglu, A. M., Schmid, G. P., Moreno, C. G. & Van Look, P. F.
(2006). Sexual and reproductive health: a matter of life and death. Lancet,
368(9547), 1595-1607.
Hernando, V., del Romero, J., Garcia, S., Rodriguez, C., del Amo, J. & Castilla,
J. (2009). Reducing sexual risk behavior among steady heterosexual

123

serodiscordant couples in a testing and counseling program. Sexually
Transmitted Diseases, 36(10), 621-628.
Kahn, J. A., Slap, G. B., Bernstein, D. I., Kollar, L. M., Tissot, A. M., Hillard, P. A.,
et al. (2005). Psychological, Behavioral, and Interpersonal Impact of
Human Papillomavirus and Pap Test Results. Journal of Women's Health,
14(7), 650-659.
Kissinger, P., Rice, J., Farley, T., Trim, S., Jewitt, K., Margavio, V., et al. (1999).
Application of Computer-assisted Interviews to Sexual Behavior Research.
American Journal of Epidemiology, 149(10), 950-954.
Kurth, A. E., Martin, D. P., Golden, M. R., Weiss, N. S., Heagerty, P. J.,
Spielberg, F., et al. (2004). A Comparison Between Audio ComputerAssisted Self-Interviews and Clinician Interviews for Obtaining the Sexual
History. Sexually Transmitted Diseases, 31(12), 719-726.
Little, R. J. A. & Rubin, D. B. (2002). Statistical Analysis With Missing Data (2nd
ed.). New York, NY: John Wiley and Sons.
Low, N., Broutet, N., Adu-Sarkodie, Y., Barton, P., Hossain, M. & Hawkes, S.
(2006). Global control of sexually transmitted infections. Lancet,
368(9551), 2001-2016.
Marks, G., Crepaz, N., Senterfitt, J. W. & Janssen, R. S. (2005). Meta-analysis of
high-risk sexual behavior in persons aware and unaware they are infected
with HIV in the United States: implications for HIV prevention programs.
JAIDS: Journal of Acquired Immune Deficiency Syndromes, 39(4), 446453.

124

Mayaud, P. & Mabey, D. (2004). Approaches to the control of sexually
transmitted infections in developing countries: old problems and modern
challenges. Sexually Transmitted Infections, 80(3), 174-182.
Mayaud, P. & McCormick, D. (2001). Interventions against sexually transmitted
infections (STI) to prevent HIV infection. British Medical Bulletin, 58(1),
129-153.
McCaffery, K., Waller, J., Forrest, S., Cadman, L., Szarewski, A. & Wardle, J.
(2004). Testing positive for human papillomavirus in routine cervical
screening: examination of psychosocial impact. BJOG: An International
Journal of Obstetrics & Gynaecology, 111(12), 1437-1443.
McCaffery, K., Waller, J., Nazroo, J. & Wardle, J. (2006). Social and
psychological impact of HPV testing in cervical screening: a qualitative
study. Sexually Transmitted Infections, 82(2), 169-174.
McGinley, K. F., Hey, W., Sussman, D. O. & Brown, G. A. (2011). Human
Papillomavirus Testing in Men. JAOA: Journal of the American
Osteopathic Association, 111(3 suppl 2), S26-S28.
McKay, T. & Mutchler, M. G. (2011). The Effect of Partner Sex: Nondisclosure of
HIV Status to Male and Female Partners Among Men who Have Sex with
Men and Women (MSMW). AIDS and Behavior, 15(6), 1140-1152.
Mutchler, M. G., Bogart, L. M., Elliott, M. N., McKay, T., Suttorp, M. J. &
Schuster, M. A. (2008). Psychosocial correlates of unprotected sex
without disclosure of HIV-positivity among African-American, Latino, and

125

White men who have sex with men and women. Archives of Sexual
Behavior, 37(5), 736-747.
Nandwani, M. C. (2010). Men's knowledge of the human papillomavirus vaccine.
Nurse Practitioner, 35(11), 32-39.
Neuman, W. L. (1997). Social research methods: Qualitative and quantitative
approaches: Allyn and Bacon.
Nyitray, A. G., Kim, J., Hsu, C. H., Papenfuss, M., Villa, L., Lazcano-Ponce, E., et
al. (2009). Test-retest reliability of a sexual behavior interview for men
residing in Brazil, Mexico, and the United States: the HPV in Men (HIM)
Study. American Journal of Epidemiology, 170(8), 965-974.
Parrish, D. D. & Kent, C. K. (2008). Access to care issues for African American
communities: implications for STD disparities. Sexually Transmitted
Diseases, 35(12 Suppl), S19-22.
Politzer, R. M., Yoon, J., Shi, L., Hughes, R. G., Regan, J. & Gaston, M. H.
(2001). Inequality in America: The Contribution of Health Centers in
Reducing and Eliminating Disparities in Access to Care. Medical Care
Research and Review, 58(2), 234-248.
Saltzman, S. P., Stoddard, A. M., McCusker, J., Moon, M. W. & Mayer, K. H.
(1987). Reliability of self-reported sexual behavior risk factors for HIV
infection in homosexual men. Public Health Reports, 102(6), 692-697.
Sherr, L., Lopman, B., Kakowa, M., Dube, S., Chawira, G., Nyamukapa, C., et al.
(2007). Voluntary counselling and testing: uptake, impact on sexual

126

behaviour, and HIV incidence in a rural Zimbabwean cohort. AIDS, 21(7),
851-860.
Strassberg, D. S. & Lowe, K. (1995). Volunteer bias in sexuality research.
Archives of Sexual Behavior, 24(4), 369-382.
Thornton, R. L. (2008). The Demand for, and Impact of, Learning HIV Status.
American Economic Review, 98(5), 1829-1863.
Tider, D. S., Parsons, J. T. & Bimbi, D. S. (2005). Knowledge of human
papillomavirus and effects on sexual behaviour of gay/bisexual men: a
brief report. International Journal of STD & AIDS, 16(10), 707-708.
United Nations. (2000). United Nations Millennium Declaration. New York, NY:
United Nations.
Vetter, K. M. & Geller, S. E. (2007). Moving forward: human papillomavirus
vaccination and the prevention of cervical cancer. Journal of Women’s
Health (Larchmt), 16(9), 1258-1268.
Waller, J., McCaffery, K., Forrest, S. & Wardle, J. (2004). Human papillomavirus
and cervical cancer: Issues for biobehavioral and psychosocial research.
Annals of Behavioral Medicine, 27(1), 68-79.
Wasserheit, J. N. (1992). Epidemiological synergy. Interrelationships between
human immunodeficiency virus infection and other sexually transmitted
diseases. Sexually Transmitted Diseases, 19(2), 61-77.
Weinhardt, L. S., Carey, M. P., Johnson, B. T. & Bickham, N. L. (1999). Effects of
HIV counseling and testing on sexual risk behavior: a meta-analytic review

127

of published research, 1985-1997. American Journal of Public Health,
89(9), 1397-1405.
Weissman, J. S., Stern, R., Fielding, S. L. & Epstein, A. M. (1991). Delayed
Access to Health Care: Risk Factors, Reasons, and Consequences.
Annals of Internal Medicine, 114(4), 325-331.
Wolitski, R. J., MacGowan, R. J., Higgins, D. L. & Jorgensen, C. M. (1997). The
effects of HIV counseling and testing on risk-related practices and helpseeking behavior. AIDS Education and Prevention, 9(3 Suppl), 52-67.
Wong, L. H., Rooyen, H. V., Modiba, P., Richter, L., Gray, G., McIntyre, J. A., et
al. (2009). Test and tell: correlates and consequences of testing and
disclosure of HIV status in South Africa (HPTN 043 Project Accept).
JAIDS: Journal of Acquired Immune Deficiency Syndromes, 50(2), 215222.
World Health Organization; Joint United Nations Programme on HIV/AIDS;
UNICEF. (2009). Towards Universal Access: Scaling up prioirty HIV/AIDS
interventions in the health section. Progress Report 2009. Geneva,
Switzerland: World Health Organization.
World Health Organization; Joint United Nations Programme on HIV/AIDS.
(1999). Sexually Transmitted Diseases: Policies and Principles for
Prevention and Care. Geneva, Switzerland: World Health
Organization/Joint United Nations Programme on HIV/AIDS.

128

World Health Organization. (2007). Global strategy for the prevention and control
of sexually transmitted infections (2006-2015). Geneva, Switzerland:
World Health Organization.

129

Section Four:
Discussion

This dissertation was prepared in a manuscript format, consisting of two
complete manuscripts. While each of these manuscripts is drafted as
independent documents, they are also part of a cohesive body of research
focused on the sexual behaviors among men in a cross-national sample from
Brazil, Mexico, and the United States (US). To organize and integrate the
discussion of the results and research implications, each of the research
questions is addressed and discussed in this final section. Furthermore, the
strengths and limitations of the dissertation, as well as the public health
implications and recommendations for future research are discussed in the
context of the overall dissertation study and theoretical framework.
This final section is subdivided into the following four sections: 1)
Overview of Significant Findings; 2) Public Health Implications; 3) Strengths and
Limitations; and 4) Conclusions. The Overview of Significant Findings provides a
summary of the findings for the two components of the study (i.e., two different
manuscripts), synthesizes and discusses the synergism of the results, and
outlines the limitations and strengths of the overall dissertation. The Public
Health Implications discusses the potential impact of the research findings in
research, policy, and practice, including the utility of the results in public health
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interventions. The theoretical framework used in this study, the Social Ecological
Model, guides the interpretation of study findings. The Strengths and Limitations
subsection presents some considerations regarding the study design and
findings. The Conclusion reiterates the key issues highlighted in this dissertation
study and provides closing remarks.

Overview of Significant Findings
While there is an abundance of research on risk factors associated with
sexual behaviors and adverse sexual health outcomes, most studies focus on
sub-populations considered to be at high risk for STIs, such as men who have
sex with men or men who use/abuse illicit drugs (Aidala et al., 2006; Dworkin,
2005; Exner, Gardos, Seal & Ehrhardt, 1999; Seal & Ehrhardt, 2004). Therefore,
there is a paucity of research investigating sexual risk factors among general
populations of men (Aidala et al., 2006; Campbell, 1995; Dworkin, Fullilove &
Peacock, 2009; Exner et al., 1999; Flood, 2003b; Higgins, Hoffman & Dworkin,
2010; Neumann et al., 2002; Seal & Ehrhardt, 2004). However, given the
communicable nature of STI transmission and the pervasiveness of STIs among
diverse populations worldwide (Gerbase, Rowley, Heymann, Berkley & Piot,
1998; World Health Organization/ Joint United Nations Programme on HIV/AIDS,
1999; World Health Organization, 2007), research on sexual behaviors and
factors among a broad range of men is warranted.
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To address the dearth of information on sexual risk and behaviors among
men, this dissertation used a cross-national dataset to address the following
specific aims and corresponding research questions:
Specific Aim 1: To identify the most salient correlates of sexual behaviors
among men residing in Brazil, Mexico, and the US.
Research Question 1.1: How does sexual risk differ among men
residing in Brazil, Mexico, and the US by age cohort?
Specific Aim 2: To assess the impact of testing and knowledge of
diagnosis with human papillomavirus (HPV) and/or other sexually
transmitted infections (STIs) on sexual risk-taking behavior among men.
Research Question 2.1: Research Question 2.2: Do men’s sexual
behaviors change after being tested for HPV and
other STIs?
Research Question 2.2: Do men’s sexual behaviors change after
being informed of diagnosis with HPV and other
STIs?

Specific Aim 1: To identify the most salient correlates of sexual behaviors among
men residing in Brazil, Mexico, and the US.
In the cross-sectional analysis of sexual risk among heterosexual men in
this cross-national dataset, age, race, marital status, educational level, age at
first vaginal sex, exchanging sex for money or drugs, lifetime number of partners,
and country of residence emerged as important factors (Table 2.5). The data
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showed that the probability of testing positive for an STI increases with
increasing age. Additionally, black men had a 1.5 fold elevated likelihood for a
positive STI test, compared to white men (AOR=1.5, 95% CI=1.15-1.96). Both
lower educational attainment (<12 years) and prior marriage (i.e., being divorced,
separated, or widowed) increased the probability of testing positive for an STI.
Overall, Brazilian men were three times as likely to test positive for an STI,
compared to US men.
Sexually risky behaviors were also found to increase the likelihood of
having a positive STI test among heterosexual men. Younger age at sexual
debut (≤14 years) heightened the odds of testing positive for an STI.
Heterosexual men who reported having 20 or more lifetime sexual partners had
an estimated 1.5 to 2.1-fold increased risk, and men who reported ever
exchanging money or drugs for sex had an increased likelihood of having a
positive STI test.
Although the longitudinal analysis was not restricted to heterosexual men,
including men categorized as homosexual and bisexual, similar correlates of
sexual behavior were identified: age, race, marital status, education, number of
lifetime sexual partners, and country of residence (Table D5). Of these
correlates, age demonstrated the greatest magnitude of association across the
various sexual behaviors assessed. For vaginal sex and oral sex, young adult
(aged 18-30) and middle aged (aged 31-44) men experienced exponential
increases in risk compared to older men (aged 45-70). Young adult men had a
more than 12-fold increased likelihood of reporting vaginal sex in past six months
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(AOR=12.63, 95% CI=6.03-26.44) and a 20-fold increased likelihood of reporting
oral sex in the past six months (AOR=20.06, 95% CI=10.27-39.19). For middle
aged men, the risk decreased slightly but remained significantly elevated, with a
4.5-fold heightened odds of reporting vaginal sex (AOR=4.52, 95% CI=2.42-8.43)
and a nearly 11-fold heightened odds of reporting oral sex (AOR=10.73, 95%
CI=6.04-19.06). Conversely, young adult and middle aged men had a reduced
likelihood of reporting no new sexual partners in the past six months (young:
AOR=0.12, 95% CI=0.07-0.22; middle-aged: AOR=0.27, 95% CI=0.16-0.45).
Similar to the cross-sectional analysis, elevated odds were observed for
Brazilian men compared to US men for vaginal sex, condom use with vaginal
sex, and paid sexual encounter. However, Mexican men were significantly more
likely report no new sexual partners in the past six months, compared to US men.
Increasing numbers of lifetime partners (≥10) were associated with an increased
likelihood of reporting vaginal sex, oral sex, and paid sexual encounters in the
past six months.
Other correlates examined in the longitudinal analysis did not demonstrate
consistency across sexual behaviors. Asian/Pacific Islander men had 75%
decreased odds reporting vaginal sex in the past six months (AOR=0.25, 95%
CI=0.07-0.86), while men of black or mixed race had a 49-53% reduced odds of
reporting no new partners in the past six months (black: AOR=0.51, 95%
CI=0.33-0.78; mixed: AOR=0.47, 95% CI=0.22-0.99). Lower educational level
(<12 years) was associated with a reduced likelihood of reporting oral sex
(AOR=0.11, 95% CI=0.05-0.27) and condom use with vaginal sex (AOR=0.45,
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95% CI=0.21-0.98) in the past six months. Single and previously married (i.e.,
being divorced, separated, or widowed) men were associated with a 84-85%
decreased odds of reporting vaginal sex in the past six months (single:
AOR=0.16, 95% CI=0.08-0.29; divorced, separated, or widowed: AOR=0.15,
95% CI=0.07-0.32), while men with single status were more than twice as likely
to report paid sexual experiences in the past six months (AOR=2.13, 95%
CI=1.34-3.38).

Research Question 1.1: How does sexual risk differ among men residing in
Brazil, Mexico, and the US by age cohort?
In this study, we examined sexual risk among heterosexual men in a
cross-national sample through a composite measure of STI positivity by age
cohort (young: 18 to 30 years; middle-aged: 31 to 44 years; older: 45 to 70
years). We found that the likelihood to test positive for an STI varied significantly
by age group among heterosexual men by a number of covariates, including
number of sexual partners, age at sexual debut, race, marital status, educational
level, and prior experience of paid sexual encounters. Among younger men,
higher educational levels were associated with lower odds of testing positive for
an STI, while higher numbers of lifetime sexual partners were associated with
higher odds. For middle-aged men, an elevated risk for a positive STI test was
observed among those who were black and divorced, separated, or widowed.
Older men who were of a younger age at their first vaginal sex encounter and
had a history of paid sexual encounters had an increased likelihood of STI
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positivity. Overall, the findings underscore that multiple factors associated with
age and life stage may influence sexual risk and STI transmission among men.
As previous research among men’s sexual behavior has predominantly
focused on adolescents and young adults (Chopra et al., 2009; Harrison,
Cleland, Gouws & Frohlich, 2005; Makenzius, Gadin, Tyden, Romild & Larsson,
2009; Mooney-Somers & Ussher, 2008; O'Donnell, O'Donnell & Stueve, 2001;
Sandfort, Orr, Hirsch & Santelli, 2008), this study yields important information
that may be of benefit in the examination of sexual risk across the lifespan.
Given the escalating incidence of HIV/AIDS and STI cases among older adults
(Casau, 2005; Coleman & Ball, 2007; Goodroad, 2003; Kohli et al., 2006;
Savasta, 2004), as well as the increasing reports of sexual risk-taking in older
cohorts (Bruhin, 2003; Kohli et al., 2006; Rogstad & Bignell, 1991; Stall &
Catania, 1994), it is critical that public health interventions integrate ageappropriate strategies that move beyond the youth and young adult
demographic.

Specific Aim 2: To assess the impact of testing and knowledge of diagnosis with
human papillomavirus (HPV) and/or other sexually transmitted infections (STIs)
on sexual risk-taking behavior among men.
-

Research Question 2.1: Do men’s sexual behaviors change after being
tested for HPV and other STIs?
This analysis identified a significant reduction in sexual risk-taking

behaviors among men in the six-month period following testing for HPV and other
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STIs. In the study population, decreased levels of vaginal and oral sex, as well
as paid sexual encounters, were observed, prior to participants being informed of
the results of testing. The study findings illustrate the potential for behavior
change with disease testing alone, as individuals may modify their behaviors to
be more favorable while under observation (Gall, Gall & Borg, 2007; Neuman,
1997). These findings may have important public health implications, as they
highlight the possibility for STI testing to be an effective preventive measure that
reduces risky behavior, regardless of the testing outcome.

-

Research Question 2.2: Do men’s sexual behaviors change after being
informed of diagnosis with HPV and other STIs?
Globally, the diagnosis and treatment of STIs has been prioritized as a

central strategy for prevention (World Health Organization, 2007). This approach
is driven by the widely accepted assumption that being aware of one’s disease
status would reduce risky sexual behaviors (Thornton, 2008; World Health
Organization/ Joint United Nations Programme on HIV/AIDS/ UNICEF, 2009).
However, the longitudinal analysis did not reveal any changes in sexual risktaking behaviors among men after being informed of their diagnosis with HPV
and/or other STIs.
The only significant finding was observed among men who tested positive
for HPV only (and not other STIs); compared to others, these men had reduced
odds of using condoms for vaginal sex. This finding is somewhat
counterintuitive, as we would hypothesize that men who were informed that they
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had HPV would adopt safer sexual practices. However, this finding may be
attributable to the general lack of knowledge and awareness regarding HPV
among men (Brewer, Ng, McRee & Reiter, 2010; Bynum, Brandt, Friedman,
Annang & Tanner, 2011; Fernandez et al., 2009; Gerend & Barley, 2009;
Nandwani, 2010; Tider, Parsons & Bimbi, 2005). Unfortunately, the dataset
lacked cognitive measures; therefore, assessments of the level of HPV and STIrelated knowledge within the study population were not possible.

Public Health Implications
The discussion of the public health implications of this dissertation
research is framed within the context of the Social Ecological Model (SEM). The
SEM is applicable to this research due to its utility in describing the complex
interaction of multiple factors with sexual behavior. Since sexual behaviors that
elevate the risk for STIs involve more than one person, the examination of such
processes intrinsically moves beyond intrapersonal theories to those that
incorporate ecological factors acting in the interpersonal, organizational,
community and policy levels. Therefore, the occurrence of several types of
sexual behavior may be attributed to factors within these various levels of
influence. Due to limitations of the dataset, this research does not address
multiple factors within the various SEM levels. Therefore, the research findings
provide a narrow presentation of factors that influence sexual behaviors among
men. However, SEM also aids in the identification and development of potential
preventative interventions to reduce sexual risks, as well important research
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measures that will aid in understanding and explaining sexual behavior. In this
section, we use the SEM as a framework to assess limitations of the dissertation
research while also providing recommendations for future investigations.
Intrapersonal Level. The intrapersonal level of the Social Ecological
Model refers to individual characteristics that have been found to influence
behaviors, including knowledge, attitudes, beliefs, and personality traits (Gregson
et al., 2001; National Cancer Institute, 2005). Public health research and
interventions frequently are grounded in the assumption that there is a correlation
between knowledge, attitudes, and practice (Glanz, Lewis & Rimer, 1997).
Therefore, by enhancing knowledge, attitudes, and risk perception regarding the
disease(s) of interest (e.g., HPV and other STIs), desired behaviors (e.g.,
reduced sexual risk behavior) can be promoted (Leval et al., 2011).
While prior investigations of HPV knowledge and attitudes have focused
almost entirely on women (Daley et al., 2008; Daley et al., 2010; Giles & Garland,
2006; Klug, Hukelmann & Blettner, 2008; Moreira et al., 2006; Pitts & Clarke,
2002; Pitts, Dyson, Rosenthal & Garland, 2007; Stark et al., 2008; Tiro,
Meissner, Kobrin & Chollette, 2007; Vanslyke et al., 2008; Waller et al., 2003),
some studies found that there is a low level of knowledge regarding HPV among
men, which has resulted in misinformation regarding transmission and prevention
(Brewer et al., 2010; Bynum et al., 2011; Daley et al., 2011; Fernandez et al.,
2009; Gerend & Barley, 2009; Nandwani, 2010; Tider et al., 2005). For example,
men may not understand that HPV is a precursor to various forms of cancer
(Brewer et al., 2010; Fernandez et al., 2009; Gerend & Barley, 2009; Nandwani,
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2010; Tider et al., 2005). Little is known regarding men’s knowledge and
awareness of other STIs, as research and interventions primarily target
HIV/AIDS, with STIs being integrated due to its role as a moderator for HIV
transmission (Low et al., 2006; Mayaud & McCormick, 2001; Wasserheit, 1992;
World Health Organization/ Joint United Nations Programme on HIV/AIDS, 1999;
World Health Organization, 2007). However, some studies have revealed that
men’s knowledge of STIs, particularly regarding signs and symptoms, is limited
(Devonshire, Hillman, Capewell & Clark, 1999; Kellock, Piercy & Rogstad, 1999;
Mason, 2005).
As previously stated, we found that being informed of one’s HPV or STI
status did not affect men’s sexual behavior. The relatively low level of knowledge
and awareness of factors related to HPV and other STIs among men, as
indicated in other studies, may explain the lack of behavioral change based on
one’s diagnosis (Brewer et al., 2010; Bynum et al., 2011; Devonshire et al., 1999;
Fernandez et al., 2009; Gerend & Barley, 2009; Kellock et al., 1999; Mason,
2005; Nandwani, 2010; Tider et al., 2005). Due to limited information, men may
not understand the behavioral link between HPV and STI transmission and
occurrence. Therefore, this finding may indicate that more individual-level
education and awareness-raising interventions that target men may be needed.
Unfortunately, the dataset utilized in this dissertation research did not
include cognitive level variables, so we are unable to ascertain the level of HPV
and STI knowledge and awareness within the study population. However,
general education levels among men in the study population were found to be
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associated with STIs and sexual behavior. Men who had less than a high school
or secondary level of education (<12 years) were at an increased likelihood of
testing positive for an STI. Additionally, men with lower level of education were
less likely to report oral sex and condom use with vaginal sex in the past six
months. While lower educational attainment has previously been associated with
an elevated risk for STIs and unprotected sex (Annang, Walsemann, Maitra &
Kerr, 2010; Irwin et al., 1999; Noden, Gomes & Ferreira, 2010; Solomon, Smith &
del Rio, 2008), the relationship between educational status and oral sex is not
well understood, as investigations of sexual risk have predominately focused on
vaginal and anal sex (Ompad et al., 2006). Further investigations of correlates
associated with oral sex are needed to yield an enhanced understanding of
sexual risk, particularly among men.
Interpersonal Level. Within the Social Ecological Model, interpersonal
processes involve interactions between family, friends, and peers (Gregson et
al., 2001; National Cancer Institute, 2005). Peer influence has been noted as a
factor in the development of masculine identity, particularly regarding sexual
attitudes, during adolescence (Flood, 2003a; Hyde, Drennan, Howlett & Brady,
2009). Previous research has revealed how interactions between young boys
may enforce norms regarding sexuality (Hyde et al., 2009; Wight, 1994).
Consequently, peer influence has been examined in investigations and
interventions addressing adolescent sexual behavior (Biglan et al., 1990; Billy &
Udry, 1985; DiClemente, 1991; Kinsman, Romer, Furstenberg & Schwarz, 1998;
Maxwell, 2002; Prinstein, Meade & Cohen, 2003; Romer et al., 1994). Although
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peer influence is relatively unexplored in adult populations, some researchers
have recently conducted social network analysis to examine factors related to
sexual behavior in special populations of men (e.g., men who have sex with men)
(Amirkhanian et al., 2005; Choi, Ning, Gregorich & Pan, 2007; Morris, Zavisca &
Dean, 1995). Unfortunately, the data do not offer information on the role of peers
in male sexual decision-making. As no known studies examine the relationships
of such social networks in sexual behaviors within a general adult population of
men, this is a possible area for future investigation.
One’s values and beliefs regarding sexuality and sexual behaviors are
informed by their familial relationships (Biglan et al., 1990; Institute of Medicine/
Committee on Prevention Control of Sexually Transmitted Diseases, 1997).
During childhood and adolescence, family connectedness, support, and
communication may impact risk and protective behaviors associated with STI
transmission, such as early initiation of sexual activity and injection drug use (Ali
& Ajilore, 2011; Miller, Kotchick, Dorsey, Forehand & Ham, 1998; O'Donnell et
al., 2001; Wight, Williamson & Henderson, 2006). Furthermore, the religious and
moral values demonstrated within the family may also influence sexual health
knowledge, attitudes, and practices (Cotton & Berry, 2007; Edwards, Haglund,
Fehring & Pruszynski, 2011; Ogland, Xu, Bartkowski & Ogland, 2011). As
families have been found to be important determinants of adolescent sexual
behavior, it is plausible that they may also influence subsequent behavior in
adulthood. While this dissertation study does not examine familial factors, future
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investigations that examine the long-term impact of such factors may prove
beneficial in the development and enhancement of family focused interventions.
In sexual behavior, an intrinsic issue is the role and influence of one’s
sexual partner. There is epidemiological evidence of the link between partner
level variables and one’s risk of HPV (Abalos et al., 2012; Castellsagué, Bosch &
Muñoz, 2003; Giuliano, Anic & Nyitray, 2010; Schiffman & Brinton, 1995;
Schiffman & Castle, 2003). In recent years, numerous studies of heterosexual
couples have revealed the heightened likelihood of HPV transmission and the
onset of related cancers between sexual partners (Abalos et al., 2012; Baken et
al., 1995; Bleeker et al., 2005; Brinton et al., 1989; Castellsagué et al., 2003;
Franco, Duarte-Franco & Ferenczy, 2001; Hernandez et al., 2008; Parada et al.,
2010; Widdice et al., 2010). However, for other STIs, much of the existing
research explores factors among women and high-risk groups of men (e.g.,
injection drug users, men who have sex with men (Aidala et al., 2006; Dworkin &
O'Sullivan, 2005; Exner et al., 1999; Seal & Ehrhardt, 2004; Seal, Exner &
Ehrhardt, 2003). Minimal research has explored partnership in the transmission
of other STIs (excluding HIV/AIDS); nevertheless, studies have indicated a
relationship exists between sexual behaviors and risk factors among partners
and STI transmission (Charnigo, Crosby & Troutman, 2010; Crosby, DiClemente,
Yarber, Snow & Troutman, 2008; Doherty, Padian, Marlow & Aral, 2005;
Drumright, Gorbach & Holmes, 2004; Evans, Bond & MacRae, 1997; Evans, Kell,
Bond & MacRae, 1995; Finer, Darroch & Singh, 1999; Gullette, Rooker &
Kennedy, 2009; Wellings et al., 2006).
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In this dissertation research, the multivariate models in the quantitative
analysis were adjusted for marital status. Both single and previously married
(i.e., being divorced, separated, or widowed) men in the study population had a
reduced likelihood of reporting vaginal sex in the past six months. Furthermore,
single men had an elevated likelihood of reporting experiences of paid sex in the
past six months, while those who previously had been married had increase odds
of testing positive for an STI. As sexual risk has been shown to vary based on
one’s marital status, it is important to consider this role in the examination of
sexual behaviors. Furthermore, an assessment of partner level variables (e.g.,
socio-demographic variables, sexual behaviors) is helpful in understanding the
context of one’s sexual risk and protective factors. However, the analysis of
interpersonal factors influencing men’s sexual relationships was not possible, as
this information was not available in the dataset.
Due to the data limitations in the present study, further exploration of the
research questions in the context of the type and nature of men’s sexual
relationships may prove beneficial in the development of comprehensive
approaches to reduce the likelihood of STI transmission. Couple-level data
should be collected when and where feasible to facilitate comprehensive
assessments of sexual risk and behavior change to better target preventive
efforts. Literature on couples-based interventions have demonstrated that
partner expectations, reactions to information, and support may determine sexual
practices and, therefore, are important in risk appraisal and reduction (Bruhin,
2003; El-Bassel et al., 2003; Perez-Jimenez, Seal & Serrano-Garcia, 2009;
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Quina, Harlow, Morokoff, Burkholder & Deiter, 2000; Wingood & DiClemente,
1998).
Organizational Level. Activities and factors that facilitate or influence
behavior change at the organizational level may include health care systems and
professional organizations (Gregson et al., 2001; National Cancer Institute,
2005). Within sexual behavior, most interventions target individuals, promoting
behaviors that promote risk reduction within relationships. However, structural
factors have been noted to influence STI prevention, such as access to health
care services and barriers within the health care system (Bond, Lauby & Batson,
2005; Dean & Fenton, 2010; Gupta, Parkhurst, Ogden, Aggleton & Mahal, 2008;
Parker, Easton & Klein, 2000).
Research has suggested that gender differences exist in health care
experiences, as men may be reluctant to obtain advice from a medical
professional and delay seeking medical care (Galdas, Cheater & Marshall, 2005;
Möller-Leimkühler, 2002; Robertson, Douglas, Ludbrook, Reid & van Teijlingen,
2008; Sandman, Simantov & An, 2000; Shoveller, Knight, Johnson, Oliffe &
Goldenberg, 2010). More specifically, men may be slow to get tested for STIs
(Flood, 2003a). It has been suggested that socio-cultural norms of traditional
masculinity support these behaviors among men (Galdas et al., 2005; Mahalik,
Burns & Syzdek, 2007; Möller-Leimkühler, 2002). Men may only access health
care services for immediate cures or treatments for overt health problems or
symptoms (Robertson et al., 2008; Shoveller et al., 2010). Consequently, the
asymptomatic nature of some STIs is problematic among men who are
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potentially at risk (Bozicevic et al., 2006; Flores et al., 2008; Lewis et al., 2008;
Mason, 2005; Rieg et al., 2008). Furthermore, when men do access health
services, physicians may fail to counsel them regarding health concerns, missing
opportunities to inform their male patients of preventive measures to reduce risk
of adverse health outcomes (Sandman et al., 2000).
Historically, physicians are considered gatekeepers to health information,
resources, and services (Dixon-Woods et al., 2002; Hesse et al., 2005; U. S.
Department of Health and Human Services, 2001). As such, they play a critical
role in prevention efforts for a variety of diseases and negative health outcomes,
including HPV and other STIs (Dixon-Woods et al., 2002). More specifically,
physicians can reduce health risks to their patients through early education and
prevention (Haslegrave & Olatunbosun, 2003). Physicians are generally deemed
the most trustworthy and reliable sources of health information, as compared to
any other source of health information (Hesse et al., 2005; Sandman et al., 2000;
Winkler et al., 2008). Therefore, personalized health education and information
regarding STI screening and prevention from a health care provider may be
highly valued and may be critical to increasing the likelihood that men acquire
such services. However, data to specifically assess the perceived role and
efficacy of health care providers in STI risk reduction among men were absent
from this analysis. Qualitative research may be fruitful in understanding the
potential contributions of physicians to behavioral interventions for men.
Although health care providers are considered a primary resource for
health information, their knowledge and attitudes regarding HPV may be
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inadequate to meet the community needs (Cuzick, Mayrand, Ronco, Snijders &
Wardle, 2006). Health care providers may lack understanding of the relationship
between HPV and cancer (Cuzick et al., 2006; Sherris et al., 2006; Winkler et al.,
2008). The attitudes of health care professionals may be perceived as a barrier
for health care access and service delivery within culturally diverse communities,
as patients may respond either negatively or positively to their provider’s
demeanor (Bradley et al., 2006; Flores, 2000). Discomfort during the screening
procedure and fear of a bad diagnosis were associated with negative contact
with the health care provider (Bradley et al., 2006).
Health care providers have requested more training opportunities on HPV
and other STIs, including materials to facilitate patient education and counseling
(Institute of Medicine/ Committee on Prevention Control of Sexually Transmitted
Diseases, 1997; Sherris et al., 2006). Providers may not be aware of the scope
of STIs and may also lack the skills and knowledge to diagnose and treat STIs
(Institute of Medicine/ Committee on Prevention Control of Sexually Transmitted
Diseases., 1997). This may be a more daunting task for providers in the
developing world, who may not have access to costly, peer-reviewed journals
(Sherris et al., 2006). However, due to the prominence of health care providers
as purveyors of health information within the community, it is critical that they
have the most accurate and current information on HPV and STIs. The lack of
training among health care providers is compounded by the unavailability of
equipment and resources for STI testing (Institute of Medicine/ Committee on
Prevention Control of Sexually Transmitted Diseases, 1997), as well as the
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unavailability of a standardized test for HPV infection in men (Centers for
Disease Control and Prevention, 2012; McGinley, Hey, Sussman & Brown, 2011;
Schiffman & Castle, 2003).
Poverty is another factor that limits access to STI prevention information
and services. People who live in poverty are more likely to be uninsured, which
results in less access to preventive care services (Betancourt, Green, Carrillo &
Ananeh-Firempong, 2003; Parrish & Kent, 2008; Politzer et al., 2001; Sandman
et al., 2000; Weissman, Stern, Fielding & Epstein, 1991). Furthermore, men with
a low income are more likely to lack a regular physician (Parrish & Kent, 2008;
Sandman et al., 2000; Weissman et al., 1991). These factors may result in
delayed care and later-stage diagnosis of infection (Betancourt et al., 2003;
Sandman et al., 2000; Weissman et al., 1991). While it would have been
beneficial to examine income within the study population, income categories are
not easily comparable across study sites in this cross-national study. Therefore,
income data were unavailable for consideration in analyses.
While this dissertation study does not examine infrastructure issues, a key
implication of the research findings is that getting tested for STIs may be an
important strategy for reduced sexual risk-taking among men. In the context of
the literature on health services, providers may play a vital role in promoting STI
screening, while also improving knowledge and awareness. As studies suggest
that the health care system tends to focus STI services and testing on women or
special populations of men (e.g., men who have sex with men), a renewed focus
is required to attract men into the health care system for preventive services.
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This may involve creating more male-friendly environments, including providers
who are provided with training in culturally-appropriate, gender-relevant health
care (Sonfield, 2004). On a broader level, economic growth and social
development are important long-term approaches to support health care access
and increase availability of resources.
Community Level. Socio-cultural norms that define the male role within
intimate relationships may also affect sexual behaviors and STI transmission
(Bertone & Ferrero Camoletto, 2009; Santana, Raj, Decker, La Marche &
Silverman, 2006). Men may be expected to be the aggressor in relationships,
actively initiating and pursuing sexual encounters (Bertone & Ferrero Camoletto,
2009; Greene & Faulkner, 2005; Seal & Ehrhardt, 2003, 2004). Additionally,
casual, non-monogamous sex, multiple sexual partners, and sexual
experimentation may be more acceptable for men, compared to women (Almonte
et al., 2008; Carey, Senn, Seward & Vanable, 2010; Greene & Faulkner, 2005;
Santana et al., 2006; Seal & Ehrhardt, 2003). As pleasure-seeking has been
noted as a driving force in sexual relationships for men (Flood, 2003a, 2003b;
Hyde et al., 2009) and a common belief among men is that condoms reduce
sensation and feeling during sex (Campbell, Peplau & Debro, 1992; Flood,
2003b; Mizuno et al., 2007), STI risk reduction through condom use may be
negatively impacted by these pervasive male ideologies. Furthermore, research
has found that heterosexual men who ascribe to more traditional male gender
roles may be more likely to engage in risky sexual practices, such as unprotected
sexual intercourse (Santana et al., 2006). This suggests that sexual risk
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reduction messages for heterosexual men may prove more effective if they build
upon traditional and change gender norms that influence sexual interactions. For
example, public health programs that exclusively promote monogamy may
demonstrate minimal success among men, as they contradict male socio-cultural
norms.
Culture within a community provides a means for how the world is seen
and interpreted (Aquino & Zago, 2007; Granda-Cameron, 1999). Consequently,
culture frames how health and diseases, such as cancer, are experienced and
understood within the community (Aquino & Zago, 2007; Granda-Cameron,
1999). In Latin American countries, such as Mexico and Brazil, cultural
expectations that closely associate multiple partners and early sexual debut with
conceptualizations of virility and machismo may lead respondents to over-report
the number of partners (Falicov, 2010; Parker, 1996; Perez-Jimenez et al., 2009;
Villarruel & Rodriguez, 2003; Wallace, 2011). Machismo is a concept that
establishes the male role in society as dominant and strong, serving as the
protector and caregiver for the family, with permission to express more sexual
freedom, including early sexual debut and multiple and concurrent partners
(Falicov, 2010; Sobralske, 2006; Sternberg, 2000). In the study, the possibility of
over-reporting associated with machismo was minimized through the use of
Computer-Assisted Self-Interviewing (CASI), which has been shown to reduce
reporting bias (Fenton, Johnson, McManus & Erens, 2001; Ghanem, Hutton,
Zenilman, Zimba & Erbelding, 2005; Kissinger et al., 1999; Kurth et al., 2004).
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However, we cannot eliminate the potential influence of socio-cultural variability
on sexual behaviors within the study population.
In many Latin American communities, religion is a central guiding
framework for behaviors associated with sexuality (Edwards et al., 2011; Ogland
et al., 2011; Perez-Jimenez et al., 2009; Torres & Cernada, 2003). However,
much of the examination of religious influence on sexual health has been
conducted among females (Edwards et al., 2011; Torres & Cernada, 2003).
Religious views reinforce traditional roles among women, which are embodied by
the concept of marianismo. Rooted in characteristics of the Virgin Mary from
Christian theology, women are expected to be self-sacrificing caregivers, who are
obedient to men and virginal, delaying sexual activity and maintaining
monogamous relationships (Cofresi, 2002; Edwards et al., 2011). Among
couples, religious background may inhibit condom use and other forms of sexual
risk reduction (Perez-Jimenez et al., 2009). It has been noted that involving faithbased groups in STI prevention activities for Latinos may strengthen their impact
and outreach (Alvarez et al., 2009; Perez-Jimenez et al., 2009). Data were not
available in this dissertation research to assess the role of religion with STI risk
and sexual behavior among men. However, qualitative assessments are
recommended as an appropriate means of investigating the influence and
context of religion in sexual knowledge, beliefs, and behaviors among men, as
well as the potential role of faith-based organizations and leaders in sexual riskreduction within this group.
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According to a report from the Institute of Medicine, stigma affects the
emotions and feelings associated with sexually transmitted infections (Institute of
Medicine/ Committee on Prevention Control of Sexually Transmitted Diseases,
1997). Social stigma has been broadly documented for HPV and other STIs
(Institute of Medicine/ Committee on Prevention Control of Sexually Transmitted
Diseases, 1997; McCaffery, Waller, Nazroo & Wardle, 2006; Mulholland & Van
Wersch, 2007; Perrin et al., 2006; Waller, Marlow & Wardle, 2007). Previous
research has indicated that stigma associated with other STIs may be due to
prejudicial feelings about STIs, fear of isolation or judgment, and/or concerns
about one’s sexual relationship (Mulholland & Van Wersch, 2007). Because
diagnosis with HPV or other STIs is associated with sexual intercourse, people
may fear being judged (Hubbell, Chavez, Mishra & Valdez, 1996; Institute of
Medicine/ Committee on Prevention Control of Sexually Transmitted Diseases,
1997; McMullin, De Alba, Chávez & Hubbell, 2005). Stigma towards STIs inhibits
public discussion and education to promote awareness and risk reduction
strategies (Institute of Medicine/ Committee on Prevention Control of Sexually
Transmitted Diseases, 1997).
The quantitative nature of this dissertation research does not allow for the
in-depth investigation of community level factors regarding sexual practices
among men. Therefore, socio-cultural norms, religious influences, and social
stigma are not examined in this study. However, qualitative investigations are
recommended as future avenues of research to specifically explore male
traditional roles and community influences on sexual behavior.
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Policy Level. A global strategy for the prevention of STIs is prompt
diagnosis and treatment (World Health Organization, 2007). However, this
strategy has primarily been promoted for the prevention of HIV/AIDS
(Laxminarayan et al., 2006). Overall, STI prevention has been a secondary goal
to HIV prevention, as STIs help facilitate HIV transmission (Low et al., 2006;
Mayaud & McCormick, 2001; Wasserheit, 1992; World Health Organization/ Joint
United Nations Programme on HIV/AIDS, 1999; World Health Organization.,
2007). However, STIs are a significant public health concern in their own right,
as they can result in adverse, long-term health outcomes (De Schryver &
Meheus, 1990; Genuis & Genuis, 2004; Gerbase et al., 1998; Mayaud & Mabey,
2004; Mayaud & McCormick, 2001; World Health Organization/ Joint United
Nations Programme on HIV/AIDS, 1999; World Health Organization, 2007). Due
to the lack of information and awareness regarding STI screening among men,
public health campaigns have been suggested as a possible means to educate
men about the testing experience (Shoveller et al., 2010). Moreoever, it has
been recommended that men have pelvic exams, similar to women, and that STI
testing and treatment be incorporated within the regular continuum of services
(Alt, 2002; Kalmuss & Tatum, 2007; Shoveller et al., 2010).
Although STI testing has been noted as a critical step in public health
prevention, the focus has primarily been on high-risk populations, such as men
who have sex with men or injection drug users (Denison, O’Reilly, Schmid,
Kennedy & Sweat, 2008; Marks, Crepaz, Senterfitt & Janssen, 2005; Wolitski,
MacGowan, Higgins & Jorgensen, 1997), or women (Aidala et al., 2006;
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Campbell, 1995; Dworkin et al., 2009; Exner et al., 1999; Flood, 2003a; Higgins
et al., 2010; Neumann et al., 2002; Seal & Ehrhardt, 2004; Seal et al., 2003).
Heterosexual men are relatively absent in the literature regarding STI risk and
prevention (Aidala et al., 2006; Campbell, 1995; Dworkin et al., 2009; Exner et
al., 1999; Flood, 2003a; Higgins et al., 2010; Neumann et al., 2002; Seal &
Ehrhardt, 2004; Seal et al., 2003). Furthermore, research on sexual behavior
and STI risk among men has been limited to younger cohorts (Chopra et al.,
2009; Harrison et al., 2005; Makenzius et al., 2009; Mooney-Somers & Ussher,
2008; Sandfort et al., 2008). The study findings underscore the potential
effectiveness of STI testing as a prevention strategy among general populations
of men, beyond high-risk groups (i.e., injection drug users, men who have sex
with men). Further investigation of the needs and perspectives of men is
required to develop and implement gender-relevant and age-appropriate STI
prevention approaches.

Strengths and Limitations
There are several important limitations to this dissertation research. Since
this study used data from an existing cross-national dataset, the research
questions and methodology were limited to the scope and breadth of the parent
study. For example, there is some ambiguity in the wording of the variable for
paid sex (i.e., “ever exchanged sex for money or drugs”), which makes it unclear
as to whether the men responding affirmatively to this item were commercial sex
workers or purchasers of services. This uncertainty affects the interpretation and
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understanding of findings regarding paid sexual encounters. However, since this
study utilized secondary data, the analysis was limited to the available data.
Furthermore, there is the potential for instrument bias, as the Risk Factor
Questionnaire that was administered at all three study sites (i.e., Brazil, Mexico,
US) was originally developed by US-based researchers in English. Although the
instrument was translated into the primary language of each of the study sites
(i.e., Portuguese in Sao Paulo, Brazil; Spanish in Cuernavaca, Mexico) and backtranslated to English to aid in the comprehension of the survey by participants at
the non-English speaking sites, the appropriateness and relevance of some
socially-constructed items on the survey instrument may be questionable. For
example, the response categories for race/ethnicity were based on generally
accepted groupings in the US, which may not be meaningful in other countries.
Given these limitations, the findings should be interpreted with caution.
Although participant solicitation was conducted in the general population
to broaden the representation at the community level, the process utilized by the
parent study was not randomized. Therefore, the results of this secondary
analysis cannot be generalizable to all men in the United States, Brazil, and
Mexico. Furthermore, the socio-cultural heterogeneity of the study should be
considered in the interpretation and understanding of the study findings. The
data utilized in this study were collected at three different study sites with
contrasting socio-cultural norms and expectations, which may differentially affect
sexual behaviors within the study population. For example, virility and machismo
are cultural concepts that are entrenched in Latin American countries, such as
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Mexico and Brazil, and may potentially result in over-reporting of sexual partners,
age of sexual debut, and frequency of sexual behaviors (Falicov, 2010; Parker,
1996; Perez-Jimenez, Seal & Serrano-Garcia, 2009; Villarruel & Rodriguez,
2003; Wallace, 2011). Consequently, the implications of the study findings may
not be unilaterally applied to men within all of the study sites.
The recruitment and enrollment procedure in this cross-national study was
not uniform across the three country-based research sites (i.e., Brazil, Mexico,
US). Brazilian men were recruited through media advertising and a urogenital
medical center, while beneficiaries of the public health system, factory
employees, and officials of the army were recruited in Mexico. In the US, men
were recruited through promotional flyers and media advertising at a local
university and in the greater metropolitan area. The variance in these
approaches may have affected the study findings, as the sub-populations may be
inherently different. For example, there is an extensive amount of literature that
investigates correlates of sexual risk, such as knowledge, attitudes, and
perceptions, and underscores the elevated likelihood of STIs and risky sexual
behaviors among male university students (Crosby, Sanders, Yarber, Graham &
Dodge, 2002; Daley, Marhefka, Buhi, Vamos, Hernandez & Giuliano, 2010;
Hightow et al., 2005; Johnson, Douglas & Nelson, 1992; Katz, Krieger & Roberto,
2011; LaBrie, Earleywine, Schiffman, Pedersen & Marriot, 2005; Partridge et al,
2007). Additionally, research with military personnel reveals that sexual
behaviors that heighten the risk of STI transmission are an important public
health concern (Bing, Russak, Ortiz & Galvan, 2005; Essien et al., 2010; Kingma
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& Yeager, 2010; Szwarcwald, de Carvalho, Barbosa Júnior, Barreira, Speranza &
de Castilho, 2005; Whitehead & Carpenter, 1999; World Health Organization/
Joint United Nations Programme on HIV/AIDS, 1998; Yeager, 2000). Reports
have estimated that STI rates among military personnel are generally two to five
times higher than that of civilian populations (World Health Organization/ Joint
United Nations Programme on HIV/AIDS, 1998; Yeager, 2000). Therefore, the
overall findings of this research must be considered with caution, as no
information were available in the dataset to define and assess the influence in
men’s contextual life experiences and roles within society on sexual behaviors,
as well as norms, beliefs, and expectations related to such behaviors. These
issues limit the generalizability of the study results.
In the longitudinal analysis (i.e., Section 3 of this dissertation, Manuscript
2), the study population consisted of men who participated in all three study visits
(i.e., baseline/Visit 1, Visit 2, and Visit 3). It is noteworthy that the men who
initially enrolled in the study may be intrinsically different from those who did not.
Previous research has determined that volunteers in sexual behavior research
may be more informed regarding sexual health and may also be more sexually
experienced (Catania, McDermott & Pollack, 1986; Gaither, Sellbom & Meier,
2003; Strassberg & Lowe, 1995). On the other hand, there may be a differential
in beliefs and attitudes about STIs among men who were lost to follow-up,
compared to those who remained in the study. Furthermore, it is possible that
structural barriers (e.g., transportation) and logistical issues (e.g., scheduling with
study staff and/or work). Due the pattern of attrition in the study population, the

157

study population across the three time points results in data that are not missing
at random (i.e., NMAR) (Allison, 2002; Little & Rubin, 2002). Therefore, the
missingness in the data could not be modeled without a broad-based
understanding of the relationship between the variables. Given the exploratory
nature of this analysis and the overarching research questions, this is not
possible.
Due to attrition bias, there is a potential threat to internal and external
validity in this dissertation research. Overall, the decrease in sample size due to
attrition may reduce power in the analysis (Barry, 2005; Miller & Hollist, 2007).
However, due to the large size of the dataset utilized in this study, attrition bias
did not minimize this study’s power. The longitudinal sample utilized in the
analysis may differ significantly from the original sample, decreasing the
generalizability of the findings to the original study population (Miller & Hollist,
2007). The systematic loss of men to follow-up (rather than random attrition)
may alter the correlations between variables within the study (Miller & Hollist,
2007). Furthermore, the differential dropout rates among participants by
exposure groups may affect the strength of the associations revealed within the
study (Barry, 2005; Miller & Hollist, 2007).
Within the secondary dataset used in this study, several of the variables
were derived from self-reported data, which may be affected by recall bias.
However, the timeframe for behavioral variables was limited to the most recent
six month period, which has been found to improve subject recall (Catania,
Gibson, Marin, Coates & Greenblatt, 1990). Additionally, due to the highly
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sensitive nature of the outcomes of interest in this research (i.e., sexual
behaviors), social desirability bias is possible in participant responses. This may
be attributed to socio-cultural norms regarding the role of men in sexual
relationships. However, Computer-Assisted Self-Interviewing (CASI), which was
used in the data collection process, has been shown to be an effective means of
requesting information on intimate issues in a less threatening manner (Fenton et
al., 2001; Ghanem et al., 2005; Kissinger et al., 1999; Kurth et al., 2004). The
use of CASI in other studies has been demonstrated to reduce non-response
rates and biases in participant responses while also enhancing data validity
(Fenton et al., 2001; Ghanem et al., 2005; Kissinger et al., 1999; Kurth et al.,
2004). Furthermore, an assessment of the risk questionnaire utilized found
strong test-retest reliability, which also demonstrates that the data should yield
minimal biases (Nyitray et al., 2009).
In spite of these limitations, this dissertation research has some
noteworthy strengths that may prove beneficial in the identification of key factors
that play an important role in sexual risk reduction in men. The study used a
large cross-national sample of a general population of men, which offers
substantial power for the detection of group variances in the analysis. Although
the possibility of residual confounding attributable to unmeasured variables
cannot be excluded, several potential confounders were controlled for in the
statistical analysis.
Since few studies have explored sexual risk factors within general
populations of men, the findings provide important information on an
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understudied group. As male-centered approaches have been noted as an
important aspect of STI prevention (World Health Organization, 2007), the study
findings will prove useful in the development and planning of programs to prevent
the spread of STIs and provide more opportunities for treatment and education
among men. Furthermore, the sub-analysis by age cohort offers critical
information on sexual behaviors across the lifespan, which will aid in addressing
the health needs of men beyond the youth and/or young adult age group. More
specifically, this dissertation research may aid in the design and implementation
of sexual risk-reduction interventions for adult males (>30 years), addressing an
important gap in preventive services and information.

Conclusions
In this dissertation research, we conducted analyses with a cross-national
sample of adult, sexually active men in Brazil, Mexico, and the United States.
We examined the prevalence and correlates of sexual behaviors by age cohort,
as well as the impact of HPV and STI testing on sexual behaviors. The study
findings highlight the need for added public health efforts to reduce STI risk and
transmission among heterosexual men beyond the adolescent period.
Furthermore, the study underscores the potential for STI testing to decrease
sexual risk-taking among men.
Due to the dearth of studies on STI risk and sexual behavior among
general populations of men, continued research is needed to yield a greater
contextual understanding of male needs and perspectives regarding sexual risk
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reduction. Knowledge of the factors associated with an increased likelihood of
STI transmission, as well as those associated with sexual risk-taking, may be
beneficial in prioritizing prevention strategies and target populations. More
specifically, this information will aid in the development and implementation of
appropriate and relevant sexual health interventions to ultimately reduce STI
incidence and prevalence, increase knowledge and awareness, and improve
quality of life.
This study underscores the potential utility of audience segmentation in
the development of public health interventions to reduce sexual risk-taking
among men by socio-demographic characteristics, particularly age, marital
status, and educational level, as well as sexual behaviors, such as age of
initiation of sexual activity and lifetime number of sexual partners. A plausible
methodological approach to aid in the understanding of these factors, as well as
the interaction between them, is chi-squared automatic interaction detection
(CHAID). CHAID produces segments within a study population that result from
an iterative process of analyzing relationships and interactions between predictor
variables (Biggs, de Ville & Suen, 1991; Forthofer & Bryant, 2000; Kass, 1980).
CHAID has previously been used to identify unique audience segments (i.e.
mutually exclusive and exhaustive subgroups) and patterns and relationships
between variables in sexual health research (Catania et al., 1995; Dilorio,
Dudley& Soet, 1998; Huba et al., 2001).
Future studies should delve into ecological factors that may influence
sexual risk among men, including partner-level correlates, community level
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factors (e.g., stigma, culture, religion), and the influence of the health care
system. Furthermore, policy and advocacy initiatives should incorporate more
broad-based approaches that engage general populations of men, rather than
those who have historically been considered to be at high risk. As there is a
growing body of research that prioritizes and targets the specific sexual health
needs of women, efforts are now needed to equip men with the knowledge, skills,
and resources to access STI prevention, screening, and treatment services.
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Appendix A: Literature Review –
Human Papillomavirus among Heterosexual Males

Introduction
The Human Papillomavirus (HPV) is a sexually transmitted virus that is
passed on through skin-to-skin and genital contact (Centers for Disease Control
and Prevention, 2010). Approximately half of all people who have had sex will
have an HPV infection at some point in their lifetime (Centers for Disease Control
and Prevention, 2010; Vetter & Geller, 2007). As the most common sexually
transmitted infection, an estimated 6.2 million persons are newly infected with
HPV annually in the United States (Dunne, Nielson, Stone, Markowitz & Giuliano,
2006; Nielson et al., 2007). HPV infections are largely asymptomatic and
transient among both men and women (Dunne et al., 2009; Giuliano, 2007;
Nielson et al., 2007), resulting in people unknowingly transmitting the virus to
their sexual partners (Giuliano, 2007).
Of the 100 known types of HPV (American Cancer Society, 2006;
Bharadwaj, Hussain, Nasare & Das, 2009; Calloway, Jorgensen, Saraiya & Tsui,
2006; Centers for Disease Control and Prevention, 2007; Dunne et al., 2006;
Schiffman & Castle, 2003), approximately 30 are associated with anogenital
cancer (Bharadwaj et al., 2009), whereas 60 are known to infect the genital tract
(Nielson et al., 2007). Roughly 15 strains may potentially cause cervical tumors
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(Lowy, Solomon, Hildesheim, Schiller & Schiffman, 2008). Given the numerous
strains that infect shared regions of the body, concurrent infection with multiple
types of HPV is common (Nielson, Harris et al., 2009).
HPV is strongly associated with the development of invasive cervical,
vulvar, oropharyngeal, and anal cancers in women and penile, oropharyngeal,
and anal cancers in men (Castellsagué, Bosch & Muñoz, 2003; Chaturvedi,
2010; Colon-Lopez, Ortiz & Palefsky, 2010; Giuliano, Lazcano-Ponce et al.,
2008; Giuliano & Salmon, 2008; Giuliano, Tortolero-Luna et al., 2008; Human
papillomavirus infection in men residing in Brazil, Mexico, and the USA," 2008;
Lowy et al., 2008; Lu et al., 2009; Nielson et al., 2007; Nyitray et al., 2008; Parkin
& Bray, 2006). The majority of cancers worldwide (71.8%) are attributable to
HPV type 16 and HPV type 18 (Chaturvedi, 2010; Colon-Lopez et al., 2010;
Parkin & Bray, 2006). More specifically, HPV is universally recognized as the
primary cause of cervical cancer (American Cancer Society, 2006; Barr &
Tamms, 2007; Bosch, 2003; Centers for Disease Control and Prevention, 2008;
Clifford, Smith, Plummer, Muñoz & Franceschi, 2003; Cox, 2006; Franco, DuarteFranco & Ferenczy, 2001; Nielson, Harris et al., 2009; Pan American Health
Organization, 2007; Sankaranarayanan, Budukh & Rajkumar, 2001; Vetter &
Geller, 2007; Walboomers et al., 1999; World Health Organization Information
Centre on HPV and Cervical Cancer, 2007a, 2007b; World Health Organization,
2006). Nearly all (99.7%) cervical cancer cases are due to infection with some
strain of HPV (Pan American Health Organization, 2004; Walboomers et al.,
1999). HPV type 16 and HPV type 18 are two oncogenic strains, which account

194

for more than two-thirds of cervical cancer cases worldwide (American Cancer
Society, 2006; Calloway et al., 2006; Centers for Disease Control and
Prevention, 2007; Cox, 2006; Lowy et al., 2008; Vetter & Geller, 2007; World
Health Organization Information Centre on HPV and Cervical Cancer, 2007a,
2007b; World Health Organization, 2006).
The non-oncogenic types of HPV are associated with genital warts and
are primarily attributable to HPV Types 6 and 11(Beutner, Reitano, Richwald,
Wiley & A. M. A. Expert Panel on External Genital Warts., 1998; Colon-Lopez et
al., 2010; Donovan, 2004; Giuliano, 2007; Giuliano, Tortolero-Luna et al., 2008;
Lacey, Lowndes & Shah, 2006; Mortensen & Larsen, 2010). There are an
estimated 500,000 to 1 million new cases of HPV-induced genital warts annually
(Beutner et al., 1998). Approximately 20-50% of genital warts cases also involve
co-infections with oncogenic HPV strains (Lacey et al., 2006). Although the
clinical symptoms of genital warts (i.e., burning, bleeding, and pain) may be
uncomfortable, the psychosocial consequences (i.e., embarrassment,
depression, anger, shame, impact on sexual and social relationships) may have
a greater impact on quality of life (Lacey et al., 2006; Mortensen & Larsen, 2010).
Overall, the impact of HPV on men’s health, as well as factors associated
with HPV infection among men, is not widely understood. Much of the research
on HPV in men has examined their role in the epidemiological chain between
HPV and cervical cancer (Agarwal, Sehgal, Sardana, Kumar & Luthra, 1993;
Almonte et al., 2008; Bosch et al., 1996; Campion et al., 1988; Giuliano, 2007;
Giuliano, Lazcano-Ponce et al., 2008; Giuliano & Salmon, 2008; Human
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papillomavirus infection in men residing in Brazil, Mexico, and the USA," 2008;
Kyo et al., 1994; Lu et al., 2009; Muñoz & Bosch, 1997; Schiffman & Brinton,
1995; Schiffman & Castle, 2003; Waller, McCaffery, Forrest & Wardle, 2004).
Various studies have shown that a high proportion of the male sexual partners of
HPV positive women were also HPV positive (Bleeker et al., 2002; Kyo et al.,
1994; Nicolau et al., 2005). Male carriers of HPV may be vectors for high-risk
HPV types, placing their female sexual partners at risk for cervical cancer
(Agarwal et al., 1993; Bosch et al., 1996; Giuliano, Lazcano-Ponce et al., 2008;
Hernandez et al., 2008; Muñoz & Bosch, 1997; Schiffman & Castle, 2003). A
recent study has identified risk factors associated with anal HPV in heterosexual
men, including reported number of lifetime female sex partners and frequency of
sex during the previous month (Nyitray et al., 2008).

HPV & Sexual Behavior
Women’s risk to HPV and cervical cancer is dependent on the sexual
behaviors and practices of their male sexual partners (Agarwal et al., 1993;
Almonte et al., 2008; Bosch et al., 1996; Castellsagué et al., 2003; de Sanjosé,
Bosch, Muñoz & Shah, 1997; Giuliano, 2007; Giuliano, Lazcano-Ponce et al.,
2008; Giuliano & Salmon, 2008; Human papillomavirus infection in men residing
in Brazil, Mexico, and the USA," 2008; Lu et al., 2009; Nielson, Schiaffino,
Dunne, Salemi & Giuliano, 2009). Previous research indicates that there is an
elevated risk of cervical cancer among women whose husbands or male partners
had significantly more sexual partners (Almonte et al., 2008; Castellsagué et al.,
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2003; Schiffman & Brinton, 1995; Waller et al., 2004). Furthermore, husbands of
patients with cervical cancer had a higher likelihood of reporting a history of
sexually transmitted infections, as compared to husbands of control subjects who
reported more frequent condom usage (Schiffman & Brinton, 1995).
Sexual behavior has been strongly associated with HPV infection and
seropositivity in men across multiple studies (Dunne et al., 2006; Giuliano,
Lazcano-Ponce et al., 2008). More specifically, lifetime number of sex partners,
number of recent sex partners, age at first sexual intercourse, condom use, and
sexual frequency are significantly associated with HPV infection in men (Dunne
et al., 2006; Lu et al., 2009; Nielson et al., 2007). Other HPV risk factors include
smoking status and the presence of genital warts (Lu et al., 2009; Nielson et al.,
2007). Unlike other factors associated with heightened risk for HPV, the
protective nature of male circumcision has been revealed in several studies
(Almonte et al., 2008; Castellsagué et al., 2002; Castellsagué et al., 2003; Drain,
Halperin, Hughes, Klausner & Bailey, 2006; Giuliano et al., 2009; Giuliano &
Salmon, 2008; Lu et al., 2009; Mcintosh, Sturpe & Khanna, 2008; Murthy &
Mathew, 2000; Nielson et al., 2007; Nielson, Schiaffino et al., 2009; Schiffman &
Brinton, 1995; Schiffman & Castle, 2003; Waller et al., 2004).

Heterosexual Men’s Sexual Behavior
While previous research has unearthed critical information on the
importance of sexual behavior in the risk and transmission of HPV, few studies
have provided an in-depth examination of men’s sexual risk-taking behaviors.
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Risky sexual behavior is generally defined as practices, such as high numbers of
sexual partners and inconsistent and incorrect condom use, that puts one at
higher risk for exposure and contraction of a sexually transmitted infection (STI)
(Janssen, Goodrich, Petrocelli & Bancroft, 2009). Studies within the area of
HIV/AIDS, as well as other STIs, have examined factors associated with male
sub-populations considered to be at high-risk, such as men who have sex with
men and substance users (Aidala et al., 2006; Dworkin, 2005; Exner, Gardos,
Seal & Ehrhardt, 1999; Seal & Ehrhardt, 2004). Minimal research has
investigated risk factors associated with heterosexual transmission of STIs
among men, instead focusing largely on women (Aidala et al., 2006; Campbell,
1995; Dworkin, Fullilove & Peacock, 2009; Exner et al., 1999; Flood, 2003;
Higgins, Hoffman & Dworkin, 2010; Neumann et al., 2002; Seal & Ehrhardt,
2004). This is shaped partially due to the nature of the epidemic, in which
heterosexual transmission is predominantly an attribute of women’s risk
(Dworkin, 2005; Flood, 2003; Seal & Ehrhardt, 2004). Consequently,
heterosexual men have been considered a “forgotten group” within sexual and
reproductive health (Exner et al., 1999; Higgins et al., 2010; Seal & Ehrhardt,
2004). In general, men are less knowledgeable about sexual and reproductive
health issues, as compared to women (Makenzius, Gadin, Tyden, Romild &
Larsson, 2009).
Due to the limited focus of STI education and preventive efforts with
heterosexual men, some may perceive that the heterosexual community,
particularly males, may be not be at risk, or relatively safe, of contracting STIs
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(Flood, 2003). This may be perpetuated by the concept that heterosexual men
are powerful and invulnerable, compared to their female counterparts who are
more biologically susceptible to STI transmission from their male partners
(Dworkin, 2005; Higgins et al., 2010; Perez-Jimenez, Seal & Serrano-Garcia,
2009). Overall, there may be limited knowledge among men and women about
the male’s role in risk reduction for unintended pregnancy and STIs (Makenzius
et al., 2009).
Besides abstinence, correct and consistent use of male condoms is the
most effective means of preventing the heterosexual transmission of many STIs
(Holmes, Levine & Weaver, 2004; Saul et al., 2000). For HPV, correct and
consistent condom use is associated with higher rates of regression of HPVassociated cervical and penile lesions, as well as accelerated clearance of
genital HPV infection (Holmes et al., 2004). Given the nature of the male
condom, safer sex practices remain largely under the direct volitional control of
the male partner (Exner et al., 1999; O'Sullivan, Hoffman, Harrison & Dolezal,
2006; Purcell et al., 2006; Seal & Ehrhardt, 2004). Furthermore, it is frequently
expected within heterosexual couples for the male partner to have condoms
available for sexual intercourse (Gullette, Rooker & Kennedy, 2009; Thorburn,
Harvey & Ryan, 2005). However, few studies have examined the correlates of
condom use among heterosexual men (Noar, Morokoff & Redding, 2001).
A major deterrent in consistent condom use among heterosexual men is
the pervasiveness of negative attitudes and beliefs regarding condom use.
Common beliefs that heighten the likelihood of sexual risk-taking behaviors
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include the idea that condoms decrease sexual pleasure and penile sensitivity
and that they are inconvenient, serving as a disruption to the sexual act (Flood,
2003; Gullette et al., 2009; Harawa, Williams, Ramamurthi & Bingham, 2006;
LaBrie, Pedersen, Thompson & Earleywine, 2008; Perez-Jimenez et al., 2009;
Seal & Ehrhardt, 2004; Semaan, Des Jarlais & Malow, 2006). Consequently,
many heterosexual men report inconsistent condom use (Aidala et al., 2006;
Exner et al., 1999; Flood, 2003; Seal & Ehrhardt, 2004). Additionally, condom
use may be partially determined by the male partner’s fear of a potential
pregnancy and fatherhood, which may be more dominant than one’s concern
about contracting an STI (Flood, 2003; Seal & Ehrhardt, 2004).
Sexual behaviors among heterosexual men have been found to be fluid,
with practices being dependent on the nature of the relationship (Aidala et al.,
2006; Exner et al., 1999; Flood, 2003; Seal & Ehrhardt, 2004). Heterosexual
men may practice serial monogamy, in which one accumulates multiple sexual
partners over their lifetime with varying levels of condom use with each partner
(Aidala et al., 2006; Exner et al., 1999; Flood, 2003; Seal & Ehrhardt, 2004).
Within serial monogamy, the relationships often involve early commitment and
early initiation of sexual activity, with the presumption of exclusivity by both
partners (O'Sullivan et al., 2006). Before establishing a longer term,
monogamous relationship, there may be transitional periods of increased risk
behavior, as men cycle through a series of concurrent or brief sexual
relationships (Aidala et al., 2006; Seal & Ehrhardt, 2004). During these
transitional periods, greater condom use consistency has been reported, as men
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report more risky sexual practices, including multiple concurrent partners and
high frequencies of casual sex (Exner et al., 1999). Conversely, within their
primary relationships, heterosexual men are less likely to use condoms (Corbett,
Dickson-Gomez, Hilario & Weeks, 2009; Flood, 2003; O'Sullivan et al., 2006).
Lack of condom use within relationships has been found to signify trust,
commitment, and intimacy among men, as well as their female partners (Corbett
et al., 2009; Flood, 2003; LaBrie et al., 2008; O'Sullivan et al., 2006; Thorburn et
al., 2005). Studies regarding condom use have yielded conflicting results. Some
studies have found that men with non-regular partners (i.e., not in a
monogamous relationship) used condoms more frequently (Evans, Bond &
MacRae, 1997; Evans, Kell, Bond & MacRae, 1995). Interestingly, other studies
have shown that men who have multiple casual sex partners are not more likely
to practice safer sex than those in monogamous relationships (Exner et al., 1999;
LaBrie et al., 2008). Furthermore, previous research has found that men
reporting concurrent, multiple sexual partners are more likely to incorrectly use
condoms (Crosby, DiClemente, Yarber, Snow & Troutman, 2008). It has also
been found that changing sexual risk behaviors is more challenging with one’s
primary sexual partner, as compared to practices with casual sexual partners
(Purcell et al., 2006).
Heterosexual men who participate in extramarital or extradyadic sexual
activities play a critical role in the introduction of STIs into their marital
relationships (Manhart, Aral, Holmes & Foxman, 2002; O'Sullivan et al., 2006;
Schensul et al., 2006). These men may engage in such activities due to reported

201

sexual dissatisfaction and their need for sexual excitement, sexual curiosity, and
sexual enjoyment (Glass & Wright, 1992; Mooney-Somers & Ussher, 2008;
Schensul et al., 2006). Sexual activity outside of the confines of the presumed
monogamous relationship has been found to be more common among men, as
compared to women (Choi, Catania & Dolcini, 1994; Manhart et al., 2002;
O'Sullivan et al., 2006; Wiederman, 1997). Among men, lifetime incidence of
extramarital sex was found to increase with age, while a curvilinear relationship
existed among women, with the greatest likelihood of extramarital sex being
among those 30-50 years old (Wiederman, 1997). Condom use levels have
been found to be consistently low (between 8 and 19%) among people reporting
extramarital sex (Choi et al., 1994).
When examining sexual risk practices among men, the majority of
research conducted has focused on younger populations, including adolescents
and young adults (Mooney-Somers & Ussher, 2008). As HIV/AIDS and STI
transmission is higher among younger age groups (LaBrie et al., 2008; Noar et
al., 2001; Tan, Wong & Chan, 2006), research has been primarily focused on
these groups. However, the increase in HIV/AIDS cases among older adults in
recent years (Casau, 2005; Coleman & Ball, 2007; Goodroad, 2003; Kohli et al.,
2006; Savasta, 2004), coupled with research documenting escalating sexual
behavior risks within older age cohorts (Kohli et al., 2006; Rogstad & Bignell,
1991), highlight the need for further research on this sub-group. Multiple studies
have found that younger heterosexual men are more likely to practice risky
sexual behaviors, such as inconsistent condom use (Aidala et al., 2006; Finer,
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Darroch & Singh, 1999; Noar et al., 2001). Conversely, other research has
reported condom use to be common among young and middle-aged
heterosexual couples but not among older couples (Bruhin, 2003; Kohli et al.,
2006; Stall & Catania, 1994). Given this conflicting evidence, additional
information is needed to understand how sexual behavior may change with age.
Furthermore, it has been acknowledged that sexual risk behaviors, likelihood of
infection with an STI, and sexual motivations of heterosexual men evolve over
time; therefore, interventions and messaging should be tailored to address these
developmental differences between young adult, middle-aged, and older men
(Seal & Ehrhardt, 2004).
Although reducing sexual risk behaviors is critical in the prevention of
STIs, such as HPV, there are inherent challenges due to the nature of sexual
behavior. Within multiple societies and cultures, sex is considered private, which
hinders open communication and discussion (Perez-Jimenez et al., 2009;
Semaan et al., 2006). Communication about sexual behaviors and safer sex
may also be hindered by conflicting perspectives due to the prescribed gender
roles of men and women (Perez-Jimenez et al., 2009). Additionally, traditional
gender roles within many heterosexual relationships may result in power
inequities that influence decision-making regarding condom use and give men
greater control over sexual practices (Campbell, 1995; Chopra et al., 2009;
Dworkin, 2005; Elwy, Hart, Hawkes & Petticrew, 2002; Exner et al., 1999;
Higgins et al., 2010; Saul et al., 2000; Seal & Ehrhardt, 2004). Furthermore,
abstinence from all forms of sexual intercourse, which is the most effective
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strategy for STI prevention, is not the preferred choice of most heterosexual men
and is usually not considered an acceptable alternative to penetrative vaginal
intercourse (Exner et al., 1999; Flood, 2003).

Impact of HPV Testing
In recent years, studies have been conducted to assess the impact of
HPV testing. However, most of these studies have focused on psychosocial
issues influenced by HPV testing, as well as cervical smear testing, among
women (Gray et al., 2006; Maissi et al., 2004; Maissi et al., 2005; McCaffery et
al., 2004; McCaffery, Waller, Nazroo & Wardle, 2006); no known studies have
investigated behavioral risk associated with HPV testing. Previous research has
indicated that women who were HPV-positive had heightened levels of anxiety,
distress, and concern (Maissi et al., 2004; McCaffery et al., 2004). The raised
anxiety and distress levels were diminished six months following initial testing;
however, concern about the test results remained elevated (Maissi et al., 2005).
Women also had reduced anxiety with increasing age (Gray et al., 2006; Maissi
et al., 2004). Due to the sexually transmitted nature of HPV, women who tested
positive for HPV reported feeling stigmatized, stressed, and concerned about
their sexual relationships (McCaffery et al., 2006). Furthermore, women were
worried and anxious about disclosing their HPV status to their sexual partner,
family members, and friends (McCaffery et al., 2006). They also felt worse about
their past and future sexual relationships (McCaffery et al., 2004). No known
studies have examined the impact of HPV testing among men.
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Conclusion
Although some studies have emerged that qualitatively explore the role of
heterosexual men in safer sex practices and STI transmission, this issue remains
relatively unexplored. Overall, public health interventions and programs may be
enhanced with a greater understanding of sexual risk behaviors and associated
factors of heterosexual men, improving health outcomes among both men and
their sexual partners.
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Appendix B
RISK FACTOR QUESTIONNAIRE
The HIM Study: BASELINE VISIT

Moffitt Cancer Center is conducting a research study in order to learn more about
Human Papillomavirus (HPV) in men. HPV is a virus that is passed on when
people have sex. It is very common in men and women. With your assistance,
the information gained from this study will be used to better serve you and the
community.
We appreciate your willingness to participate in this project.
All of the information you provide for us is strictly confidential, and your name will
not be associated with this questionnaire and will never be used in reports.

Please read each question and provide the answer that best fits your situation.
Remember, you have the option of refusing to answer any question that you do
not wish to answer.

If you have any questions feel free to ask the project interviewer.

1.

Do you consider yourself Spanish/Hispanic/Latino?
_____ Yes
_____ No
_____ Refuse

2.

Which one of the following would you say best represents your race?
_____ White
_____ Black or African American
_____ Asian
_____ Native Hawaiian or Other Pacific Islander
_____ American Indian, Alaska Native
_____ Other
_____ Refuse
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3.

In which country were you born?
_____ U.S.
_____ Mexico
_____ Brazil
_____ Other
_____ Refuse

4.

How many years have you lived in the U.S.?
_____ Years
_____ Refuse

5.

In which country have you lived most of your life?
_____ U.S.
_____ Mexico
_____ Brazil
_____ Other
_____ Refuse

6.

Date of birth
Month: _____ Day: _____ Year: _____

7.

What is your current marital status?
_____ Single, never married
_____ Married
_____ Cohabiting, Living together
_____ Divorced/Separated
_____ Widowed
_____ Refuse

8.

How many years of school did you complete?
_____ Did not complete 6th grade
_____ 6th-8th grade
_____ 9th-11th grade
_____ Completed high school/GED
_____ Vocational school
_____ Some college
_____ Graduated college
_____ Postgraduate or professional school
_____ Refuse
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9.

Have you had at least one drink of any alcoholic beverage in the past
month?
_____ Yes
_____ No (Skip to question 12.)
_____ Refuse

10.

A drink of alcohol is 1 can or bottle of beer, 1 glass of wine, 1 can or bottle
of wine cooler, 1 cocktail, or 1 shot of liquor. During the past 1 month, how
many days did you have at least one drink of any alcoholic beverage?
_____ Days
_____ Refuse
11. On the days when you drank, about how much did you drink on average?
(Choose all that apply)
_____ Bottles of beer
_____ Glasses of wine
_____ Bottles of wine cooler
_____ Number of cocktails
_____ Shots of liquor
_____ Other types of alcohol
_____ Refuse

12.

Have you ever used any form of tobacco (cigarettes, pipes, cigars, chew,
snuff)?
_____ Yes
_____ No (Skip to question 20.)
_____ Refuse

13.

During your entire life, have you smoked at least 100 cigarettes, which is
about 5 packs of cigarettes?
_____ Yes
_____ No (Skip to question 19.)
_____ Refuse

14.

How old were you when you started smoking cigarettes?
_____ Years
_____ Refuse

15.

About how many years have you smoked cigarettes?
_____ Years
_____ Refuse
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16.

How many cigarettes on average do/did you smoke per day?
_____ Cigarettes
_____ Refuse

17.

Do you smoke cigarettes now?
_____ Yes
_____ No
_____ Refuse

18.

During the past 12 months have you stopped smoking for 1 day or longer
because you were trying to quit?
_____ Yes
_____ No
_____ Don’t know
_____ Refuse

19.

Do you currently use chewing tobacco or snuff?
_____ Every Day
_____ Some Days
_____ Not at all
_____ Refuse

20.

During the past month, approximately how many hours were you exposed
to other people's cigarette smoke in an enclosed location (i.e., home,
vehicle, work, bar, restaurant)? If never, enter a 0 and select "Hours per
day".
_____ Hours _____ Per Day
_____ Per Week
_____ Per Month
_____ Refuse

21.

If you spent an hour in the mid-day sun for the first time without
sunscreen, which of these reactions best describes what would happen to
your skin: (Check only one)
_____ A blistering sunburn
_____ A sunburn without blisters
_____ A mild sunburn that becomes a tan
_____ A tan with no sunburn
_____ No change in skin color
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22.

A sunburn is any reddening or discomfort of your skin that lasts longer
than 2 hours after exposure to the sun or other UV (ultraviolet) sources,
such as tanning beds or sunlamps. How many times in your life have you
been sunburned severely enough to cause blistering?
_____None (never had a blistering sunburn)
_____ 1 blistering sunburn
_____ 2 blistering sunburns
_____ More than 2 blistering sunburns

The next questions we are going to ask you are sensitive. It is useful to have
this information because HPV infection may differ depending on your sexual
history.

23.

Have you ever been diagnosed with a sexually transmitted disease or
infection by a doctor or health care provider?
_____ Yes
_____ No
_____ Don’t know
_____ Refuse

24.

Has a doctor or health care provider ever diagnosed you with any of the
following?

Genital warts
Genital herpes
Chlamydia
Gonorrhea
Syphilis
NGU (non-gonococcal
urethritis)
Hepatitis B
Hepatitis C
HIV

25.

Yes
_____
_____
_____
_____
_____
_____

No
_____
_____
_____
_____
_____
_____

Don’t know
_____
_____
_____
_____
_____
_____

_____
_____
_____

_____
_____
_____

_____
_____
_____

Have you ever had a sex partner who has had a sexually transmitted
disease?
_____ Yes
_____ No
_____ Don’t know
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_____ Refuse

26.

Have you ever had a sex partner who has had genital warts?
_____ Yes
_____ No
_____ Don’t know
_____ Refuse

27.

Have you ever had a sex partner who has had an abnormal Pap smear?
_____ Yes
_____ No
_____ Don’t know
_____ Refuse

28.

Have you ever had a female sex partner who has received an HPV
vaccine?
_____ Yes
_____ No (skip to question 31)
_____ Don’t know (skip to question 31)
_____ Refuse (skip to question 31)

29.

How many of your female partners have had an HPV vaccine?
_____ partner(s)
_____ Refuse

30.

Has your current partner had an HPV vaccine?
_____ Yes
_____ No
_____ Don’t know
_____ Refuse

31.

Have you been circumcised?
_____ Yes
_____ No
_____ Don’t know
_____ Refuse

We are going to ask you questions about sexual relations. For the questions on
sexual intercourse, we define sexual intercourse as your penis in someone else’s
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vagina or anus.

32.

Have you ever performed vaginal, anal, or oral sex (your penis in partner's
vagina, anus, or mouth or your partner's penis in your anus or mouth)?
_____ Yes
_____ No (Skip to Medical History Questionnaire)
_____ Refuse

33.

Have you ever performed vaginal sex (your penis in partner’s vagina)?
_____ Yes
_____ No (Skip to question 42)
_____ Refuse

34.

How old were you when you first had vaginal sex?
_____ Years
_____ Refuse

35.

In your life, what is the number of women with whom you have had vaginal
sex?
_____ Women
_____ Refuse

36.

In the past 6 months, how many different women have you had vaginal
sex with?
_____ Women
_____ Refuse

37.

In the past 6 months, how many women have you had vaginal sex with for
the first time?
_____ Women
_____ Refuse

38.

In the past 6 months, how many times did you have vaginal sex?
_____ Times
_____ Refuse
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39.

In the past 6 months, when you had vaginal sex, how often did you use
condoms?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ No vaginal sex in past 6 months
_____ Refuse

40.

How long has it been since you had vaginal sex?
_____ Hours
_____ Days
_____ Weeks
_____ Months
_____ Years
_____ Refuse

41.

Did you use a condom the last time you had vaginal sex?
_____ Yes
_____ No
_____ Don’t remember
_____ Never used a condom with vaginal sex
_____ Refuse

42.

Have you ever performed oral sex (your penis in your partner’s mouth or
your partner’s vagina in your mouth or your partner’s penis in your
mouth)?
_____ Yes
_____ No (Skip to question 50)
_____ Refuse

43.

Did you perform oral sex on your partner in the past 6 months?
_____ Yes
______No (Skip to question 45)
______Refuse

44.

In the past 6 months, how many times did you perform oral sex on your
partner?
_____ Times
_____ Refuse
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45.

How long has it been since you performed oral sex on your partner?
_____Hours
_____Days
_____Weeks
_____Months
_____Years
_____Refuse

46.

Has a partner ever performed oral sex on you? (Your penis in your
partner’s mouth)
_____ Yes
_____ No (Skip to question 50)
_____ Refuse

47.

Did your partner perform oral sex on you in the past 6 months?
_____Yes
_____No (Skip to question 49)
_____Refuse

48.

In the past 6 months, how many times did your partner perform oral sex
on you?
_____ Times
_____ Refuse

49.

How long has it been since your partner performed oral sex on you?
_____Hours
_____Days
_____Weeks
_____Months
_____Years
_____Refuse

50.

Have you ever performed insertive anal sex (your penis in partner’s
anus)?
_____ Yes
_____ No (Skip to question 56)
_____ Refuse
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51.

Have you performed insertive anal sex in the past 6 months?
_____ Yes
_____ No (Skip to question 54)
_____ Refuse

52.

In the past 6 months, how many times did you perform insertive anal sex?
_____ Times
_____ Refuse

53.

In the past 6 months, when you had insertive anal sex, how often did you
use condoms?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ Refuse

54.

How long has it been since you performed insertive anal sex?
_____ Hours
_____ Days
_____ Weeks
_____ Months
_____ Years
_____ Refuse

55.

Did you use a condom the last time you performed insertive anal sex?
_____ Yes
_____ No
_____ Don’t remember
_____ Refuse

56.

Have you ever performed receptive anal sex (your partner’s penis in your
anus)?
_____ Yes
_____ No (Skip to introduction to question 62)
_____ Refuse

57.

Have you had receptive anal sex in the past 6 months?
_____ Yes
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_____ No (Skip to question 60)
_____ Refuse

58.

In the past 6 months, how many times did you have receptive anal sex?
_____ Times
_____ Refuse

59.

In the past 6 months, when you had receptive anal sex, how often did your
partner use condoms?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ Refuse

60.

How long has it been since you had receptive anal sex?
_____ Hours
_____ Days
_____ Weeks
_____ Months
_____ Years
_____ Refuse

61.

Did your partner use a condom the last time you had receptive anal sex?
_____ Yes
_____ No
_____ Don’t remember
_____ Refuse

For the next few questions, we are going to ask you about your steady partner
you see regularly.

62.

Do you have a steady female sex partner?
_____ Yes
_____ No (Skip to introduction to question 70)
_____ Refuse
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63.

The last time you had sex, was the partner a steady partner?
_____ Yes
_____ No
_____ Refuse

64.

How long have you been having sexual intercourse with your steady
partner?
_____ Days
_____ Weeks
_____ Months
_____ Years
_____ Refuse

65.

In the past 3 months, when you had sexual intercourse with your steady
partner, how often did you use condoms?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ Have not had sex with steady partner in past 3 months
_____ Refuse

66.

The first time you had sex with your steady partner, did one of you use a
condom?
_____ Yes
_____ No
_____ Don’t remember
_____ Refuse

67.

In the past 3 months, did you have sex with someone other than your
steady partner?
_____ Yes
_____ No (Skip to introduction to question 70)
_____ Refuse

68.

How many people other than your steady partner have you had sex with in
the past 3 months?
_____ People
_____ Refuse
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69.

In the past 3 months, when you had sexual intercourse with your other
partner(s), how often did you use condoms?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ Refuse

The next questions we are going to ask are sensitive, and have to do with some
private sex practices. Your answers are private and used only for research
purposes.

70.

Have you ever exchanged sex for money or drugs?
_____ Yes
_____ No (Skip to introduction to question 77)
_____ Refuse

71.

Have you ever paid a woman to have sex (vaginal or anal or oral) with
you?
_____ Yes
_____ No (Skip to introduction to question 77)
_____ Refuse

72.

In the past 3 months, have you paid a woman to have sex with you?
_____ Yes
_____ No (Skip to introduction to question 77)
_____ Refuse

73.

In the past 3 months, how many times have you paid a woman to have
sex with you?
_____ Times
_____ Refuse

74.

In the past 3 months, when you paid for sex, was it: (Choose all that
apply)
_____ In the U.S.
_____ Outside the U.S.
_____ Refuse
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75.

In the past 3 months, what kind of sex did you pay for? (Choose all that
apply)
_____ Vaginal sex (your penis in partner’s vagina)
_____ Oral sex (your penis in partner’s mouth or partner’s vagina in your
mouth)
_____ Anal sex, insertive (your penis in partner’s anus)
_____ Other
_____ Refuse

76.

In the past 3 months, when you paid for vaginal, oral, or anal sex, how
often did you use condoms?
____ Always
____ More than half the time
____ Half the time
____ Less than half the time
____ Never
____ Refuse

We are now going to ask you additional sensitive questions. It is useful to have
this information because HPV infection may differ depending on the type of sex.
Your answers are strictly confidential and used only for research purposes.

77.

Have you ever had sex with a man (your penis in partner's anus or mouth,
or our partner's penis in your anus or mouth)?
_____ Yes
_____ No (Thank you for your participation – please end the
questionnaire)
_____ Refuse (Thank you for your participation – please end the
questionnaire)

78.

Have you ever performed oral sex with a man (your penis in partner’s
mouth or your partner’s penis in your mouth)?
_____ Yes
_____ No
_____ Refuse

79.

Have you ever performed anal sex with a man (your penis in partner’s
anus or your partner’s penis in your anus)?
_____ Yes
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_____ No (Skip to question 83)
_____ Refuse (Skip to question 83)

80.

In your life, what is the number of men with whom you have had anal sex
(your penis in partner’s anus or partner’s penis in your anus)?
_____ Men
_____ Refuse

81.

In the past 3 months, how many men have you had anal sex with?
____ Men
_____ Refuse

82.

In the past 3 months, how many men have you had anal sex with for the
first time?
_____ Men
_____ Refuse

83.

Have you ever paid a man to have sex (anal or oral) with you?
_____ Yes
_____ No (Thank you for your participation – please end the
questionnaire)
_____ Refuse

84.

In the past 3 months, have you paid a man to have sex with you?
_____ Yes
_____ No (Thank you for your participation – please end the
questionnaire)
_____ Refuse (Thank you for your participation – please end the
questionnaire)

85.

In the past 3 months, how many times have you paid a man to have sex
with you?
_____ Times
_____ Refuse

86.

In the past 3 months, when you paid for sex with a man, was it: (Choose
all that apply)
_____ In the U.S.
_____ Outside the U.S.
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_____ Refuse

87.

In the past 3 months, what kind of sex (with a man) did you pay for?
(Choose all that apply)
_____ Oral sex (your penis in partner’s mouth)
_____ Anal sex, insertive (your penis in partner’s anus)
_____ Other
_____ Refuse

88.

In the past 3 months, when you paid for anal or oral sex with a man, how
often did you use condoms?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ Refuse

YOUR CONTRIBUTION IS VERY IMPORTANT TO OUR STUDY. YOU ARE
HELPING US TO PLAN FOR BETTER HEALTH CARE IN THE COMMUNITY.
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Appendix C
RISK FACTOR QUESTIONNAIRE
The HIM Study: FOLLOW-UP VISITS

Moffitt Cancer Center is conducting a research study in order to learn more about
Human Papillomavirus (HPV) in men. HPV is a virus that is passed on when
people have sex. It is very common in men and women. With your assistance,
the information gained from this study will be used to better serve you and the
community.
We appreciate your willingness to participate in this project.
All of the information you provide for us is strictly confidential, and your name will
not be associated with this questionnaire and will never be used in reports.
Please read each question and provide the answer that best fits your situation.
Remember, you have the option of refusing to answer any question that you do
not wish to answer.
If you have any questions feel free to ask the project interviewer.

1.

Do you consider yourself Spanish/Hispanic/Latino?
_____ Yes
_____ No
_____ Refuse

2.

Which one of the following would you say best represents your race?
_____ White
_____ Black or African American
_____ Asian
_____ Native Hawaiian or Other Pacific Islander
_____ American Indian, Alaska Native
_____ Other
_____ Refuse

3.

What is your current marital status?
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_____ Single, never married
_____ Married
_____ Cohabiting, Living together
_____ Divorced/Separated
_____ Widowed
_____ Refuse

4.

How many years of school did you complete?
_____ Did not complete 6th grade
_____ 6th-8th grade
_____ 9th-11th grade
_____ Completed high school/GED
_____ Vocational school
_____ Some college
_____ Graduated college
_____ Postgraduate or professional school
_____ Refuse

5.

Have you had at least one drink of any alcoholic beverage in the past
month?
_____ Yes
_____ No (Skip to question 8)
_____ Refuse

6.

A drink of alcohol is 1 can or bottle of beer, 1 glass of wine, 1 can or bottle
of wine cooler, 1 cocktail, or 1 shot of liquor. During the past 1 month, how
many days did you have at least one drink of any alcoholic beverage?
_____ Days
_____ Refuse

7.

On the days when you drank, about how much did you drink on average?
(Choose all that apply)
_____ Bottles of beer
_____ Glasses of wine
_____ Bottles of wine cooler
_____ Number of cocktails
_____ Shots of liquor
_____ Other types of alcohol
_____ Refuse
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8.

During the past 6 months, or since your last visit, have you used any form
of tobacco (cigarettes, pipes, cigars, chew, snuff)?
_____ Yes
_____ No (Skip to question 11)
_____ Refuse

9.

During the past 6 months or since your last visit, how many cigarettes on
average did you smoke per day?
_____ Cigarettes/day
_____ Refuse

10.

Do you smoke cigarettes now?
_____ Yes
_____ No
_____ Refuse

11.

During the past 6 months or since your last visit, have you used any forms
of nicotine replacement (patches, nicotine gum, etc.)?
_____ Yes
_____ No
_____ Refuse

12.

Do you currently use chewing tobacco or snuff?
_____ Every day
_____ Some days
_____ Not at all
_____ Refuse

13.

If you spent an hour in the mid-day sun for the first time without
sunscreen, which of these reactions best describes what would happen to
your skin: (Check only one)
_____ A blistering sunburn
_____ A sunburn without blisters
_____ A mild sunburn that becomes a tan
_____ A tan with no sunburn
_____ No change in skin color

14.

A sunburn is any reddening or discomfort of your skin that lasts longer
than 2 hours after exposure to the sun or other UV (ultraviolet) sources,
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such as tanning beds or sunlamps. How many times in your life have you
been sunburned severely enough to cause blistering?
_____ None (never had a blistering sunburn)
_____ 1 blistering sunburn
_____ 2 blistering sunburns
_____ More than 2 blistering sunburns

The following section will ask you questions about kissing and oral hygiene.

15.

How many different people have you kissed in the past 6 months?
(Kissing is defined as open mouth kissing, or putting your tongue in a
person’s mouth)
_____ People
_____ Refuse

16.

How many different people have you ever kissed (Kissing is defined as
open mouth kissing, or putting your tongue in a person’s mouth)?
_____0
_____1-9 people
_____10-24 people
_____25-49 people
_____50 or more people
_____ Refuse

17.

Have you been diagnosed with gingivitis as an adult (Gingivitis is a mild
form of gum (periodontal) disease)?
_____ Yes
_____ No
_____ Refuse

18.
How many teeth have you had extracted due to gum disease, gingivitis, or
decay?
_____ Teeth
_____ Refuse

19.

How often on average do you brush your teeth? (Choose only one
answer)
_____ Times/day
_____ Times/week
_____ Times/month
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_____ Refuse

20.

Do your gums consistently bleed when you brush your teeth or are your
gums swollen?
_____ Yes
_____ No
_____ Refuse

21.

Have you ever had warts in your mouth or throat?
_____Yes
_____No (Skip to introduction to question 24)
_____Refuse (Skip to introduction to question 24)

22.

How many warts have you had in your mouth?
____Warts
____ Refuse

23.

When did you have warts in your mouth?
____ Currently have warts in my mouth
____ 1 month ago
____ 6 months ago
____ More than 6 months ago
____ Refuse

The next questions we are going to ask you are sensitive. It is useful to have this
information because HPV infection may differ depending on your sexual history.

24.

During the past 6 months or since your last visit, have you been
diagnosed with a sexually transmitted disease or infection, other than
HPV, by a doctor or health care provider?
____Yes
____No
____Don’t know
____Refuse

25.

During the past 6 months or since your last visit, has a doctor or health
care provider diagnosed you with any of the following?
Genital warts

___Yes ___No ___ Don’t know ___Refuse
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Genital herpes
Chlamydia
Gonorrhea
Syphilis
NGU (Non-gonococcal
urethritis)
Hepatitis B
Hepatitis C
HIV

___Yes
___Yes
___Yes
___Yes

___No
___No
___No
___No

___ Don’t know
___ Don’t know
___ Don’t know
___ Don’t know

___Refuse
___Refuse
___Refuse
___Refuse

___Yes
___Yes
___Yes
___Yes

___No
___No
___No
___No

___ Don’t know
___ Don’t know
___ Don’t know
___ Don’t know

___Refuse
___Refuse
___Refuse
___Refuse

26.

During the past 6 months or since your last visit, have you had a sex
partner who has had a sexually transmitted disease or infection?
____ Yes
____ No
____ Don’t know
____ Refuse

27.

During the past 6 months or since your last visit, have you had a sex
partner who has had genital warts?
____ Yes
____ No
____ Don’t know
____ Refuse

28.

During the past 6 months or since your last visit, have you had a sex
partner who has had an abnormal Pap smear?
____ Yes
____ No
____ Don’t know
____ Refuse

29.

Have you ever had a female sex partner who has received an HPV
vaccine?
____ Yes
____ No (Skip to question 32)
____ Don’t know (Skip to question 32)
____ Refuse (Skip to question 32)

30.

How many of your female partners have had an HPV vaccine?
____ Partner(s)
____ Refuse
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31.

Has your current partner had an HPV vaccine?
____ Yes
____ No
____ Don’t know
____ Refuse

32.

Have you ever received an HPV vaccine?
_____ Yes
_____ No (Skip to introduction to question 36)

33.

When did you receive your first dose of the HPV vaccine?
Month:_____ Day:_____ Year:_____

34.

When did you receive your second dose of the HPV vaccine? (If you have
not had your second dose yet, please add zero for month, day, and year.)
Month:_____ Day:_____ Year:_____

35.

When did you receive your third dose of the HPV vaccine? (If you have
not had your third dose yet, please add zero for month, day, and year.)
Month:_____ Day:_____ Year:_____

The following section will ask you questions about sexual relations.

36.

During the past 6 months or since your last visit, have you performed
vaginal, anal, or oral sex (your penis in partner's vagina, anus, or mouth or
your partner's penis in your anus or mouth)?
_____ Yes
_____ No (Thank you for your participation – please end the
questionnaire)
_____ Refuse

37.

During the past 6 months or since your last visit, have you performed
vaginal sex (your penis in partner’s vagina)?
_____ Yes
_____ No
_____ Never had vaginal sex (Skip to question 47)
_____ Refuse
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38.

How old were you when you first had vaginal sex?
_____ Years
_____ Refuse

39.

In your life, what is the number of women with whom you have had vaginal
sex?
_____ Women
_____ Refuse

40.

During the past 6 months or since your last visit, how many new female
sexual partners have you had?
_____ Women
_____ Refuse

41.

In the past 6 months, how many women have you had vaginal sex with?
_____ Women
_____ Refuse

42.

In the past 6 months, how many women have you had vaginal sex with for
the first time?
_____ Women
_____ Refuse

43.

In the past 6 months, how many times did you have vaginal sex?
_____ Times
_____ Refuse

44.

In the past 6 months, when you had vaginal sex, how often did you use a
condom?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ No vaginal sex in past 6 months
_____ Refuse
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45.

How long has it been since you had vaginal sex?
_____ Hours
_____ Days
_____ Weeks
_____ Months
_____ Years
_____ Refuse

46.

Did you use a condom the last time you had vaginal sex?
_____ Yes
_____ No
_____ Don’t remember
_____ Never used a condom with vaginal sex
_____ Refuse

47.

Have you ever had oral sex (your penis in your partner’s mouth or your
partner’s vagina in your mouth or your partner’s penis in your mouth)?
_____ Yes
_____ No (Skip to question 55)
_____ Refuse

48.

Did you perform oral sex on your partner in the past 6 months?
_____ Yes
_____ No (Skip to question 50)
_____ Refuse

49.

In the past 6 months, how many times did you perform oral sex on your
partner?
_____ Times
_____ Refuse

50.

How long has it been since you performed oral sex on your partner?
_____ Hours
_____ Days
_____ Weeks
_____ Months
_____ Years
_____ Refuse
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51.

Has a partner ever performed oral sex on you? (Your penis in your
partner’s mouth)
_____ Yes
_____ No (Skip to question 55)
_____ Refuse

52.

Did your partner perform oral sex on you in the past 6 months?
_____ Yes
_____ No (Skip to question 54)
_____ Refuse

53.

In the past 6 months, how many times did your partner perform oral sex
on you?
_____ Times
_____ Refuse

54.

How long has it been since your partner performed oral sex on you?
_____Hours
_____Days
_____Weeks
_____Months
_____Years
_____Refuse

55.

Have you ever performed insertive anal sex (your penis in partner’s
anus)?
_____ Yes
_____ No (Skip to question 61)
_____ Refuse

56.

Have you performed insertive anal sex in the past 6 months?
_____Yes
_____ No (Skip to question 59)
_____Refuse

57.

In the past 6 months, how many times did you perform insertive anal sex?
_____Times
_____Refuse
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58.

In the past 6 months, when you had insertive anal sex, how often did you
use condoms?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ Refuse

59.

How long has it been since you performed insertive anal sex?
_____ Hours
_____ Days
_____ Weeks
_____ Months
_____ Years
_____ Refuse

60.

Did you use a condom the last time you performed insertive anal sex?
_____ Yes
_____ No
_____ Don’t remember
_____ Refuse

61.

Have you ever had receptive anal sex (your partner’s penis in your anus)?
_____ Yes
_____ No (Skip to introduction to question 67)
_____ Refuse

62.

Have you had receptive anal sex in the past 6 months?
_____Yes
_____ No (Skip to question 65)
_____Refuse

63.

In the past 6 months, how many times did you have receptive anal sex?
_____Times
_____Refuse

64.

In the past 6 months, when you had receptive anal sex, how often did your
partner use condoms?
_____ Always
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_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ Refuse

65.

How long has it been since you had receptive anal sex?
_____ Hours
_____ Days
_____ Weeks
_____ Months
_____ Years
_____ Refuse

66.

Did your partner use a condom the last time you had receptive anal sex?
_____ Yes
_____ No
_____ Don’t remember
_____ Refuse

For the next few questions, we are going to ask you about steady partner(s), or
partner(s) you see regularly.

67.

Do you have a steady female sex partner?
_____ Yes
_____ No (Skip to introduction to question 75)
_____ Refuse

68.

The last time you had sex, was the partner a steady partner?
_____ Yes
_____ No
_____ Refuse

69.

How long have you been having sexual intercourse with your steady
partner?
_____ Days
_____ Weeks
_____ Months
_____ Years
_____ Refuse
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70.

In the past 3 months, when you had sexual intercourse with your steady
partner, how often did you use condoms?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ Have not had sex with steady partner in past 3 months
_____ Refuse

71.

The first time you had sex with your steady partner, did one of you use a
condom?
_____ Yes
_____ No
_____ Don’t remember
_____ Refuse

72.

In the past 3 months, did you have sex with someone other than your
steady partner?
_____ Yes
_____ No (Skip to introduction to question 75)
_____ Refuse

73.

How many people other than your steady partner have you had sex with in
the past 3 months?
_____ People
_____ Refuse

74.

In the past 3 months, when you had sexual intercourse with your other
partner(s), how often did you use condoms?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ Refuse
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The next questions we are going to ask are sensitive, and have to do with some
private sex practices. Your answers are private and used only for research
purposes.

75.

In the past 6 months or since your last visit, have you exchanged sex for
money or drugs?
_____ Yes
_____ No (Skip to introduction to question 83)
_____ Refuse

76.

In the past 6 months or since your last visit, have you paid a woman to
have sex (vaginal or anal or oral) with you?
_____ Yes
_____ No (Skip to introduction to question 83)
_____ Refuse

77.

In the past 6 months or since your last visit, what kind of sex did you pay
for? (Mark all that apply.)
_____ Vaginal sex (your penis in partner’s vagina)
_____ Oral sex (your penis in partner’s mouth or partner’s vagina in your
mouth)
_____ Anal sex, insertive (your penis in partner’s anus)
_____ Other
_____ Refuse

78.

In the past 3 months, have you paid a woman to have sex with you?
_____ Yes
_____ No (Skip to introduction to question 83)
_____ Refuse

79.

In the past 3 months, how many times have you paid a woman to have
sex with you?
_____ Times
_____Refuse

80.

In the past 3 months, when you paid for sex, was it: (Choose all that
apply)
_____ In the U.S.
_____ Outside the U.S.
_____ Refuse
251

81.

82.

In the past 3 months, what kind of sex did you pay for? (Choose all that
apply)
_____ Vaginal sex (your penis in partner’s vagina)
_____ Oral sex (your penis in partner’s mouth or partner’s vagina in your
mouth)
_____ Anal sex, insertive (your penis in partner’s anus)
_____ Other
_____ Refuse

In the past 3 months, when you paid for vaginal, oral, or anal sex, how
often did you use condoms?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ Refuse

We are now going to ask you additional sensitive questions. It is useful to
have this information because HPV infection may differ depending on the type
of sex. Your answers are strictly confidential and used only for research
purposes.

83.

In the past 6 months or since your last visit, have you had sex with a man
(your penis in partner's anus or mouth, or your partner's penis in your
anus or mouth)?
_____ Yes
_____ No (Thank you for your participation – please end the
questionnaire)
_____ Refuse

84.

In the past 6 months or since your last visit, have you performed oral sex
with a man (your penis in partner’s mouth or your partner’s penis in your
mouth)?
_____ Yes
_____ No
_____ Refuse
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85.

In the past 6 months or since your last visit, have you performed anal sex
with a man (your penis in partner’s anus or your partner’s penis in your
anus)?
_____ Yes
_____ No (Skip to question 90)
_____ Refuse (Skip to question 90)

86.

During the past 6 months or since your last visit, have you had a new male
sex partner?
_____ Yes
_____ No
_____ Refuse

87.

In your life, what is the number of men with whom you have had anal sex
(your penis in partner’s anus or partner’s penis in your anus)?
_____ Men
_____ Refuse

88.

In the past 3 months, how many men have you had anal sex with?
_____ Men
_____ Refuse

89.

In the past 3 months, how many men have you had anal sex with for the
first time?
_____ Men
_____ Refuse

90.

During the past 6 months or since your last visit, have you paid a man to
have sex (anal or oral) with you?
_____ Yes
_____ No (Thank you for your participation – please end the
questionnaire)
_____ Refuse

91.

In the past 3 months, have you paid a man to have sex with you?
_____ Yes
_____ No (Thank you for your participation – please end the
questionnaire)
_____ Refuse (Thank you for your participation – please end the
questionnaire)
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92.

In the past 3 months, how many times have you paid a man to have sex
with you?
_____ Times
_____ Refuse

93.

In the past 3 months, when you paid for sex with a man, was it: (Choose
all that apply)
_____ In the U.S.
_____ Outside the U.S.
_____ Refuse

94.

In the past 3 months, what kind of sex (with a man) did you pay for?
(Choose all that apply)
_____ Oral sex (your penis in partner’s mouth)
_____ Anal sex, insertive (your penis in partner’s anus)
_____ Other
_____ Refuse

95.

In the past 3 months, when you paid for anal or oral sex with a man, how
often did you use condoms?
_____ Always
_____ More than half the time
_____ Half the time
_____ Less than half the time
_____ Never
_____ Refuse

YOUR CONTRIBUTION IS VERY IMPORTANT TO OUR STUDY. YOU ARE
HELPING US TO PLAN FOR BETTER HEALTH CARE IN THE COMMUNITY.
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Appendix D
Supplemental Tables for Manuscript 2

Table D1: Test results for HPV and other STIs in study population by level of participation (i.e., attrition) a
TOTAL

Pre-Diagnosis
Only c

Pre-Diagnosis &
Post-Diagnosis c

N=3,052

n=701 (23.0%)

n=2,351 (77.0%)

n (%)

n (%)

n (%)

512 (16.8)

117 (22.9)

395 (77.2)

1,376 (45.1)

288 (20.9)

1,088 (79.1)

Positive for other STIs only

211 (6.9)

68 (32.2)

143 (67.8)

Negative for both HPV and other STIs

953 (31.2)

228 (23.9)

725 (76.1)

HPV and STI Test Results b

Positive for both HPV and other STIs
Positive for HPV only

P-value d

0.0030

Abbreviations: HPV=Human Papillomavirus; STI=Sexually Transmitted Infections
a
Percentages may not total to 100 due to rounding. Totals exclude unknown/refused values.
b
Other STIs include chlamydia, gonorrhea, herpes, and syphilis.
c
Pre-Diagnosis Only group includes men who received HPV & STI results (Baseline/Visit 1 to Visit 2) but
subsequently dropped out of the study. Pre-Diagnosis & Post-Diagnosis group includes men who received HPV &
STI results and subsequently returned to participate in the study (Baseline/Visit 1 to Visit 3).
d
Significant values in bold font. P-values <0.05 considered significant.
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Table D2: Baseline demographic and behavioral characteristics in study population by level of participation (i.e., attrition) a

n (%)

Pre-Diagnosis
Only b
n=701
(23.0%)
n (%)

Pre-Diagnosis &
Post-Diagnosis b
n=2,351
(77.0%)
n (%)

1,187 (38.9)
870 (28.5)
995 (32.6)

244 (20.6)
310 (35.6)
147 (14.8)

943 (79.4)
560 (64.4)
848 (85.2)

1,451 (47.5)
1,175 (38.5)
426 (14.0)

309 (21.3)
295 (25.1)
97 (22.8)

1,142 (78.7)
880 (74.9)
329 (77.2)

1,482 (49.1)
481 (15.9)
75 (2.5)
62 (2.1)
919 (30.4)

264 (17.8)
89 (18.5)
17 (22.7)
12 (19.4)
311 (33.8)

1,218 (82.2)
392 (81.5)
58 (77.3)
50 (80.7)
608 (66.2)

1,289 (42.5)
1,743 (57.5)

381 (29.6)
313 (18.0)

908 (70.4)
1,430 (82.0)

1,377 (45.1)
1,038 (34.0)
360 (11.8)
276 (9.1)

252 (18.3)
306 (29.5)
90 (25.0)
53 (19.2)

1,125 (81.7)
732 (70.5)
270 (75.0)
223 (80.8)

574 (18.8)
802 (26.3)
840 (27.5)
622 (20.4)
212 (7.0)

191 (33.3)
175 (21.8)
157 (18.7)
131 (21.1)
46 (21.7)

383 (66.7)
627 (78.9)
683 (81.3)
491 (78.9)
166 (78.3)

TOTAL
Characteristics

Country of Residence
Brazil
Mexico
United States
Age
18-30 years
31-44 years
45-70 years
Race
White
Black
Asian/ Pacific Islander
American Indian/ Alaskan
Mixed
Hispanic
Yes
No
Marital Status
Single
Married
Cohabitating
Divorced/ Separated/ Widowed
Educational Level
<12 years
12 years
13-15 years
16 years
≥17 years

N=3,052

P-value c

<.0001

0.0693

<.0001

<.0001

<.0001

<.0001
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Table D2 (Continued)
Sexual Orientation
0.6482
Heterosexual
2,692 (88.2)
624 (23.2)
2,068 (76.8)
Homosexual
136 (4.5)
27 (19.9)
109 (80.2)
Bisexual
224 (7.3)
50 (22.3)
174 (77.7)
Circumcision Status
<.0001
Yes
1,127 (36.9)
202 (17.9)
925 (82.1)
No
1,925 (63.1)
499 (25.9)
1,426 (74.1)
Smoking Status
<.0001
Yes
676 (22.2)
193 (28.6)
483 (71.5)
No
2,376 (77.9)
508 (21.4)
1,868 (78.6)
Number of Lifetime Sexual Partners
0.5975
1
239 (8.0)
55 (23.0)
184 (77.0)
2-9
1,282 (42.7)
311 (24.3)
971 (75.7)
10-19
630 (21.0)
146 (23.2)
484 (76.8)
20-49
602 (20.1)
130 (21.6)
472 (78.4)
≥50
250 (8.3)
51 (20.4)
199 (79.6)
a
Percentages may not total to 100 due to rounding. Totals exclude unknown/refused values.
b
Pre-Diagnosis Only group includes men who received HPV & STI results (Baseline/Visit 1 to Visit 2) but subsequently
dropped out of the study. Pre-Diagnosis & Post-Diagnosis group includes men who received HPV & STI results and
subsequently returned to participate in the study (Baseline/Visit 1 to Visit 3).
c
Significant values in bold font. P-values <0.05 considered significant.
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Table D3: Self-reported sexual behaviors among study participants at baseline by level of participation (i.e., attrition) a

n (%)

Pre-Diagnosis
Only b
n=701
(23.0%)
n (%)

Pre-Diagnosis &
Post-Diagnosis b
n=2,351
(77.0%)
n (%)

2,952 (96.7)
100 (3.3)

680 (23.0)
21 (21.0)

2,272 (77.0)
79 (79.0)

2,646 (86.7)
406 (13.3)

578 (21.8)
123 (30.3)

2,068 (78.2)
283 (69.7)

571 (16.7)
2,476 (81.3)

157 (27.5)
542 (21.9)

414 (72.5)
1,934 (78.1)

TOTAL
Behaviors

Vaginal sex in past 6 months
Yes
No
Oral sex in past 6 months
Yes
No
Paid for sex in past 6 months
Yes
No
Condom use for vaginal sex in recent past
No vaginal sex
Always
Sometimes
Never
Number of new sexual partners in past 6 months
0
1
2
3+

N=3,052

P-value c

0.6342

0.0002

0.0041

0.0333
100 (3.6)
300 (10.9)
2,136 (77.5)
220 (8.0)

21 (21.0)
55 (18.3)
508 (23.8)
64 (29.1)

79 (79.0)
245 (81.7)
1,628 (76.2)
156 (70.9)

1,868 (63.8)
697 (23.8)
182 (6.2)
181 (8.2)

431 (23.1)
157 (22.5)
45 (24.7)
37 (20.4)

1,437 (76.9)
540 (77.5)
137 (75.3)
144 (79.6)

0.7892

a

Percentages may not total to 100 due to rounding. Totals exclude unknown/refused values.
Pre-Diagnosis Only group includes men who received HPV & STI results (Baseline/Visit 1 to Visit 2) but subsequently dropped out of
the study. Pre-Diagnosis & Post-Diagnosis group includes men who received HPV & STI results and subsequently returned to participate
in the study (Baseline/Visit 1 to Visit 3).
c
Significant values in bold font. P-values <0.05 considered significant.
b
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Table D4. Change in self-reported sexual behaviors following HPV/STI testing and receipt of test results by HPV and/or
STI diagnosis a, b
POSITIVE FOR BOTH HPV AND OTHER STIs
Behaviors
Vaginal sex in
past 6 months
Oral sex in past
6 months
Paid for sex in
past 6 months
Condom use
for vaginal sex
in recent past
Number of new
sexual partners
in past 6
months

Behaviors
Vaginal sex in
past 6 months
Oral sex in past
6 months
Paid for sex in
past 6 months

Response
Categories
Yes
No
Yes
No
Yes
No
No vaginal sex
Always
Sometimes
Never
0
1
2
3+

Response
Categories
Yes
No
Yes
No
Yes
No

STUDY VISITS
Visit 1
n (%)
371 (94.4)
22 (5.6)
297 (89.2)
36 (10.8)
97 (30.0)
226 (70.0)
17 (5.0)
32 (9.3)
263 (76.7)
31 (9.0)
171 (61.7)
53 (19.1)
17 (6.1)
36 (13.0)

Visit 2
Visit 3
n (%)
n (%)
301 (76.6)
292 (74.3)
92 (23.4)
101 (25.7)
275 (82.6)
270 (81.1)
58 (17.4)
63 (18.9)
33 (10.2)
30 (9.3)
290 (89.8)
293 (90.7)
56 (16.3)
66 (19.2)
33 (9.6)
30 (8.8)
234 (68.2)
227 (66.2)
20 (5.8)
20 (5.8)
138 (49.8)
143 (51.6)
76 (27.4)
67 (24.2)
29 (10.5)
41 (14.8)
34 (12.3)
26 (9.4)
POSITIVE FOR HPV ONLY
STUDY VISITS

Visit 1
n (%)
1,042 (97.3)
29 (2.7)
848 (91.5)
79 (8.5)
163 (18.0)
742 (82.0)

Visit 2
n (%)
923 (86.2)
148 (13.8)
768 (82.9)
159 (17.2)
39 (4.3)
866 (95.7)
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Visit 3
n (%)
902 (84.2)
169 (15.8)
789 (85.1)
138 (14.9)
33 (3.7)
872 (96.4)

Change from
c
Visit 1 to Visit 2
McNemar
p-value
<.0001

Change from
c
Visit 2 to Visit 3
McNemar
p-value
0.2076

0.0005

0.4111

<.0001

0.5316

<.0001

0.6069

0.0282

0.3587

Change from
c
Visit 1 to Visit 2
McNemar
p-value
<.0001

Change from
c
Visit 2 to Visit 3
McNemar
p-value
0.0583

<.0001

0.0443

<.0001

0.3657

Table D4 (Continued)
Condom use for
vaginal sex in
recent past
Number of new
sexual partners
in past 6
months

Behaviors

No vaginal sex
Always
Sometimes
Never
0
1
2
3+

Response
Categories

25 (2.6)
101 (10.4)
761 (78.6)
81 (8.4)
485 (59.1)
209 (25.5)
68 (8.3)
59 (7.2)

<.0001

0.2596

0.0403

0.9861

Change from
c
Visit 1 to Visit 2
McNemar
p-value
<.0001

Change from
c
Visit 2 to Visit 3
McNemar
p-value
0.5316

0.3173

0.1655

<.0001

0.6547

0.0055

0.7915

0.1051

0.5814

97 (10.0)
111 (11.5)
98 (10.1)
76 (7.9)
694 (71.7)
708 (73.1)
79 (8.2)
73 (7.5)
446 (54.3)
445 (54.2)
219 (26.7)
222 (27.0)
91 (11.1)
85 (10.4)
65 (7.9)
69 (8.4)
POSITIVE FOR STIs ONLY
STUDY VISITS

Visit 1
Visit 2
Visit 3
n (%)
n (%)
n (%)
Vaginal sex in
Yes
134 (95.7)
103 (73.6)
100 (71.4)
past 6 months
No
6 (4.3)
37 (26.4)
40 (28.6)
Oral sex in past
Yes
90 (81.8)
86 (78.2)
81 (73.6)
6 months
No
20 (18.2)
24 (21.8)
29 (26.4)
Paid for sex in
Yes
28 (27.2)
10 (9.7)
11 (10.7)
past 6 months
No
75 (72.8)
93 (90.3)
92 (89.3)
No vaginal sex
5 (4.3)
20 (17.1)
24 (20.5)
Condom use for
Always
11 (9.4)
13 (11.)
8 (6.8)
vaginal sex in
Sometimes
95 (81.2)
75 (84.1)
77 (65.8)
recent past
Never
6 (5.1)
9 (7.7)
8 (6.8)
Number of new
0
69 (75.)
56 (60.9)
58 (63.0)
sexual partners
1
15 (16.3)
26 (28.3)
21 (22.8)
in past 6
2
2 (2.2)
6 (6.5)
10 (10.9)
months
3+
6 (6.5)
4 (4.4)
3 (3.3)
Abbreviations: STI=Sexually Transmitted Infections
a
Percentages may not total to 100 due to rounding. Analysis excludes unknown/refused values.
b
Other STIs include chlamydia, gonorrhea, herpes, and syphilis.
c
Significant values in bold font. P-values < 0.05 considered significant.
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Table D5. Adjusted estimates for sexual behaviors among study participants (full model) a
Vaginal sex in
past 6 months b

Covariates

Oral sex in
past 6 months

Paid sex in
past 6 months

AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
MODEL ESTIMATES BY STUDY PERIOD
PRE-DIAGNOSIS PERIOD:
Visit 2 compared to Visit 1/
Baseline
POST-DIAGNOSIS PERIOD:
Visit 3 compared to Visit 2

Condom use with
vaginal sex in
recent past c
AOR (95% CI)

# of new sexual
partners in past 6
months d
AOR (95% CI)

0.34 (0.27-0.41)

0.59 (0.48-0.72)

0.25 (0.20-0.32)

0.94 (0.71-1.24)

0.72 (0.61-0.84)

0.87 (0.70-1.08)

0.96 (0.77-1.20)

1.05 (0.81-1.37)

1.05 (0.79-1.39)

1.01 (0.89-1.20)

MODEL ESTIMATES ACROSS ALL THREE VISITS
e

HPV and STI Results
Positive for both HPV and
other STIs
Positive for HPV only
Positive for other STIs
Negative for HPV and other
STIs
Country of Residence
Brazil
Mexico
United States
Race
White
Black
Asian/ Pacific Islander
American Indian/ Alaskan
Mixed
Hispanic
Yes
No
Age
18-30 years
31-44 years
45-70 years

0.57 (0.29-1.12)
1.15 (0.69-1.90)
0.48 (0.19-1.21)
Referent

0.78 (0.41-1.47)
1.40 (0.88-2.21)
0.46 (0.20-1.08)
Referent

1.01 (0.60-1.70)
0.66 (0.42-1.03)
1.45 (0.71-2.94)
Referent

0.69 (0.39-1.24)
0.61 (0.40-0.92)
0.64 (0.28-1.43)
Referent

0.51 (0.31-0.83)
0.50 (0.34-0.72)
1.43 (0.70-2.96)
Referent

5.28 (2.62-10.67)
2.35 (0.74-7.45)
Referent

1.82 (0.94-3.54)
0.70 (0.23-2.13)
Referent

6.25 (3.56-10.96)
2.21 (0.76-6.42)
Referent

2.91 (1.60-5.29)
0.67 (0.25-1.78)
Referent

0.60 (0.36-1.00)
2.68 (1.15-6.28)
Referent

Referent
0.57 (0.31-1.05)
0.25 (0.07-0.86)
1.09 (0.21-5.75)
0.67 (0.24-1.87)

Referent
0.62 (0.35-1.09)
0.59 (0.17-2.09)
0.82 (0.21-3.14)
0.84 (0.31-2.28)

Referent
1.32 (0.86-2.02)
1.12 (0.33-3.83)
1.49 (0.57-3.88)
1.51 (0.58-3.92)

Referent
1.16 (0.70-1.93)
16.05 (0.94-274.13)
0.57 (0.19-1.76)
1.79 (0.75-4.30)

Referent
0.51 (0.33-0.78)
0.55 (0.21-1.44)
0.67 (0.24-1.93)
0.47 (0.22-0.99)

0.98 (0.51-1.86)
Referent

1.49 (0.80-2.76)
Referent

0.65 (0.41-1.04)
Referent

1.07 (0.62-1.84)
Referent

0.95 (0.61-1.49)
Referent

12.63 (6.03-26.44)
4.52 (2.42-8.43)
Referent

20.06 (10.27-39.19)
10.73 (6.04-19.06)
Referent

0.61 (0.34-1.08)
0.86 (0.52-1.43)
Referent

1.43 (0.78-2.61)
1.19 (0.70-2.00)
Referent

0.12 (0.07-0.22)
0.27 (0.16-0.45)
Referent
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Table D5 (Continued)
Marital Status
0.16 (0.08-0.29)
2.13 (1.34-3.38)
0.10 (0.06-0.16)
Single
1.70 (0.97-2.96)
1.19 (0.72-1.96)
Married
Referent
Referent
Referent
Referent
Referent
0.39 (0.23-0.67)
Cohabitating
1.11 (0.48-2.58)
1.46 (0.76-2.82)
0.75 (0.42-1.32)
0.61 (0.35-1.05)
0.15 (0.07-0.32)
0.18 (0.10-0.33)
1.68 (0.82-3.45)
0.94 (0.51-1.74)
0.80 (0.43-1.50)
Divorced/ Separated/
Widowed
Educational Level
0.11 (0.05-0.27)
0.45 (0.21-0.98)
<12 years
0.98 (0.38-2.50)
0.61 (0.29-1.25)
0.55 (0.27-1.13)
12 years
1.19 (0.50-2.83)
0.59 (0.25-1.39)
0.60 (0.31-1.18)
0.78 (0.37-1.65)
0.71 (0.36-1.38)
0.49 (0.25-0.96)
13-15 years
2.04 (0.87-4.79)
1.05 (0.45-2.47)
0.67 (0.34-1.33)
1.13 (0.53-2.38)
16 years
1.85 (0.77-4.46)
1.18 (0.50-2.80)
0.69 (0.35-1.35)
1.40 (0.65-3.01)
0.94 (0.48-1.86)
≥17 years
Referent
Referent
Referent
Referent
Referent
Sexual Orientation
Heterosexual
Referent
Referent
Referent
Referent
Referent
b
b
46.08 (6.76-314.12)
0.22 (0.11-0.44)
Homosexual
1.87 (0.93-3.75)
0.04 (0.02-0.09)
9.87 (3.65-26.68)
2.68 (1.60-4.51)
0.23 (0.13-0.40)
1.21 (0.55-2.62)
Bisexual
Circumcision Status
1.60 (1.05-2.44)
Yes
1.19 (0.67-2.11)
1.30 (0.76-2.22)
0.76 (0.48-1.21)
1.11 (0.68-1.79)
No
Referent
Referent
Referent
Referent
Referent
Smoking Status
Yes
0.78 (0.47-1.32)
1.27 (0.77-2.10)
1.18 (0.79-1.78)
1.04 (0.67-1.59)
0.89 (0.61-1.30)
No
Referent
Referent
Referent
Referent
Referent
# of Lifetime Partners
1
Referent
Referent
Referent
Referent
Referent
2-9
1.90 (0.94-3.87)
1.42 (0.73-2.78)
1.60 (0.75-3.39)
1.67 (0.89-3.12)
1.07 (0.60-1.88)
3.14 (1.39-7.11)
2.93 (1.34-6.41)
3.50 (1.61-7.59)
0.38 (0.20-0.71)
10-19
1.31 (0.66-2.62)
5.82 (2.48-13.68)
5.79 (2.52-13.30)
4.70 (2.17-10.19)
0.19 (0.10-0.37)
0.99 (0.50-2.00)
20-49
5.21 (1.85-14.65)
6.90 (2.44-19.50)
8.67 (3.74-20.09)
0.09 (0.04-0.19)
≥50
0.90 (0.38-2.12)
Abbreviations: AOR=Adjusted Odds Ratio; CI=Confidence Interval; HPV=Human Papillomavirus; STI=Sexually Transmitted Infections
a
Significant values in bold font.
b
Men categorized as homosexual men were excluded from analysis for vaginal sex due to plausibility of behavior.
c
Modeling any condom use (sometimes and always) vs. never using condoms during last six months. Men reporting no vaginal sex during last
six months were excluded from analysis.
d
Modeling zero new sexual partners during last six months vs. 1, 2, or 3+ new sexual partners.
e
Other STIs include chlamydia, gonorrhea, herpes, and syphilis.
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Table D6: Visit x HPV/STI diagnosis interaction for sexual behaviors among study participants a, b
Interaction

Visit 1
Positive for
HPV & STIs
Positive for
HPV only
Positive for
other STIs
Negative for
HPV & STIs
Visit 2
Positive for
HPV & STIs
Positive for
HPV only
Positive for
other STIs
Negative for
HPV & STIs
Visit 3
Positive for
HPV & STIs
Positive for
HPV only
Positive for
other STIs
Negative for
HPV & STIs

Vaginal sex in
past 6 months c

Oral sex in
past 6 months

Paid sex in
past 6 months

(F=0.23, p=0.9658)

(F=1.19, p=0.3101)

(F=0.89, p=0.4995)

Estimate

t-Value

P-value

Estimate

t-Value

P-value

Estimate

t-Value

-0.5909

-1.54

0.1242

-0.05597

-0.16

0.8745

-0.0301

0.0582

0.18

0.8556

0.5336

2.05

0.0409

-0.6705

-1.29

0.1961

-0.7124

-1.48

0.1388

Condom use with vaginal sex # of new sexual partners in
in recent past d
past 6 months e
(F=0.49, p=0.8142)

(F=0.53, p=0.7891)

P-value Estimate t-Value

P-value Estimate t-Value

P-value

-0.11

0.9142

-0.6404

-1.86

0.0629

-0.6280

-2.28

0.0225

-0.2563

-1.10

0.2708

-0.5925

-2.30

0.0217

-0.6925

-3.36

0.0008

0.2326

0.61

0.5439

-0.3343

-0.66

0.5078

0.5990

1.48

0.1379

Referent Referent Referent

Referent

-0.4659

-1.23

0.2188

-0.2871

-0.81

0.4163

0.2276

0.66

0.5104

-0.1804

-0.51

0.6085

-0.7730

-2.80

0.0050

0.2315

0.82

0.4128

0.1358

0.53

0.5971

-0.2695

-0.88

0.3767

-0.4339

-1.70

0.0883

-0.7263

-3.51

0.0005

-0.7201

-1.40

0.1605

-0.6325

-1.30

0.1937

0.5547

1.19

0.2347

-0.4304

-0.87

0.3830

0.1752

0.44

0.6614

Referent Referent

Referent

Referent Referent Referent Referent Referent Referent Referent Referent

Referent Referent Referent

Referent

-0.6502

-1.73

0.0840

-0.3998

-1.12

0.2607

-0.1823

-0.53

0.5948

-0.2771

-0.77

0.4405

-0.6502

-2.37

0.0179

0.1215

0.43

0.6659

0.3312

1.27

0.2039

-0.7191

-2.39

0.0170

-0.4777

-1.84

0.0664

-0.6759

-3.28

0.0010

-0.8218

-1.61

0.1084

-0.9867

-2.02

0.0438

0.3253

0.70

0.4829

-0.5927

-1.18

0.2387

0.3056

0.77

0.4438

Referent Referent Referent

Referent

Referent Referent

Referent Referent

Referent

Referent

Referent Referent Referent Referent Referent Referent Referent Referent

Referent Referent Referent Referent Referent Referent Referent Referent

Abbreviations: HPV=Human Papillomavirus; STI=Sexually Transmitted Infections
a
Significant values in bold font. P-values <0.05 considered significant.
b
Model is adjusted for the following variables: country of residence, race, ethnicity/Hispanic, age, marital status, educational level, sexual orientation, circumcision status, smoking status, and
number of lifetime sexual partners.
c
Men categorized as homosexual men were excluded from analysis for vaginal sex due to plausibility of behavior.
d
Modeling any condom use (sometimes/always) vs. never using condoms during last 6 months. Men reporting no vaginal sex during last 6 months were excluded.
e
Modeling zero new sexual partners during last six months vs. 1, 2, or 3+ new sexual partners.
f
Other STIs include chlamydia, gonorrhea, herpes, and syphilis.
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